-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S+e+dyEVkMSxESnM8nyk3TOb2qbZwqR3WMGrm6/KsuUiCUglKiAYy6SfLAYJaDb6 +2V6BLFkEXkeMjXUIaZTLg== 0000897101-09-001829.txt : 20090909 0000897101-09-001829.hdr.sgml : 20090909 20090909165502 ACCESSION NUMBER: 0000897101-09-001829 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20090731 FILED AS OF DATE: 20090909 DATE AS OF CHANGE: 20090909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 091060978 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 10-Q/A 1 medtronic093906s1_10-qa.htm AMENDMENT TO FORM 10-Q FOR QUARTERLY PERIOD ENDED JULY 31, 2009 Medtronic, Inc. Form 10-Q for quarter ended 7-31-2009

 

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q/A
(Amendment No. 1)

 

 

x

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2009

 

 

Commission File Number 1-7707

(MEDTRONIC LOGO)

MEDTRONIC, INC.

(Exact name of registrant as specified in its charter)


 

 

 

 

 

 

Minnesota

 

41-0793183

 

 

(State of incorporation)

 

(I.R.S. Employer

 

 

 

 

Identification No.)

 

710 Medtronic Parkway
Minneapolis, Minnesota 55432
(Address of principal executive offices) (Zip Code)

(763) 514-4000
(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.      Yes   x      No   o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data Filing required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes       No   o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

 

Large accelerated filer   x

Accelerated filer   o

 

Non-accelerated filer   o

Smaller Reporting Company   o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes   o     No   x

Shares of common stock, $.10 par value, outstanding on September 3, 2009: 1,106,803,531

 

 
 

Explanatory Note

      The sole purpose of this Amendment No. 1 to our Quarterly Report on Form 10-Q for the period ended July 31, 2009, as filed with the Securities and Exchange Commission on September 9, 2009, is to furnish Exhibit 101 which was previously furnished as Exhibit 100 to the Form 10-Q, and to amend the Exhibit Index referenced in Part II, Item 6 of the report accordingly.

      No other changes have been made to the Form 10-Q other than those described above. This Amendment No. 1 does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or update in any way disclosures made in the Form 10-Q.








2




Item 6. Exhibits

 

 

 

(a)

Exhibits

 

 

 

 

10.1*

Form of Amended and Restated Change of Control Employment Agreement for Medtronic Executive Officers.

 

 

 

 

12.1*

Medtronic, Inc. Computation of Ratio of Earnings to Fixed Charges.

 

 

 

 

31.1*

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

31.2*

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.1*

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.2*

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

101.INS**

XBRL Instance Document

 

 

 

 

101.SCH**

XBRL Schema Document

 

 

 

 

101.CAL**

XBRL Calculation Linkbase Document

 

 

 

 

101.DEF**

XBRL Definition Linkbase Document

 

 

 

 

101.LAB**

XBRL Label Linkbase Document

 

 

 

 

101.PRE**

XBRL Presentation Linkbase Document


 

 

 

 

 

*

Previously filed or furnished, as applicable, with our Form 10-Q as filed on September 9, 2009

 

**

Furnished with this Form 10-Q/A





3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Medtronic, Inc.

 

(Registrant)

 

 

Date: September 9, 2009

/s/ William A. Hawkins

 

William A. Hawkins

 

Chairman and Chief Executive Officer

 

 

Date: September 9, 2009

/s/ Gary L. Ellis

 

Gary L. Ellis

 

Senior Vice President and

 

Chief Financial Officer






4


GRAPHIC 2 img001.jpg GRAPHIC begin 644 img001.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`, M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8 M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\? M'Q\?'Q\?'Q\?_\``$0@`?P#?`P$1``(1`0,1`?_$`+<``0`"`P$!`0`````` M```````'"`,%!@0"`0$!``(#`0````````````````0%`@,&`1```0,$`0(# M!04$!`@/`````0(#!``1!082(0:EJ(2!]M M91BY.B56>-TULC>=WZP+\US'ZEBLAMK)MQCNH<]L^C M9K!;AKF.WK*R]DT&3),6&MQ]Y/HNK`#0E<1X\C9/Q]4@]18BM]G,QG:E*U%0 MNTKV=!'NY=J<8S=85U:::N&PL3C<7C<7$1"QL5F%$;_!'CH2V@?8E(`J@E-R M=6ZLMHQ2U)4*H?43N#&6[C^C"9;<;UYL1'75H#@<="RIP+"@04(4KA8CQO[: MZKE.7PV:M^O3]2FSEY2N:OX26_IWP.JJUIO:L>VTC.3FUQ!``JHYKY@E7#'97363NOCIUD*=B5OS6NU'I5/&Z%<-'S'<7`8;.[3IF/:F=OOGI+\;$S2I+Z8[:KN/1K!%D6N/%5N)^$D M7/0YB%F;C;NMJ[15?@]-Y56IW(1R>7I%`2D<^8ZJ5R)M;K43+9AV9.U@KMB\-<3T[#;.VYQ5Q2IOU[%H]YE M/<7NOJT-C+[-`QNQ:LH@/YC`K4M3:"?[4WLE21^XD>14*]_$L77AMN49\)#\ MFY!)M*4.,=/T(!PN33)[FJD,/ES'Y3(N)E%84$R( M'+I-:XQ5.AD!:[FK8Y>))/8;.C&]X\_@8=F\3DG)B68R04H2J,ZI;)2GK;BW MR35=S2UBR\)OU*GQ1+RDJ76N-2S=YF`:M"=<3'VW'H! M"76'5`?,!(L.85XG]5CYJO:Y2Y[T'8EMVQ?3P*_,1=N:N1V;UII6G22S#F1I ML-B9%<#L:2VEYAU/@I"P%)4/M!JKE%IT9/3355L,U>'HH!0"@%`*`4`H!0"@ M%`*`4`H!0"@%`*`CCOSEID?24X:`HIR&RRV,1'M>]I"OXGAY*2G@?WJL.6P3 MNXGL@L7<0\]-J%([9.FGR[3M,-KV.Q6N1-?90%0(L9,3B0!S0$<%%5O-?4J] MYJ'.ZY3<][=23&VE'#NH0U`:UW5U,]M>Y,),C`-2U2=5S+P/RRD+4HI;>6DC M@M!<4#?X>O7X;$VTG.[_`'K+I.GF6_KZ40(N-O\`MW/2M:;TTZJ5V,S7\UVQ MR+V:T^"O-Z%D&_4RF!;<+JHY('\>/RY%2"GQ\>E[]+%.$;DA MB5MV6Y158/:M-./$B;/C5'.[FN9C5`S_`"3./PGTQ`E*$L.K>##[*VK@((*> M1%[?%T/&K:S[CR\X7/5&ORJB++"KB-K>%C]E,VJY+_+'P/;+_OUZ7XENJY(NQ0'ERV+A97&2L9-;#L2:TMA] ML^:'$E)_QUE";BTUM1C.*DFF1AV;VF-A-%RV,V.:AC^Y4B9 M`?OZ;[=[$I/$@@@$$$>!%5]RW*$L,E1DV$U)53J>^L#(4`H!0"@%`*`4`H!0 M"@%`*`4`H!0&LV?-HP6N9/-+1ZJ<=%>D^E>W,M(*@B_ER(M6RS;*AA+;+#3AN@(Y<@%%-NO&_O/C5O4U+=NV,897 M2I\C,:S%7ZD_6)=G5H9\5JCN6Y"WC9('M^+K7L+UO,O#<2C-[)+CTF,[=RRJ MP>*/!Z:;=9"3N7P>P=[,9/U^"G'8V7EX/R[`'`E1>;"EJ2"I*2M=S9/0?M-W M[4K>4<9.K4)?)D)34KR:5%B1\SL'DLQW8V-IC%*S2H$V<])QK#I9==:8?+1] M)8NKF"0JR03[J6[D;>6A66&J6O;M51.-;DM6+6]1*>BZS!S<5R5VXW3+8#*P MRKYW7\FI,A+*[VXK8/$%/+\Y"_N/2JO,W7!TO6XRCNDM7Q\-1*M6\7[^6LN#^?:U&V:#X?-X12P\/M:(4I1\[!L#WU%5C+7/3-P?\WU-ON7 MX>J*EU:>!D_W]LQ!RS6G;#C$6)+CD,E`MUZE9:-ONH^65]-R$NTR_,IZHR1& M#,'*]P^X>=@8!A].FYV=!FY>6^TXSQ1%;NM'4]%K6M5@#U(!Z"K*4XV+,92? M]R*DE2CV_0@M.[GQ*`.@3 M>XJJYG3W%QP1KUD_)>E_U,E"JXF"@%`*`4`H!0"@%`*`4`H!0"@%`*`\&?P\ M?-8/(8>2I26,A'=C.K3^)*74%!(]XO>L[VN) MQ>J2,3`FQW9"<9@\XMXAI2G"0TEU`4%)XW_-QZ#S\:NO8R^9E*XI.+IBE&G? M0KE.[96%I-;GI^AOSM?>G3742-LQ;.SX5X7>D81"C(BGQ/)OBWR2/W;>U8\* MCJQEKVJW)PEPEL?:;\=Z'J6)=!E3]2>ENDMQ,5F94F_%$=J(@K4JU[?VOL-Z MQ_XJYO<%VC\^'!A?<+O-F0'=:T40XH`)=S+P:6L$];-%<=2>GGUHLMEH>NY5 M_P`J\3SW[TGY8473HB%=VP>RL;GD5NV_:4(RQPKA=534TZ+OH5]U2C.K6&3UI=._Q9U/;+(: M_"[F:YFI>0;1.S>(<=R;SB!'97+<)3R2HJ4DJ64*2L].3B5&PY6J)FU.5B<4 MM49T6_5ILZ*$C+2BKBDWZE\:Z::B5.Y_;>7D5M;5J)3C]VQA]5B0V`CYI`%E M,O?E5=/0%7[IZ'I5Y3-J*]NYKMR^'2B7F;#?GAZU\3BM'[H=ZIT&1*7B(>Q" M`_\`+Y/'-$P\E&6+_C0H)0>5NG!*OV$";F,GE8NF)QJM3VQ9&M9J\U5)2IMX MZ=ATR>Y_=6>@HQ7;:4V]U^.=*0P@>'DXAGEX_JJ,LG87JNKL39O]^Z]D.\T> MO]PN_6PS(_AI5X=.-S;I1NJW=3?I>I]3(N;LXX46 MU:S:=O-NC;;I^-SC)'J2&@F6V+71(;^%Y%A_3!(]HL?.M>:L.U<<'N-MBYC@ MF=%6@VB@*T_5.N5CMOUW+0WRU*$1Q""DCDGTG;W(]BO5(Z]#X5TG(TI0G%[* MHJ\^W&<9(S=C]*A]P<7F,ON,=NL>99AY>48VG3^)ZV^A?+8>Y6"NIN>O=X^)V&L-9?0^Z.-T=.7E9/6LO!>? MQ[$[BM<=QGDK@AWH2`AH_"+#KX>=0KN&]9=W"HSBU6F^O09VHNU<4$ZQ:/9B M>..^HO,QDI2PSF,&U+XCIZKS3J&PH6\^*5_X*QFL63B]\9M=^LV1BE??3'Q. MWWC:HFJZID<[)(M#:)9;/YWE?"TCR_$L@5"R]EW9J"WDB]=4(N3.?[):U+PF MA1G70=?3";CVWK?S"ZIW7A],?*NI&G)VW&WKVO7I MV'>U")0H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`4!"\SUNT6[/Y)#:CV]V5[E M+0VFZ]R])]-.XL\K##;1I^]>-RZ M6*<#N+1)^3FR00FT2:DI/J>STOXEP?!72MV4LR:N6'ZMJZX_4UYBXJPN+9LT M^)\!YWN_NC7I)6.W>M2.:G%"R,C-0?A`N.K8'^2>MBH6]:_%M.O[T_\`M7U, M6OR)_P#SC\=/EUDT53ED*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@%`*`\V2QL M#)P'\?D&$284E!;?8<%TJ2?$$5E";BTTZ-&,HJ2H]A$O]W.X/:YYUW4VU[/I M9)<2H>*;K/IJ/N2J]1K_`"^[;56JQXK6C?;S M=N3I6CZ2!.[."1([_P`>.DA<;.2L:MI2?PE+WIL*(((O\:%>!J^R-W_9M_:I M?4K[\$[ZX2H6HP\)O&86#!N$MPHS3%R>@#2`CQ)/L]MF0@E"2?"RU"I=C(7KCJE1<7J1HNYFW'4 MW4BWMP<9)5N>F[3#5@-6R#(R\''SG4MJALN.6Y!2P`V0>"DA0Z$>=66;;7MW M+;Q36IM+:U\_H0LO3S0GY4]>OK_P--)V'+:RRWK/;[?I.=*;I@XF#BVGRFZB MJWS)Y`BYN5(O]E;HV8W&YWK6'BW)KX&,KCM^6W+%V>/T+':HYGG-:QB]@0EO M-JC-G((3QL'N/Q?@^&]_'CTOX5SU[#C>#TUU%I;Q85BVFUK69B@%`*`4`H!0 M"@%`*`4`H!0"@%`*`4`H!0"@%`:'8M#TW8[JS>'C37;GMU#U7<83&I8J:(B8SPV7;O&]LMGD-0=L8SC6:*DM>@^](?C. MJY`=%-M!QKXB199L/U7K1FIWK57!P<>A*J/& M\`0)`27'['Q'K.%;EOZU45[-7+GJDWIP+2%F$-B/+MG:W1MLR,?(Y[&B7+C( M#2'`XZU=`45!*_34CD`2;7K*QG;MI.,'1,\N9>$W62-[B<%A,.QZ&)@1X#)M M=N,TAH&PM7+$X>J+76J&49QEL=3X MS&[:AA)8AY?,P\?*4@.!B0\AM90HD!5E$="4FENQ6S'=0XL-@I!40DGI=:165S+7(*LHM(\A>C)T3J;JM!L% M`*`4`H!0"@%`*`\V2R>/QD)V=D9+<2$P`7I#R@AM`)"1R4KH.I`K*,7)T2JS MQR256<\.ZW;4_P#N?&]?^\M^[W^^I'X-_P"R7<:OR+?W(ZAIUMUI#K2@MMQ( M4A:3<%*A<$'WU%:H;CZH!0$%?5#MV;PD?7XF'R4K'/R5R77UQ'G&%*0V&TI" ME-J3<76>E7G)_/[GWEG?I_W=_,=MW9&8FN29>'>?;F2I#BGGBU;UTK6I5U&R5E(\ M?PURW-S)J,4TN"W&VQ?GC56]I-*@OJCSM@QL5]!LIIZ8PVL$>U*E@UNAE[DE6,9/L9K=Z"=&U7K-I"GP M9S`D09+4J.K\+S"TN(/V*22*U--;3.,D]AF6M*$E:R$H2"5*)L`!XDFO$JGK M9J(VYZ?*G"!&SN/?G%7$1&Y;"W2KPMZ:5E5_NK=++W$JN,J=3-<;L):DT^TJ M?]1W_P!M97_11?\`9T5U/)OV%ULI\[^ZSJ_I.=::S>Q.NK2VVB&TI:U$)2`' M#;?:_EK">;2@M-PZ[TNDFMW)(M6 M75?Q>"-7,'Y^P]7TK/--=PL@IU:6TG$O`%1`%S*C6'6O.>+^ROZO!CE[\[ZO M%%JOFXO#U/6;X7X\N0MR'E>_C7*-%S4)EQ%J"4/-J4?!(4"3^V@/UZ3&8*`\ MZAHN'BV%J">2O8F_B:]2/&Q)E1HK*GY+J&&$?C=<4$(%S;JI5A1*H;H:5ON! MH;CX8;V3%K?)XAI,V.5E7LXA=[UN>5NTKAE3J9K]Z'W+O-ZA:%H2M"@I"A=* MDFX(/F"*T&U.IC-H_6I,=X$M.H<`\>"@JU M^OE1IK:$TS7PMIUB=.5`A9>%*G(OSB,R6G'1;J;MI45?LK.5F:57%I=1BKD6 MZ5534=U-?G[#H&7PV/+8F2VVTLEY0;1=+R%FZCX=$UMR=U6[L9/8F89B#G!I M%9O_`,Y]P[`A>.-_"TQ'7I?ITKIO^8L_S=Q5_@SXHMSB([D;$PHSA!<88:;6 M4FXNA`2;'[JY*T:SBE\,IEX4!=K\94AIDV^Q:D^VLH69R]*;ZD M82NQ6UH\[&\:5(0MQC8,:ZVVE3CBT3&%!*$"ZE$A?0)'B:R>7N)T<9=S,5?A M]R[RMGU59#U^X$*&E5T0\-=)R.%+3?&15Y^59TX(AH-N M*0I:4DH1;FH`V%_"YJYJMA".UT3?%:[JVXXD*(7G(+;4:QM_$#OI+`/6W\!] MQ7]6H.;RGN7+7(XHM<4>IT=29N_O>/)Y/,R-7P,MD.>FE;O'GZ:.BKJL1?R%QUJQS?,+=AI2K5\"/:R\ M[FPUVM;3M&B;(J1`<7$G1'2S.AJ)X.>FHA;+R!T(N"/=Y5G>L6\Q;H]CUI^) MC"9_9&H&'P;ZF,0]$9DY)*%64X\^D+]!PCQ2T"+CS5X^`JMY M9RY0K*:K).B[-Y)S6:QT2V$>Z9VXW+@F2B%Q]9U3C;*4J5OLK;9A!1\GI>OO,)5KK)+[$8N=EM.F893$9KDE')Q94E*> M2RE(N3YFJSFLU&5J3V*9-R<6XS2X?4CS:=0V+5,DG&9^)\G.4TE]+7J-._PU MDI2KDTIQ/BD^=65C,0NK%!U1$N6I0=)'[JFF[)MN1HT[=I4`("N3*G$_B;4+7O5=8S$+N:Q0=5[?_D2KEJ4+-)?=X'`:=L:];V6 M!G4,A]R`LNMLDV"E\"$@GV7/6K',6?<@X<2+:N8)8C]F[?F\GLK6P9>0N?-1 M(1(5ZBK#X%A80@=0A/2P`%A7D,M"$,$514#NMRQ/6S+N6\[)M^4)4 M2Q&!(892?!+3=[)%OO/G7F6RL+,:17:+EV4W63/7E^U^\8C66-FR.,4QB)'I ME+Q4@K2'?[,N-@E:`KI^(>8]M86\]:G<]M/S'LK,U'$UJ/9VT[K;%I&586P^ MY(PI6!-Q:E%3:FR?B+:2;($N)G8S$K;Z#=_4?+CS.XH MF1EAR/)Q\1YEP>"D+05)/W@UHY.FK-']S-V?=9KJ.6TY6[R<;FL-J\5^0F!%2VJF!9J9M>2V?Z8I(KCOG?I][M-Q4R?Y&5A0!]) M,B.7`%>U'J7^VJ])[8A6$^A?KX$95:D4DWM7I_\UTKN!EEH*OD\5Z4>XZ%85\TO MC[T_*I_XU5>?S&&[:CQE^GB2K-I2A.3W+]?`C*K0BA2E*45*)4I1N2>I)-$J M`EOM7@N]&2UMQW2LLB)BFY*T.L>LALA_BDJ*DE*CU24U3YV[EHW*78UE0GY: M-UQ\CHJF3(_3KW=R,Z1/G?*/S)*U.R'UR4\EK4;J4;)\S2'-LO%)*J2Z`\A< M;JVB--FUS):YF7L1D0CYI@-J*FE>HVI+K:7$*0L=%`I6.HJSL7HW(XH["'Q?NQ>[#XLM.7R M6%K?4K_W$FPYV^[%,A*2Y%?R,IQEQ-N*TJ>4>8MY*\:Z#)1<;,4]N%%9=DI2 M;6QLE7Z3'V$[-G&%.)#SL-M3;9("E!#OQ$#SMR%ZJN?>B/63N7/6T:3ZGY<= M_N:$-+"U1H##3P'7BODXOB?ZJQ6[DD6K+Z9/P-6?DG+^ROZE\F>\O?]SL)$^K'_`-$8G_S- M/^SNU7?]/BB7S#T+K^I771]>1L>WXC!N.%IJ?)0T\X/$-WNOC[^(-O?7 M1YJ[[=N4EN14V[;G)16\LSWNU3%X3LK.Q^!AMPX4-<0N-M('):$OH3=:C=2E MZC M#\?(:^S(!#S>OXM*TGH4D1Q\)_=\*@Y!UC)_SR^9)S/\/]")-^D8?]?V8_\` M-1.O]9WW?\-5O/MD.WP)/+MK($R'_;Y/^E7_`,HU>6O0NHKF3KKLJ,KZ6/AUJBS"?YT>SY%C&2>6:6[ZD!UT)6G7]V8TEC>9GS% M[NL0W&U$<06U0VBFUO$`?#?W5"Y?).TJ<7\V2S33XEUER8Z&0 M^MU"6"`0Z5`(LKP/+PZUQ="_66EUM:6.:/3XOJ"E!-F4I4>7@#7,9K1ZJ4TZRWRD%[3Z:UTZBJ?R3W MZFO]KC]>)O5J,H)Q:KO532:HGN+&E24ZC_ M`#-3R+"7_)R\ZFWY>9C)'B;7 M`ZD579?/3E-J<)1CN\K^)*NY>*2:DF]^M$>8T9$SFAC?5^=)(9^7Y!R]C?CQ MZ^%[^ZK*>&GFV$55KJ-Z[I&;9XGI^$]:JX3C^75?\`KX/[B4J>QJ^[ MP-?V9B.I[HZXHJ;L)0)LZV3^!7D%7K;S&XG8EMV<&>Y3]Q%R-CCX23@9\?.+ M:;Q#S*VYKCZTMMI;6+$J6H@)M?H?(UQ]ER4TX^K<75Q)Q:>PI=OF@0M?F/.X M?/XS.8BY4R[&G15R$IO\*7&$N%=GE7L]M56=SEQ1I:C)M[\+U?`E6+$9.LFDNM:]-.)[?J4C*<[F+4T6PW M\E&XW<;3TL;6!4*PY/-*QOVO1026HEN*T+/XG?TE M51>>RJH;=^Y]!LY6\8S4Z+\Q'<425M*:+@ M40%7X\;]/&IO+\TW;C&<9)I;<+H^!%OVE&6IIKK1'OR3WZFO]YBA9+N_HNH;!A,1(.?QF'VR)CXZ4,3I;+`D,<+I2 MH*5<&]^"[6\CTZCG.7YF[;F_+*5MM[$]1:YNU&=&FE+ITT^5<,EC)&.DF.^X MPXL$CG&D,R4&WL6PMQ/[:Z2$U)55>U-?,JFJ'REJ:Y'`NH1DA2D\U<6[IN3Q 0Y$)*O'H.IKQRBGT_$'__V3\_ ` end EX-101.INS 3 mdt-20090731.xml 0000064670 2008-04-26 2008-07-25 0000064670 2009-07-31 0000064670 2008-07-25 0000064670 2009-04-25 2009-07-31 0000064670 2009-04-24 0000064670 2008-04-26 2009-04-24 0000064670 2008-10-24 0000064670 2009-09-03 0000064670 2008-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Medtronic, Inc. 0000064670 --04-30 2009-07-31 10-Q Yes No Yes false Large Accelerated Filer 42400000000 1106803531 3706000000 966000000 855000000 370000000 324000000 1368000000 1318000000 62000000 96000000 -96000000 -151000000 66000000 47000000 3372000000 2791000000 561000000 915000000 116000000 192000000 445000000 723000000 0.205 0.188 0.40 0.64 0.40 0.64 1112600000 1125200000 1114600000 1131700000 3933000000 444000000 0 1022000000 522000000 1492000000 600000000 535000000 7284000000 5057000000 2724000000 2333000000 8226000000 2408000000 3037000000 286000000 23574000000 658000000 373000000 123000000 1316000000 3132000000 6307000000 351000000 485000000 93000000 10430000000 - 0 111000000 13243000000 -210000000 13144000000 23574000000 63000000 61000000 1271000000 405000000 3123000000 1426000000 605000000 622000000 7452000000 4887000000 2608000000 2279000000 8195000000 2477000000 2769000000 416000000 23588000000 522000000 382000000 130000000 1212000000 3147000000 6253000000 329000000 475000000 87000000 10406000000 0 112000000 13272000000 -202000000 13182000000 23588000000 - 662000000 901000000 62000000 115000000 1.00 1.00 0.10 0.10 3113000000 188000000 8000000 68000000 62000000 0 -29000000 35000000 -136000000 621000000 0 150000000 1156000000 860000000 83000000 -529000000 148000000 6000000 228000000 36000000 0 344000000 -394000000 53000000 -249000000 68000000 58000000 173000000 6000000 -3000000 55000000 11000000 -42000000 59000000 -81000000 800000000 29000000 127000000 1103000000 558000000 -21000000 -680000000 481000000 300000000 211000000 198000000 11000000 175000000 4000000 -14000000 110000000 62000000 38000000 1170000000 43000000 38000000 1060000000 1000000 -110000000 494000000 193000000 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>&#160;Note 1 &#8211; Basis of Presentation<br/>&#160;<br/>The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, financial condition and cash flows in conformity with U.S. GAAP. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) consider ed necessary for a fair presentation of the results of Medtronic, Inc. and its subsidiaries (Medtronic or the Company) for the periods presented. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. For further information, refer to the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended April 24, 2009.<br/><br/>All prior periods presented have been retrospectively adjusted for the impact of the adoption of Financial Accounting Standards Board (FASB) Staff Position (FSP) Accounti ng Principles Board (APB) Opinion No. 14-1, &#8220;Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)&#8221; (FSP APB No. 14-1), and FSP Emerging Issues Task Force (EITF) Issue No. 03-6-1, &#8220;Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities&#8221; (FSP EITF No. 03-6-1) (see Note 3).<br/><br/>The Company has evaluated its subsequent events through September 9, 2009, the filing date of the Company&#8217;s Quarterly Report on Form&#160;10-Q for the period ended July&#160;31, 2009.<br/>&#160;<br/>The Company&#8217;s fiscal years 2010, 2009 and 2008 will end or ended on April 30, 2010, April 24, 2009 and April 25, 2008, respectively.<br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 2 &#8211; New Accounting Pronouncements<br/><br/>In December 2008, the FASB issued FSP Statement of Financial Accounting Standards (SFAS) No. 132(R)-1, &#8220;Employers&#8217; Disclosures About Postretirement Benefit Plan Assets&#8221; (FSP SFAS No. 132(R)-1). FSP SFAS No. 132(R)-1 requires increased disclosures about an entity&#8217;s postretirement benefit plan assets. Specifically, FSP SFAS No. 132(R)-1 requires an entity to disclose information regarding its investment policies and strategies, its categories of plan assets, its fair value measurements of plan assets and any significant concentrations of risk in plan assets. FSP SFAS No. 132(R)-1 is effective for the Company beginning in the first quarter of fiscal year 2010 but o nly requires the revised annual disclosures on a prospective basis. The Company will provide the additional disclosures necessary to the consolidated financial statements beginning in the Company&#8217;s fiscal year 2010 Annual Report on Form 10-K.<br/><br/>In June 2009, the FASB issued SFAS No. 168, &#8220;The FASB Accounting Standards Codification&#8482; and the Hierarchy of Generally Accepted Accounting Principles&#8221; (SFAS No. 168). SFAS No. 168 replaces SFAS No. 162, &#8220;The Hierarchy of Generally Accepted Accounting Principles,&#8221; and establishes the FASB Accounting Standards Codification (the Codification) as the source of authoritative accounting principles to be applied by nongovernmental entities in the preparation of financial statements. In addition, SFAS No. 168 explicitly recognizes rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws as authoritative GAAP for SEC registrants. On the effective date of SFAS No. 168, all nongrandfathered, non-SEC accounting literature not included in the Codification is deemed nonauthoritative. SFAS No. 168 will be effective for the Company beginning in the second quarter of fiscal year 2010. Upon adoption, the Company will reference GAAP by using the numbering system prescribed by the Codification. As the Codification was not intended to change existing GAAP, it will not have any impact on the Company&#8217;s consolidated financial statements. <br/><br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 3 &#8211; Retrospective Adoption of Accounting Pronouncements<br/><br/>In May 2008, the FASB issued FSP APB No. 14-1. FSP APB No. 14-1 requires the proceeds from the issuance of applicable convertible debt instruments to be allocated between a liability component (issued at a discount) and an equity component. The resulting debt discount is amortized over the period the convertible debt is expected to be outstanding as additional non-cash interest expense. FSP APB No. 14-1 changes the accounting treatment for the Company&#8217;s $2.200 billion of 1.500 percent and $2.200 billion of 1.625 percent Senior Convertible Notes due 2011 and 2013, respectively, which were issued in April 2006 (collectively, t he Senior Convertible Notes), and the $15 million remaining balance of the Company&#8217;s Contingent Convertible Debentures due 2021 (the Debentures). <br/><br/>The effect of the adoption of FSP APB No. 14-1 on the Senior Convertible Notes at April 2006 was a debt discount of $967 million and an increase of $614 million, net of tax, to shareholders&#8217; equity. <br/><br/>The resulting debt discount for the Company&#8217;s Debentures is to be amortized over the period from the effective date, January 2005, through the first date holders of the Debentures had the ability to put them back to the Company, September 2006. Therefore, the retrospective adoption of FSP APB No. 14-1 for the Debentures had no impact on results of operations for periods following fiscal year 2007. <br/><br/>In addition, in June 2008, the FASB issued FSP EITF No. 03-6-1. FSP EITF No. 03-6-1 provides that unvested share-based payment awards that contain nonforfeitable rights to div idends or dividend equivalents (whether paid or unpaid) are participating securities and shall be included in the computation of earnings per share (EPS) pursuant to the two-class method. The Company adopted FSP EITF No. 03-6-1 in the first quarter of fiscal year 2010 and is required to retrospectively adjust all prior-period EPS data. The resulting impact of the adoption of FSP EITF No. 03-6-1 was to include 3.5 million and 4.3 million of unvested restricted shares in the basic weighted average shares outstanding calculation for the three months ended July 31, 2009 and July 25, 2008, respectively. <br/><br/>The following table illustrates the impact of the adoption of FSP APB No. 14-1 and FSP EITF No. 03-6-1 on certain financial statement line items in the condensed consolidated statement of earnings for the three months ended July 31, 2009:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="245" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Previous</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="127" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="134" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font si ze="2">&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Method</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="127" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP APB No. 14-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="134" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP EITF No. 03-6-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</fo nt></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Reported</b></font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Interest expense, net</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;23&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="115" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">43&#160;</font></td><td width="12" height="17" al ign="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="116" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;66&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Provision for income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right" ><font size="2">&#160;131&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(15)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;116&#160;</font></td></tr&g t;<tr><td width="245" height="17" align="left"><font size="2">Net earnings</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;473&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(28)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2"> ;&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;445&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2"><b>Earnings per share:</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width=" 18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Basic</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.43&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></ td><td width="115" height="17" align="right"><font size="2">&#160;(0.03)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.40&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Diluted</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><fo nt size="2">&#160;0.43&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(0.03)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.40&#160;</font></td></tr>< /table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated balance sheet as of July 31, 2009:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td& gt;<td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Previous</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b& gt;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Method</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid # 000000;"><font size="2"><b>As Reported</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b><u>ASSETS</u></b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" alig n="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Prepaid expenses and other current assets (debt issuance costs)</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;542&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;(7)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;535&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax assets, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;103&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(103)</font>< /td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total assets</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,684&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(110)</font></td><td width="12" height="17" align="left">&l t;font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,574&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b><u>LIABILITIES AND SHAREHOLDERS' EQUITY</u></b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size ="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term debt</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,782&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(475)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height ="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,307&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax liabilities, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;62&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"> <font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;62&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabilities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;10,843&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(413)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></ td><td width="83" height="17" align="right"><font size="2">&#160;10,430&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Retained earnings</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,940&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;303&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" a lign="right"><font size="2">&#160;13,243&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,841&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;303&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font siz e="2">&#160;13,144&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabilities and shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,684&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(110)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;2 3,574&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated statement of cash flows for the three months ended July 31, 2009:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width= "83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Previous </b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td wi dth="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Method</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><t d colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Reported</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>Operating Activities</b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b& gt;&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net earnings</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;473&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height=" 17" align="right"><font size="2">&#160;(28)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;445&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Amortization of discount on senior convertible notes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><fo nt size="2">&#160;43&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;43&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Deferred income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;83&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(15)</font> </td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;68&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net cash provided by operating activities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;621&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td widt h="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;621&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="12" width="715" height="32" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 and FSP EITF No. 03-6-1 on certain financial statement line items in the condensed consolidated statement of earnings for the three months ended July 25, 2008:</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height=" 17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="21 6" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>As Originally</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="127" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="134" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left">< font size="2">&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Reported</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="127" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP APB No. 14-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="134" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP EITF No. 03-6-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#16 0;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Adjusted</b></font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Interest expense, net</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">9&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="115" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">38&#160;</font></td><td width="12" height="17" alig n="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="116" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;47&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Provision for income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"&g t;<font size="2">206&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(14)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;192&#160;</font></td></tr><tr> <td width="216" height="17" align="left"><font size="2">Net earnings</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">747&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(24)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font&g t;</td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;723&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2"><b>Earnings per share:</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align= "left"><font size="2">&#160;</font></td><td width="116" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Basic</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">0.67&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height= "17" align="right"><font size="2">&#160;(0.02)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;(0.01)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.64&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Diluted</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">0.66&#160;</fon t></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(0.02)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.64&#160;</font></td></tr></table></div><div><table styl e="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated balance sheet as of April 24, 2009:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"& gt;<font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>As Originally</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width=" 18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Reported</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b& gt;As Adjusted</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b><u>ASSETS</u></b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&# 160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Prepaid expenses and other current assets (debt issuance costs)</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;630&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;(8)</font>& lt;/td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;622&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax assets, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;65&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(65)</font></td><td width="12" height="17" alig n="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total assets</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,661&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(73)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font> </td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,588&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b><u>LIABILITIES AND SHAREHOLDERS' EQUITY</u></b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td> <td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term debt</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,772&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(519)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2"> ;&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,253&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax liabilities, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;115&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font& gt;</td><td width="83" height="17" align="right"><font size="2">&#160;115&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabilities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;10,810&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(404)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" alig n="right"><font size="2">&#160;10,406&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Retained earnings</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,941&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;331&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&am p;#160;13,272&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,851&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;331&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;13,182&#160;</ font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabilities and shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,661&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(73)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,588&#160;</font></td>&l t;/tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated statement of cash flows for the three months ended July 25, 2008:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>As Originally</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"&g t;<font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Reported</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="1 7" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Adjusted</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>Operating Activities</b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font> ;</td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net earnings</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;747&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size= "2">&#160;(24)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;723&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Amortization of discount on senior convertible notes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;38&#16 0;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;38&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Deferred income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;11&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(14)</font></td><td width="12" height ="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(3)</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net cash provided by operating activities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;800&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;800&#160;</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 4 &#8211; Acquisitions<br/>&#160;<br/>During the first quarter of fiscal year 2010, the Company adopted SFAS No. 141(R), &#8220;Business Combinations&#8221; (SFAS No. 141(R)). SFAS No. 141(R) replaced SFAS No. 141, &#8220;Business Combinations.&#8221; SFAS No. 141(R) establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interests in the acquiree and the goodwill acquired. SFAS No. 141(R) retains the underlying purchase method of accounting for acquisitions, but incorporates a number of changes. These changes include the capitalization of purchased in-process research an d development (IPR&amp;D), expensing of acquisition related costs and the recognition of contingent purchase price consideration at fair value at the acquisition date. In addition, changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period will be recognized in earnings rather than as an adjustment to the cost of the acquisition. This accounting treatment for taxes is applicable to acquisitions consummated both prior to and subsequent to the adoption of SFAS No. 141(R). The adoption of SFAS No. 141(R) did not change the requirement to expense IPR&amp;D immediately with respect to asset acquisitions. With the exception of deferred tax asset valuation allowances and acquired income tax uncertainties related to previous acquisitions, this statement will be applied prospectively to business combinations consummated after fiscal year 2009. The adoption of SFAS No. 141(R) did not have a material impact on our condensed consolida ted financial statements during the three months ended July 31, 2009. <br/><br/>When the Company acquires another company or a group of assets, the purchase price is allocated, as applicable, among IPR&amp;D, other identifiable intangible assets, net tangible assets and goodwill, if any, as required by U.S. GAAP. Goodwill represents the excess of the aggregate purchase price over the fair value of net assets, including IPR&amp;D, of acquired businesses. The values assigned to IPR&amp;D and other identifiable intangible assets are based on valuations that have been prepared using methodologies and valuation techniques consistent with those used by independent appraisers. These techniques include estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values utilizing an appropriate risk-adjusted rate of return (discount rate). The discount rate used is determined at the time of the acquisition in accordance with accepted valuation methods. For IPR&amp;D, these methodologies include consideration of the risk of the project not achieving commercial feasibility and include a factor that takes into account the uncertainty surrounding the successful development of the IPR&amp;D.<br/>&#160;<br/>At the time of acquisition, the Company plans that all acquired IPR&amp;D will reach technological feasibility, but there can be no assurance that the commercial viability of these products will actually be achieved. The nature of the efforts to develop the acquired technologies into commercially viable products consists principally of planning, designing and conducting clinical trials necessary to obtain regulatory approvals. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, and patent issuance, validity and litigation, if any. If commercial viabi lity were not achieved, the Company would likely look to other alternative uses for the same technology.<br/><br/>Fiscal Year 2010<br/><br/>There were no significant acquisitions during the three months ended July 31, 2009.<br/><br/>Fiscal Year 2009<br/>&#160;</p></font></div><div><font size="2"><p>Restore Medical Acquisition<br/>&#160;<br/>In July 2008, the Company acquired Restore Medical, Inc. (Restore). Restore&#8217;s Pillar Palatal Implant System provides the Company with a minimally invasive, implantable medical device used to treat the soft palate component of sleep breathing disorders, including mild to moderate obstructive sleep apnea and snoring. The Company accounted for the acquisition as a business combination. Restore shareholders received $1.60 per share in cash for each share of Restore common stock they owned. Total consideration for the transaction, net of cash acquired, was approximately $29 million. In connection with the acquisition of Restore, the Company acquired $17 million of technology-based intangible assets with an average estimated useful life of 10 years, $8 million of net tangible assets and $5 million of goodwill. The goodwill is not deductible for tax purposes. The pro forma impact of the Restore acquisition was not significant to the results of the Company for the three months ended July 25, 2008. The results of operations have been included in the Company&#8217;s consolidated statements of earnings since the date of acquisition.<br/><br/>Contingent Consideration<br/>&#160;<br/>Certain of the Company&#8217;s business combinations or purchases of intellectual property involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones and/or various other favorable operating conditions. While it is not certain if and/or when these payments will be made, the Company has dev eloped an estimate of the potential contingent consideration for each of its acquisitions with an outstanding potential obligation. At July 31, 2009, the estimated potential amount of future contingent consideration that the Company is expected to make associated with all business combinations or purchases of intellectual property is approximately $399 million. The milestones associated with the contingent consideration must be reached in future periods ranging from fiscal years 2010 to 2016 in order for the consideration to be paid.<br/><br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 5 &#8211; Certain Litigation Charges<br/><br/>The Company classifies material litigation reserves recognized as certain litigation charges. During the three months ended July 31, 2009, the Company recorded certain litigation charges of $444 million related to the global resolution of all outstanding intellectual property litigation with Abbott Laboratories (Abbott). The terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. Both parties also agreed to a cross-license of the disputed patents within the defined field. The $444 million settlement amount includes a $400 million payment to be made to Abbott and a $42 m illion success payment to be made to evYsio Medical Devices, LLC (evYsio). In addition, a $2 million payment is to be made to evYsio in connection with an amendment to the parties&#8217; existing agreement in order to expand the scope of the definition of the license field from evYsio.<br/><br/>During the three months ended July 25, 2008, there were no certain litigation charges.</p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 6 &#8211; Restructuring Charges<br/>&#160;<br/>Fiscal Year 2009 Initiative<br/>&#160;<br/>In the fourth quarter of fiscal year 2009, the Company recorded a $34 million restructuring charge, which consisted of employee termination costs of $29 million and asset write-downs of $5 million. As part of the Company&#8217;s &#8220;One Medtronic&#8221; strategy, the Company continues to pursue opportunities to streamline the organization and standardize or centralize certain functional activities which are not unique to individual businesses. In connection with these efforts to create &#8220;One Medtronic,&#8221; this initiative is designed to streamline operations, by further consolidating manufactur ing and eliminating certain non-core product lines, and to further align resources around the Company&#8217;s higher growth opportunities. This initiative impacts most businesses and certain corporate functions. Of the $5 million of asset write-downs, $3 million relates to inventory write-offs and production-related asset impairments and therefore was recorded within cost of products sold in the consolidated statement of earnings. The employee termination costs of $29 million consist of severance and the associated costs of continued medical benefits and outplacement services.<br/><br/>As a continuation of the fiscal year 2009 initiative, in the first quarter of fiscal year 2010, the Company incurred $72 million of incremental restructuring charges, which consisted of employee termination costs of $62 million and asset write-downs of $10 million. Of the $10 million of asset write-downs, $7 million relates to inventory write-offs and production-related asset impairments and therefore was re corded within cost of products sold in the condensed consolidated statement of earnings. Included in the $62 million restructuring charge is $9 million of incremental defined benefit pension and post-retirement related expenses for those employees who accepted early retirement packages. These costs are not included in the table summarizing restructuring costs below because they are associated with costs that are accounted for under the pension and post-retirement rules. For further discussion on the incremental defined benefit pension and post-retirement related expenses, see Note 19. <br/>&#160;<br/>As of the end of the first quarter of fiscal year 2010, the Company has identified approximately 1,500 positions for elimination which will be achieved through early retirement packages offered to employees, voluntary separation and involuntary separation. Of these 1,500 positions, approximately 500 positions have been eliminated as of July 31, 2009. The restructuring initiatives are sch eduled to be substantially complete by the end of the first quarter of fiscal year 2011.<br/>&#160;<br/>A summary of the activity related to the fiscal year 2009 initiative is presented below:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="217" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="8" width="419" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fiscal Year 2009 Initiative</b></font></td></tr><tr><td rowspan="3" width="217" height="42" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="3" width="64" height="42" align="center"><font size="2">&#160;</font></td><td colspan="2" w idth="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Employee</b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Termi nation</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Asset</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2"><b>&#160;</b></font></td><td width="100" height="14" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Costs</b></font></td><td width="31" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size ="2"><b>Write-downs</b></font></td><td width="31" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Total</b></font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at April 25, 2008</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="borde r-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Restructuring charges</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">29&#160;</font&g t;</td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">5&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">34&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Payments/write-downs</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100 " height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(1)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(5)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(6)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at April 24, 2009</b>< ;/font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">28&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">28&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Restructuring charges</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">53&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">10&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left">< ;font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">63&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Payments/write-downs</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(19)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(10)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" alig n="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(29)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">62&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font>< /td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">62&#160;</font></td></tr></table></div><div><font size="2"><p>Global Realignment Initiative<br/>&#160;<br/>In the fourth quarter of fiscal year 2008, the Company began a global realignment initiative which focused on shifting resources to those areas where the Company has the greatest opportunities for growth and streamlining operations to drive operating lever age. The global realignment initiative impacted most businesses and certain corporate functions. Within the Company&#8217;s Cardiac Rhythm Disease Management (CRDM) business, the Company reduced research and development infrastructure by closing a facility outside the U.S., reprioritizing research and development projects to focus on the core business and consolidating manufacturing operations to drive operating leverage. Within the Company&#8217;s Spinal business, the Company reorganized and consolidated certain activities where Medtronic&#8217;s existing infrastructure, resources and systems could be leveraged to obtain greater operational synergies. The global realignment initiative was also designed to further consolidate manufacturing of CardioVascular products, streamline distribution of products in select businesses and to reduce general and administrative costs in the Company&#8217;s corporate functions. <br/><br/>In the first quarter of fiscal year 2010, the Company recor ded a $8 million reversal of excess reserves primarily as a result of favorable severance negotiations as well as a higher than expected percentage of employees identified for elimination finding positions elsewhere in the Company. This $8 million reversal of excess reserves was partially offset by a $5 million charge the Company recorded in the first quarter of fiscal year 2010 related to the further write-down of a non-inventory related asset resulting from the continued decline in the international real estate market. <br/><br/>As of the end of the first quarter of fiscal year 2009, the Company had identified approximately 900 positions for elimination which were to be achieved through both voluntary and involuntary separation. Of the 900 positions identified, approximately 760 have been eliminated as of July 31, 2009. The restructuring initiatives are scheduled to be substantially complete by the end of the second quarter of fiscal year 2010.<br/>&#160;<br/>A summary of the activity related to the global realignment initiative is presented below:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="217" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="8" width="419" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Global Realignment Initiative</b></font></td></tr><tr><td rowspan="3" width="217" height="42" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="3" width="64" height="42" align="center"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Employee< ;/b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Termination</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;< /font></td><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Asset</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2"><b>&#160;</b></font></td><td width="100" height="14" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Costs</b></font></td><td width="31" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Write-downs</b></font></td><td width="31" height="16" align="left"><font size ="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Total</b></font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at April 24, 2009</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">15&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">15&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Restructuring charges</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font&g t;</td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">&#160;5&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">5&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Reversal of excess accrual</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(8)</font></td><td width="31" height="20" align="left"><fo nt size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(8)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Payments/write-downs</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(3)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(5)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(8)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Currency adjustment, net</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at July 31, 2009</b></font&g t;</td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">5&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width= "19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">5&#160;</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 7 &#8211; Investments<br/><br/>In April 2009, the FASB issued FSP SFAS No. 115-2 and SFAS No. 124-2, &#8220;Recognition and Presentation of Other-Than-Temporary Impairments&#8221; (FSP SFAS Nos. 115-2 and 124-2) which amended the existing guidance on determining whether an impairment for investments in debt securities is other-than-temporary as well as requiring additional annual and interim disclosures. Under FSP SFAS Nos. 115-2 and 124-2, impairment on debt securities will be considered other-than-temporary if the Company (1) intends to sell the security, (2) more likely than not will be required to sell the security before recovering its costs, or (3) does not expect to recover the security&#8217;s fair value versus its amortized cost basis. FSP SFAS No s. 115-2 and 124-2 further indicates that, depending on which of the above factor(s) causes the impairment to be considered other-than-temporary, (1) the entire shortfall of the security&#8217;s fair value versus its amortized cost basis or (2) only the credit loss portion would be recognized in earnings while the remaining shortfall would be recognized in other comprehensive income. FSP SFAS Nos. 115-2 and 124-2 requires the Company to initially apply the provisions of the standard to previously other-than-temporary impaired debt securities existing as of the date of initial adoption by making a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The cumulative-effect adjustment reclassifies the non-credit portion of a previously other-than-temporarily impaired debt security held as of the date of initial adoption from retained earnings to accumulated other comprehensive income. FSP SFAS Nos. 115-2 and 124-2 was effective for the Company in the first quart er of fiscal year 2010 and resulted in a cumulative-effect adjustment of $3 million as of April 25, 2009.<br/><br/>Information regarding the Company&#8217;s short-term and long-term investments at July 31, 2009 is as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="319" height="14" align="left"><font size="2">&#160;</font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2">&#160;</font></td><td width="64" height="14" align="left"><font size="2"><b>&#160;</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center"><font size="2"><b>Unrealized </b></font> </td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center"><font size="2"><b>Unrealized </b></font></td><td width="14" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2">&#160;</font></td><td width="73" height="14" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="319" height="14" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Cost</b></font></td><td width="12" height="14" align="l eft"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Gains</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td><td width="14" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="92" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Corporate debt securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td> <td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;852&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">13&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(18)</font& gt;</td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="73" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;847&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Auction rate securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;195&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2"> &#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(43)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;152&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Mortgage backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font> ;</td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;654&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">8&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(39)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;& lt;/font></td><td width="73" height="17" align="right"><font size="2">&#160;623&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Government and agency securities </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;1,082&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">5&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width ="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(2)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;1,085&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Certificates of deposit</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;34&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;34&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Other asset backed securities&#160;& amp;#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;280&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;3&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(9)</font></td><td width="14" height="17" align="left">& lt;font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;274&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Marketable equity securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;12&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;6&#160;&l t;/font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;18&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Cost method, equity method and other investments</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2" >&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;526&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="14" height="17 " align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="73" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;526&#160;</font></td></tr><tr><td width="319" height="18" align="left"><font size="2">Total short-term and long-term investments</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,635&#160;</font></td><td width="12" height="18" align="l eft"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;35&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(111)</font></td><td width="14" height="18" align="left" style="border-bottom: 3px double #FFFFFF;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="73" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,559&#160;</font></td></tr></table></div><div><font size="2"><p>Information regarding the Company&#8217;s short-term and long-term investments at April 24, 2009 is as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="306" height="17" align="left"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font s ize="2"><b>&#160;</b></font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center"><font size="2"><b>Unrealized </b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center"><font size="2"><b>Unrealized </b></font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="306" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" he ight="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Cost</b></font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Gains</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">< ;b>Fair Value</b></font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Corporate debt securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">817&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">8&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</fon t></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(20)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">805&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Auction rate securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height=" 17" align="right"><font size="2">199&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(80)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">119&#160;</font></td></tr><tr> <td width="306" height="17" align="left"><font size="2">Mortgage backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">789&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">9&#160;</font></td><td width="18" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2"> (52)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">746&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Government and agency securities </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">693&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">5&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(1)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">697&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Certificates of deposit</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><t d width="64" height="17" align="right"><font size="2">2&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">2&#160;</font&g t;</td></tr><tr><td width="306" height="17" align="left"><font size="2">Other asset backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">297&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">3&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(22)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">278&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Marketable equity securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">12&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td&g t;<td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">12&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Cost method, equity method and other investments</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" heigh t="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">515&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2"> &#160;-&#160;</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">515&#160;</font></td></tr><tr><td width="306" height="18" align="left"><font size="2">Total short-term and long-term investments</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,324&#160 ;</font></td><td width="15" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">25&#160;</font></td><td width="18" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">(175)</font></td><td width="17" height="18" align="left" style="border-bottom: 3px double #FFFFFF;"><font size="2">&#160 ;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,174&#160;</font></td></tr></table></div><div><font size="2"><p>The following table shows the gross unrealized losses and fair values of the Company&#8217;s investments in individual securities that have been in a continuous unrealized loss position deemed to be temporary for less than 12 months and for more than 12 months, aggregated by investment category as of July 31, 2009:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="319" height="17" align="left"><font size="2">&#160;</font></td><td width="13" hei ght="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td colspan="4" width="159" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Less than 12 months</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="189" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>More than 12 months</b></font></td></tr><tr><td width="319" height="14" align="left"><font size="2">&#160;</font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2">&#160;</font></td><td width="64" height="14" align="left" s tyle="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="14" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Unrealized </b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="14" height="14" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="92" height="14" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Unrealized</b></font></td></tr ><tr><td width="319" height="14" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td><td width="14" height="14" align="left"><font siz e="2">&#160;</font></td><td colspan="2" width="92" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Corporate debt securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;117&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="b order-top: 1px solid #000000;"><font size="2">&#160;(1)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;83&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="73" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(17)</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Auction rate securities</font></td><td width="13" height="17" ali gn="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;152&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><t d width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;(43)</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Mortgage backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;104&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(5)</font></td><td width="12" height="17" align= "right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;113&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;(34)</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Government and agency securities </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;342& amp;#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(2)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="319" height="17 " align="left"><font size="2">Other asset backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#1 60;51&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;(9)</font></td></tr><tr><td width="319" height="18" align="left"><font size="2">Total short-term and long-term investments</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;563&#160;</font></td><td width="12" height="18" align="left"><font size="2"> &#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(8)</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;399&#160;</font></td><td width="14" height="18" align="left" style="border-bottom: 3px double #FFFFFF;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style ="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="73" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(103)</font></td></tr></table></div><div><font size="2"><p>The Company&#8217;s investments in marketable debt securities detailed above are classified and accounted for as available-for-sale and include corporate debt securities, government and agency securities, certificates of deposit and mortgage backed and other asset backed securities including auction rate securities. Market conditions during the first quarter of fiscal year 2010 and subsequent to the Company&#8217;s quarter-end continue to indicate significant uncertainty on the part of investors on the economic outlook for the U.S. and for financial institutions. This uncertainty has created reduced liquidity across the fixed income investment market, including certain securities in which the Company has invested. As a result, some of the Company&#8217;s investments have experienced reduced liquidity including unsuccessful monthly auctions for auction rate security holdings. At July 31, 2009, the Company concluded that the unrealized losses associated with the remaining securities were not other-than-temporary as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell, before recovery of the amortized cost.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="13" width="718" height="17" align="left"><font size="2">Activity related to the Company&#8217;s short-term and long-term investment portfolio is as follows:</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" he ight="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="229" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="11" width="425" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="229" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="197" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font> </td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="5" width="197" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 25, 2008</b></font></td></tr><tr><td width="229" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Debt (a)</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="bo rder-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Equity (b)</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Debt (a)</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Equity (b)</b></font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Proceeds from sales</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></t d><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;860&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"&g t;<font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;558&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Gross realized gains </font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px soli d #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;14&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top : 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Gross realized losses</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style= "border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(1)</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(2)</font></td>< td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Impairment losses recognized</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(7)</font></ td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(3)</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(3)</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" al ign="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(2)</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&am p;#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td colspan="8" width="521" height="17" align="left"><font s ize="2">(a) Includes available-for-sale (AFS) debt securities.</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td colspan="13" width="718" height="17" align="left"><font size="2">(b) Includes marketable equity securities, cost method, equity method and other investments. </font></td></tr></table></div><div><font size="2"><p>The total other-than-temporary impairment losses on AFS debt securities for the three months ended July 31, 2009 was $24 million, of which $17 million was recognized in other comprehensive income resulting in $7 million of charges being recognized in earnings. These charges relate to credit losses on certain mortgage backed securities and auction rate securities. The amount of credit losses represents the difference between the present value of cash flows expected to be collected on these securities and the amortized cost. Based on the Company&#8217;s assessment of the credit quality of the underlying collateral and credit support available to each of the remaining securities in which invested, the Company believes it has recorded all necessary other-than-temporary impairments as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell before recovery of the amortized cost. For additional discussion, see the &#8220;Liquidity and Capital Resources&#8221; section of management&#8217;s discussion and analysis.&#160;<br/><br/>The following table s hows the credit loss portion of other-than-temporary impairments on debt securities held by the Company as of the dates indicated and the corresponding changes in such amounts:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="548" height="17" align="left"><font size="2">&#160;</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="548" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr& gt;<tr><td width="548" height="17" align="left"><font size="2"><b>Balance at April 24, 2009</b></font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">0&#160;</font></td></tr><tr><td width="548" height="17" align="left"><font size="2">Credit losses remaining in retained earnings upon adoption</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="548" height="17" align="left"><font size="2">Credi t losses recognized on securities previously not impaired</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td></tr><tr><td width="548" height="18" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;">&l t;font size="2">&#160;11&#160;</font></td></tr></table></div><div><font size="2"><p>The July 31, 2009 balance of AFS debt securities by contractual maturity is shown in the following table at fair value. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows, assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td rowspan="2" width="560" height="32" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="78" height="32" align="center"><font size="2">&#160;</font></td><td colspan="2" width="79" height="1 9" align="center"><font size="2"><b>July 31, </b></font></td></tr><tr><td colspan="2" width="79" height="13" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due in one year or less</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width="9" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="70" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;750&#160;</font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due after one year through five years</font></td><td width="78" height="17" align="left"><font si ze="2">&#160;</font></td><td width="9" height="17" align="right"><font size="2">&#160;</font></td><td width="70" height="17" align="right"><font size="2">&#160;2,064&#160;</font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due after five years through ten years</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width="9" height="17" align="right"><font size="2">&#160;</font></td><td width="70" height="17" align="right"><font size="2">&#160;33&#160;</font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due after ten years</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width="9" height="17" align="right" style="border-bott om: 1px solid #000000;"><font size="2">&#160;</font></td><td width="70" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;168&#160;</font></td></tr><tr><td width="560" height="18" align="left"><font size="2">Total debt securities</font></td><td width="78" height="18" align="left"><font size="2">&#160;</font></td><td width="9" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="70" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">3,015&#160;</font></td></tr></table></div><div><font size="2"><p>As of July 31, 2009 and April 24, 2009, the aggregate carrying amount of equity and other securities without a quoted market pr ice and accounted for using the cost or equity method was $526 million and $515 million, respectively. The total carrying value of these investments is reviewed quarterly for changes in circumstance or the occurrence of events that suggest the Company&#8217;s investment may not be recoverable. The fair value of cost or equity method investments is not adjusted if there are no identified events or changes in circumstances that may have a material adverse effect on the fair value of the investment.<br/>&#160;<br/>Gains and losses recognized on debt instruments are recorded in interest expense, net in the condensed consolidated statements of earnings. Gains and losses recognized on equity instruments are recorded in other expense, net in the condensed consolidated statements of earnings. Gains and losses from the sale of investments are calculated based on the specific identification method.<br/>&#160;<br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 8 &#8211; Fair Value Measurements<br/>&#160;&#160;<br/>Assets and Liabilities That Are Measured at Fair Value on a Recurring Basis<br/>&#160;<br/>For the Company, effective April 26, 2008, fair value under SFAS No.&#160;157 &#8220;Fair Value Measurements&#8221; (SFAS No. 157), is principally applied to financial assets and liabilities such as marketable equity securities and debt securities that are classified and accounted for as available-for-sale, and derivative instruments. Derivatives include cash flow hedges, freestanding derivative forward contracts, net investment hedges and interest rate swaps. These items were previously and will continue to be marked-to-market at each reporting period; however, the definition of fair value is now applied using SFAS No.&#160;157. The information in the following paragraphs and tables primarily addresses matters relative to these financial assets and liabilities. Separately, there were no material fair value measurements with respect to nonfinancial assets or liabilities that are recognized or disclosed at fair value in the Company&#8217;s financial statements on a recurring basis subsequent to the effective date of SFAS No.&#160;157.<br/>&#160;<br/>The following tables provide information by level for assets and liabilities that are measured at fair value, as defined by SFAS No.&#160;157, on a recurring basis.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="215" height="17" align="center"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>Fair Value</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center"><font size="2"><b>Fair Value Measurements</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>at</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Using Inputs Considered as</b></font></t d></tr><tr><td width="215" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 1</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="3" width="123" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 2</b></font></td><td width="19" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 3</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Assets:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></t d><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160; </font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Corporate debt securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;847&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;22&#160;</font></td><td width="31" height="17" align="left"><font si ze="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;807&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;18&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Auction rate securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;& lt;/font></td><td width="85" height="17" align="right"><font size="2">&#160;152&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><fon t size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;152&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Mortgage backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;623&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="l eft"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;586&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;37&#160;</font></td></tr><tr><td width="215" height="19" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Government and agency securities</font></td><td width="4" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;1,085&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;186&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;899&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td ><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Certificates of deposit</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;34&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font& gt;</td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;34&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Other asset backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</fo nt></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;274&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;257&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;17&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Marketable equity securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;18&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right">< ;font size="2">&#160;18&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative assets</font></td><td width="4" height="17" align="left">& lt;font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;169&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;163&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" hei ght="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;6&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total assets</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td&g t;<td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,202&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;389&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000 000;"><font size="2">&#160;2,589&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;224&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">&#160;</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height ="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" alig n="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Liabilities:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="rig ht"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative liabilities</font></td><td width="4" height="17" align="left"><font size="2"> ;&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px so lid #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total liabilities</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="bor der-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font ></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="215" height="17" align="center"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>Fair Value</b></font>& lt;/td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center"><font size="2"><b>Fair Value Measurements</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>at</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Using Inputs Considered as</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2"><b>(in millions)< ;/b></font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>April 24, 2009</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 1</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="3" width="123" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 2</b></font></td><td width="19" height="17" align="center" style="bord er-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 3</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Assets:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#1 60;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Corporate debt securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;805&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;8&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</fo nt></td><td width="85" height="17" align="right"><font size="2">&#160;771&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;26&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Auction rate securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;119&#160;</ font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&am p;#160;119&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Mortgage backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;746&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;709&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;37&#160;</font></td></tr><tr><td width="215" height="19" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Government and agency securities</font></td><td width="4" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"> <font size="2">&#160;697&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;174&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;523&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="8 5" height="19" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Certificates of deposit</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;2&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;2&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Other asset backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td>< td width="85" height="17" align="right"><font size="2">&#160;278&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;255&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#16 0;</font></td><td width="85" height="17" align="right"><font size="2">&#160;23&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Marketable equity securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;12&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;12&#160;</font></td><td width="31" height="17" align="left"><font size ="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative assets</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;436&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;436&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font> </td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total assets</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;">& lt;font size="2">&#160;3,095&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;630&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,260&#160;</font></td><td width="19" height="18" align="left"&g t;<font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;205&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">&#160;</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><t d width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="borde r-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Liabilities:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size=" 2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative liabilities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"> <font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="lef t"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total liabilities</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;31&#160;</font>& lt;/td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td></tr></table></div><div><font size="2"><p>Level 3 Valuation Techniques<br/>&#160;<br/>Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. Level 3 financial assets also include certain investment securities for which there is limited market activity such that the determination of fair value requires significant judgment or estimation. Level 3 inves tment securities primarily include certain corporate debt securities, auction rate securities, certain mortgage backed securities and certain asset backed securities for which there was a decrease in the observability of market pricing for these investments. At July 31, 2009, these securities were valued primarily using broker pricing models that incorporate transaction details such as contractual terms, maturity, timing and amount of future cash flows, as well as assumptions about liquidity and credit valuation adjustments of marketplace participants at July 31, 2009.<br/>&#160;<br/>The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the table above that used significant unobservable inputs (Level 3).<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="512" height="17" align="left"><font size="2">&#16 0;</font></td><td colspan="5" width="213" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="512" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="5" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 25, 2008</b></font></td></tr><tr><td width="512" height="17" align="left"><font size="2"><b>Beginning Balance</b></font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">205&#160;</font></td><td width="5" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">448&#160;</font></td></tr><tr><td width="512" height="17" align="left"><font size="2">Total realized losses and other-than temporary impairment losses included in earnings</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" ali gn="right"><font size="2">&#160;(4)</font></td><td width="5" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(3)</font></td></tr><tr><td width="512" height="17" align="left"><font size="2">Total unrealized gains/(losses) included in other comprehensive income</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;45&#160;</font></td><td width="5" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right "><font size="2">&#160;(7)</font></td></tr><tr><td width="512" height="17" align="left"><font size="2">Net purchases, issuances, and settlements</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(22)</font></td><td width="5" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(152)</font></td></tr><tr><td width="512" height="18" align="left"><font size="2"><b>Ending Balance</b></font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$& lt;/font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;224&#160;</font></td><td width="5" height="18" align="right"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;286&#160;</font></td></tr></table></div><div><font size="2"><p>Realized gains or losses included in earnings are included in interest expense, net in the condensed consolidated statement of earnings.<br/>&#160;<br/>Assets and Liabilities that are Measured at Fair Value on a Nonrecurring Basis<br/>&#160;<br/>Th e Company had no financial assets or liabilities that are measured on a nonrecurring basis subsequent to their initial recognition during the three months ended July 31, 2009.&#160;<br/><br/>Non-financial assets such as goodwill, intangible assets and property, plant and equipment are measured at fair value when there is an indicator of impairment and recorded at fair value only when impairment is recognized. No impairments existed as of July 31, 2009.<br/><br/>Financial Instruments Not Measured at Fair Value<br/><br/>The estimated fair value of the Company&#8217;s long-term debt at July 31, 2009 was $6.728 billion compared with a carrying value of $6.725 billion and at April 24, 2009 an estimated fair value of $6.375 billion compared with a carrying value of $6.665 billion. Fair value was estimated using quoted market prices. The fair values and carrying values consider the terms of the related debt and exclude the impacts of debt discounts and derivative/hedgi ng activity.<br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 9 &#8211; Financing Arrangements<br/>&#160;<br/>Senior Convertible Notes<br/>&#160;<br/>In April 2006, the Company issued $2.200 billion of 1.500 percent Senior Convertible Notes due 2011 and $2.200 billion of 1.625 percent Senior Convertible Notes due 2013 (collectively, the Senior Convertible Notes). The Senior Convertible Notes were issued at par and pay interest in cash semi-annually in arrears on April&#160;15 and October&#160;15 of each year. The Senior Convertible Notes are unsecured unsubordinated obligations and rank equally with all other unsecured and unsubordinated indebtedness. <br/><br/>Concurrent with the issuance of the Senior Convertible Notes, the Company purchased call options on its common stock in pri vate transactions. The call options allow the Company to receive shares of the Company&#8217;s common stock and/or cash from counterparties equal to the amounts of common stock and/or cash related to the excess conversion value that it would pay to the holders of the Senior Convertible Notes upon conversion.<br/><br/>In separate transactions, the Company sold warrants to issue shares of the Company&#8217;s common stock at an exercise price of $76.56 per share in private transactions. Pursuant to these transactions, warrants for 41 million shares of the Company&#8217;s common stock may be settled over a specified period beginning in July 2011 and warrants for 41 million shares of the Company&#8217;s common stock may be settled over a specified period beginning in July 2013.<br/><br/>In June 2008, the FASB issued EITF Issue No. 07-5, &#8220;Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity&#8217;s Own Stock&#8221; (EITF No. 07-5) . EITF No. 07-5 provides guidance for determining whether an equity-linked financial instrument (or embedded feature) is indexed to an entity's own stock and classified in shareholders&#8217; equity or whether it should be bifurcated and classified as a separate asset or liability and marked-to-market through earnings. The Company adopted EITF No. 07-5 in the first quarter of fiscal year 2010. In applying EITF No. 07-5, the Company concluded that the purchased call options and sold warrants were indexed to its own stock and should continue to be classified in shareholders&#8217; equity; thus consistent with prior periods, EITF Issue No. 00-19, &#8220;Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock&#8221; (EITF No. 00-19) would still apply. <br/><br/>Under EITF No. 00-19, the notes are accounted for as a combined instrument because the conversion spread meets the requirements of EITF No. 00-19, including the pr ovisions contained in paragraphs 12&#8211;32 of EITF No. 00-19. Accordingly, the &#8220;conversion spread&#8221; is not separated as a derivative.<br/><br/>EITF No. 00-19 provides that contracts are initially classified as equity if (1)&#160;the contract requires physical settlement or net-share settlement, or (2)&#160;the contract gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The settlement terms of the Company&#8217;s purchased call options and sold warrant contracts provide for net cash settlement for the particular contract or net share settlement, depending on the method of settlement, as discussed above, which is at the option of the Company. Based on the guidance from EITF&#160;No. 00-19 and SFAS No.&#160;133, &#8220;Accounting for Derivative Instruments and Hedging Activities&#8221; (SFAS No. 133), the purchased call option contracts were recorded as a reduction of eq uity and the warrants were recorded as an addition to equity as of the trade date. SFAS No.&#160;133 states that a reporting entity shall not consider contracts to be derivative instruments if the contract issued or held by the reporting entity is both indexed to its own stock and classified in shareholders&#8217; equity in its statement of financial position. The Company concluded the purchased call option contracts and the warrant contracts should be accounted for in shareholders&#8217; equity.<br/><br/>Effective April 25, 2009, the Company accounts for the Senior Convertible Notes in accordance with FSP APB No. 14-1. FSP APB No. 14-1 requires the proceeds from the issuance of the Senior Convertible Notes to be allocated between a liability component (issued at a discount) and an equity component. The resulting debt discount is amortized over the period the Senior Convertible Notes are expected to be outstanding as additional non-cash interest expense. This change in accounting f or the Senior Convertible Notes has been applied to the Company&#8217;s prior period financial statements on a retrospective basis, as required by FSP APB No. 14-1. For additional information on the impact of this change to the Company&#8217;s financial statements, refer to Note 3.<br/><br/>The following table provides equity and debt information for the Senior Convertible Notes under FSP APB No. 14-1. <br/>&#160;</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2011</b></font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align ="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2013</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td rowspan="2" width="341" height="31" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="15" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>April 24,</b></font></td><td rowspan="2" width="16" height="31" align="center"><font size="2">&#16 0;</font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="15" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>April 24,</b></font></td><td width="19" height="15" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="83" height="16" align="center" style="border - -bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="19" height="16" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Carrying amount of the equity component</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" sty le="border-top: 1px solid #000000;"><font size="2">420&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">420&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">547&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px sol id #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">547&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font& gt;</td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td width="71" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td width="71" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Principal amount of the Senior Convertible Notes</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="14" height ="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr&g t;<tr><td width="341" height="17" align="left"><font size="2">Unamortized discount</font></td><td width="12" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(157)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(181)</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">&a mp;#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(318)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(338)</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Net carrying amount</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" styl e="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,043&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,019&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,882& amp;#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,862&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="14" height= "18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="16" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="ri ght" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="19" height="18" align="right"><font size="2">&#160;</font></td></tr><tr><td colspan="12" width="717" height="55" align="left"><font size="2">At July 31, 2009, the unamortized balance of the debt discount will be amortized over the remaining life of the Senior Convertible Notes, which is approximately 2 years for the 2011 Senior Convertible Notes and 4 years for the 2013 Senior Convertible Notes. The following table provides interest rate and interest expense amounts related to the Senior Convertible Notes.</font></td><td width="19" height="55" align="left"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td ><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td wi dth="19" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2011</b></font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2013</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" styl e="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td rowspan="2" width="341" height="34" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2"& gt;<b>&#160;</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td rowspan="2" width="16" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="83" height="17" align="cent er" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr>&l t;tr><td width="341" height="17" align="left"><font size="2">Effective interest rate</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">5.97&#160;</font></td><td width="14" height="17" align="left"><font size="2">%</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">5.97&#160;</font></td><td width="16" height="17" align="left"><font size="2">%</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;6.03&#160;</font></td><td width="14" height="17" align="left"><font size="2">%</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;6.03&#160;</font></td><td width="19" height="17" align="right"><font size="2">%</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Interest cost related to contractual interest coupon</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">9&#160;</font></td><td width="14" height="17" al ign="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">8&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">10&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">9&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align= "left"><font size="2">Interest cost related to amortization of the discount</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">23&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">21&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">21&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">18&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr></table></div><div><font size="2"><p>Senior Notes<br/>&#160;<br/>In March 2009, the Company issued three tranches of Senior Notes (New Senior Notes) with the aggregate face value of $1.250 billion. The first tranche consisted of $550 million of 4.500 percent Senior Notes due 2014, the second tranche consisted of $400 million of 5.600 percent Senior Notes due 2019 and the third tranche consisted of $300 million of 6.500 percent Senior Notes due 2039. The first tranche was issued at par, the second tranche was issued at a discount which resulted in an effective interest rate of 5.609 percent and the third tranche was issued at a discount which resulted in an effective interest rate of 6.519 percent. Interest on each series of New Senior Notes is payable semi-annually, on March 15 and September 15 of each year, commencing September 15, 2009. The New Senior Notes are unsecured senior obligations of the Company and rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which the New Senior Notes were issued contain customary covenants. The Company used the net proceeds from the sale of the New Senior Notes for repayment of a portion of its commercial paper and for general corporate uses.<br/><br/>In September 2005, the Company issued two tranches of Senior Notes with the aggregate face value of $1.000 billion. The first tranche consisted of $400 million of 4.375 percent Senior Notes due 2010 and the second tranche consisted of $600 million of 4.750 percent Senior Notes due 2015. Each tranche was issued at a discount which resulted in an effective interest rate of 4.433 percent and 4.760 percent for the five and ten year Senior Notes, respectively. Interest on each series of Senior Notes is payable semi-annually, on March 15 and September 15 of each year. The Senior Notes are unsecured unsubordinated obligations of the Company and rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which Senior Notes were issued contain customary covenants. The Company used the net proceeds from the sale of the Senior Notes for repayment of a portion of its commercial paper.<br/>&#160;<br/>In June 2009, the Company entered into two five year interest rate swap agreements with notional amounts of $150 million each. These interest rate swap agreements were designated as fair value hedges of the changes in fair value of a portion of the Company&#8217;s fixed-rate $550 million Senior Notes due 2014. On the first interest rate swap agreement, the Company pays variable interest equal to the one-month London Interbank Offered Rate (LIBOR) plus 134 basis points and it receiv es a fixed interest rate of 4.50 percent. For the second interest rate swap agreement, the Company pays variable interest equal to the one-month LIBOR plus 137.25 basis points and it receives a fixed interest rate of 4.50 percent. The outstanding market value of these swap agreements was a $6 million unrealized gain at July 31, 2009 which is recorded in long-term debt with the offset recorded in other assets on the condensed consolidated balance sheet.<br/>&#160;<br/>Contingent Convertible Debentures<br/>&#160;<br/>As of July 31, 2009 and April 24, 2009, the Company has $15 million remaining in aggregate principal amount of 1.250 percent Contingent Convertible Debentures, Series B due 2021 (the Debentures) outstanding. Interest is payable semi-annually. Each Debenture is convertible into shares of common stock at an initial conversion price of $61.81 per share; however, the Debentures are not convertible before their final maturity unless the closing price of our common stock reaches 110 percent of the conversion price for 20 trading days during a consecutive 30 trading day period.&#160; Upon conversion of the Debentures, the Company will pay holders cash equal to the lesser of the principal amount of the Debentures or their conversion value, and shares of the Company&#8217;s common stock to the extent the conversion value exceeds the principal amount of the Debentures. The Company may be required to repurchase the remaining debentures at the option of the holders in September 2011 or 2016. For put options exercised by the holders of the Debentures, the purchase price is equal to the principal amount of the applicable debenture plus any accrued and unpaid interest thereon to the repurchase date. If the put option is exercised, the Company will pay holders the repurchase price solely in cash. The Company can redeem the debentures for cash at any time.<br/>&#160;<br/>Commercial Paper<br/>&#160;<br/>The Company maintains a commercial paper pr ogram that allows the Company to have a maximum of $2.250 billion in commercial paper outstanding, with maturities up to 364&#160;days from the date of issuance. As of July 31, 2009 and April 24, 2009, outstanding commercial paper totaled $506 million and $385 million, respectively. During the three months ended July 31, 2009, the weighted average original maturity of the commercial paper outstanding was approximately 46 days, and the weighted average interest rate was 0.25 percent. The issuance of commercial paper reduces the amount of credit available under our existing lines of credit.<br/><br/>Bank Borrowings&#160;&#160;&#160;<br/><br/>Bank borrowings consist primarily of borrowings from non-U.S. banks at interest rates considered favorable by management and where natural hedges can be gained for foreign exchange purposes.<br/>&#160;<br/>Lines of Credit<br/>&#160;<br/>The Company has existing unsecured lines of credit of approximatel y $2.839 billion with various banks at July 31, 2009. The existing lines of credit include a five-year $1.750 billion syndicated credit facility dated December&#160;20, 2006 that will expire on December 20, 2011 (Credit Facility). The Credit Facility provides backup funding for the commercial paper program and may also be used for general corporate&#160;purposes. The Credit Facility provides the Company with the ability to increase its capacity by an additional $500 million at any time during the life of the five-year term of the agreement.<br/><br/>As of July 31, 2009 and April 24, 2009, the Company has unused lines of credit and commercial paper capacity of approximately $2.681 billion and $2.799 billion, respectively. <br/>&#160;<br/>Interest rates on these borrowings are determined by a pricing matrix, based on the Company&#8217;s long-term debt ratings, assigned by Standard and Poor&#8217;s Ratings Group and Moody&#8217;s Investors Service. Facility fees are payable on the credit facilities and are determined in the same manner as the interest rates.</p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 10 &#8211; Derivatives and Foreign Exchange Risk Management<br/><br/>The Company uses operational and economic hedges, as well as forward exchange derivative contracts to manage the impact of foreign exchange rate changes on earnings and cash flows. In order to reduce the uncertainty of foreign exchange rate movements, the Company enters into derivative instruments, primarily forward exchange contracts, to manage its exposure related to foreign exchange rate changes. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets, liabilities, net investments and probable commitments. At inception of the forward contract, the derivative is designated as either a fre estanding derivative, net investment hedge or cash flow hedge. Principal currencies hedged are the Euro and the Japanese Yen. The Company does not enter into forward exchange derivative contracts for speculative purposes. The gross notional amount of these contracts outstanding at July 31, 2009 and April 24, 2009 was $5.656 billion and $5.296 billion, respectively. The aggregate foreign currency gains/(losses) were $39 million and $(64) million for the three months ended July 31, 2009 and July 25, 2008, respectively. These gains/(losses) represent the net impact to the condensed consolidated statements of earnings for the derivative instruments presented below offset by remeasurement gains/(losses) on foreign currency denominated assets and liabilities.<br/><br/>The information that follows explains the various types of derivatives and financial instruments used by the Company, how and why the Company uses such instruments, how such instruments are accounted for and how such instruments impact th e Company&#8217;s condensed consolidated balance sheets and statements of earnings. <br/><br/>Freestanding Derivative Forward Contracts<br/><br/>Freestanding derivative forward contracts are used to offset the Company&#8217;s exposure to the change in value of certain foreign currency denominated assets and liabilities. These derivatives are not designated as hedges, and therefore, changes in the value of these forward contracts are recognized currently in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities. The cash flows from these contracts are reported as operating activities in the consolidated statements of cash flows. The gross notional amount of these contracts, not designated as hedging instruments, outstanding at July 31, 2009 was $1.266 billion. <br/><br/>The amount of losses and location of the losses in the condensed consolidated statement of earnings related to derivative instrum ents not designated as hedging instruments for the three months ended July 31, 2009 were as follows: <br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="287" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="11" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="11" height="17" align="left"><font size="2"><i>&#160;</i></font></td><td width="177" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="11" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="16" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="178" height="17" align="left"><font size="2" ><b>&#160;</b></font></td></tr><tr><td width="287" height="30" align="left" style="border-bottom: 1px solid #000000;"><font size="2"><b>Derivatives Not Designated as Hedging Instruments under SFAS No. 133</b></font></td><td width="11" height="30" align="center"><font size="2"><b>&#160;</b></font></td><td width="11" height="30" align="center"><font size="2"><b>&#160;</b></font></td><td width="177" height="30" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Location</b></font></td><td width="11" height="30" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="194" height="30" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Amount</b></font></td></tr><tr>& lt;td width="287" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">Foreign exchange contracts</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="177" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">Other expense, net</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="178" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(95)</font></td></tr></table></div><div><font size="2"><p>Net Investment Hedges<br/><br/>Net inve stment hedges are used to hedge the long-term investment (equity) in foreign operations. For hedges that meet effectiveness requirements, the net gains/(losses) related to changes in the current rates, or spot rates, are recorded as a cumulative translation adjustment, a component of accumulated other comprehensive (loss)/ income (AOCI) on the consolidated balance sheets. Net gains/(losses) associated with changes in forward rates of the contracts are reflected in other expense, net in the consolidated statements of earnings. Recognition in earnings of amounts previously recorded as a cumulative translation adjustment is limited to circumstances such as complete or substantially complete liquidation of the long-term investment (equity) in foreign operations. The cash flows from these contracts are reported as investing activities in the consolidated statements of cash flows. As of July 31, 2009, there were no open net investment hedge contracts. For the three months ended July 31, 2009, there were no reclass ifications of the effective portion of net investment hedges out of AOCI into income; therefore, consistent with the fourth quarter of fiscal year 2009, $27 million in gains remained in cumulative translation within AOCI.<br/><br/></p></font></div><div><font size="2"><p>Cash Flow Hedges<br/><br/>Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions, denominated in a foreign currency that will take place in the future. For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. No gains or losses relating to ineffectiveness of cash flow hedges were recognized in earnings during the three months ended July 31, 2009 and July 25, 2008. No co mponents of the hedge contracts were excluded in the measurement of hedge ineffectiveness and no hedges were derecognized or discontinued during the three months ended July 31, 2009 and July 25, 2008. The cash flows from these contracts are reported as operating activities in the consolidated statements of cash flows. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at July 31, 2009 was $4.090 billion and will mature within the subsequent 36-month period.<br/><br/>The amount of gains/(losses) and location of the gains/(losses) in the condensed consolidated statement of earnings and other comprehensive income (OCI) related to derivative instruments designated as cash flow hedges for the three months ended July 31, 2009 are as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="156" height="45" align="left"><font size="2"><b>(in millions)< /b></font></td><td width="11" height="45" align="center"><font size="2"><b>&#160;</b></font></td><td width="16" height="45" align="right"><font size="2">&#160;</font></td><td width="194" height="45" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Gross Losses Recognized in OCI on Effective Portion of Derivative</b></font></td><td width="10" height="45" align="right"><font size="2">&#160;</font></td><td width="10" height="45" align="right"><font size="2">&#160;</font></td><td colspan="4" width="309" height="45" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effective Portion of Gains on Derivative Reclassified from AOCI into Income</b></font></td></tr><tr><td width="156" height="49" align="left" style="border-bottom: 1px solid #00000 0;"><font size="2"><b>Derivatives in SFAS No. 133 Cash Flow Hedging Relationships</b></font></td><td width="11" height="49" align="center"><font size="2"><b>&#160;</b></font></td><td width="16" height="49" align="center"><font size="2">&#160;</font></td><td width="194" height="49" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Amount</b></font></td><td width="10" height="49" align="center"><font size="2"><b>&#160;</b></font></td><td width="10" height="49" align="center"><font size="2"><b>&#160;</b></font></td><td width="141" height="49" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Location</b></font></td><td width="11" height="49" align="cen ter" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="16" height="49" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="141" height="49" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Amount</b></font></td></tr><tr><td width="156" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">Foreign exchange contracts</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">$</font></td><td width="194" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(340)</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td width="141" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">Other expense, net</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">$</font></td><td width="141" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">23&#160;</font></td></tr><tr><td width="156" height="17" align="center"><font size="2">&#160;</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">&#160;</font></td><td width="194" height=" 17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td width="141" height="17" align="center"><font size="2">Cost of products sold</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">&#160;</font></td><td width="141" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">8&#160;</font></td></tr><tr><td width="156" height="18" align="left"><font size="2"><b>Total</b></font></td><td width="11" height="18" align="center"><font size="2"><b>&#160;</b& gt;</font></td><td width="16" height="18" align="right"><font size="2">$</font></td><td width="194" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(340)</font></td><td width="10" height="18" align="center"><font size="2">&#160;</font></td><td width="10" height="18" align="center"><font size="2">&#160;</font></td><td width="141" height="18" align="center"><font size="2">&#160;</font></td><td width="11" height="18" align="center"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">$</font></td><td width="141" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">31&#160;</font></td></tr></table></div>& lt;div><font size="2"><p>As of July 31, 2009, the Company had a balance of $1 million in after-tax net unrealized gains associated with cash flow hedging instruments recorded in AOCI. The Company expects that $4 million in losses of this balance will be reclassified into the consolidated statement of earnings over the next twelve months.<br/><br/>Fair Value Hedges<br/><br/>For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivatives as well as the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in current earnings.<br/><br/>Interest rate derivative instruments designated as fair value hedges are designed to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, the Company agrees to exchange, at specified intervals, the difference between fixed and floating inter est amounts calculated by reference to an agreed-upon notional principal amount.<br/><br/>As of July 31, 2009, the Company had interest rate swaps designated as fair value hedges of underlying fixed rate obligations. In June 2009, the Company entered into two fixed-to-floating interest rate swap agreements with an aggregate notional amount of $300 million designated as fair value hedges of the fixed interest rate obligation under the existing $550 million, 5 year, 4.50 percent New Senior Notes that were issued in March 2009. These fair value hedges are 100 percent effective and, thus, there is no net impact on earnings. As a result, the market value of these interest rate swap agreements is a $6 million unrealized gain at July 31, 2009 which is recorded as an increase in long-term debt with the offset recorded as an increase in other assets on the condensed consolidated balance sheet. The gross notional amount of these contracts, designated as fair value hedges outstanding at July 31, 2009 was $3 00 million.<br/><br/></p></font></div><div><font size="2"><p>During the three months ended July 31, 2009 and July 25, 2008, the Company did not have any ineffective fair value hedging instruments. In addition, the Company did not recognize any gains or losses during the three months ended July 31, 2009 and July 25, 2008 on firm commitments that no longer qualify as fair value hedges. <br/><br/>Balance Sheet Presentation<br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br/>The following table summarizes the location and fair value amounts of derivative instruments reported in the condensed consolidated balance sheet as of July 31, 2009. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not, and are further segregated by type of contract within those two categories.<br/></p>&l t;/font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="264" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="4" width="229" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Asset Derivatives</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="4" width="229" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Liability Derivatives</b></font></td></tr><tr><td width="264" height="31" align="left"><font size="2"><b>(in millions)</b></font></td><td width="106" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b> Balance Sheet Location</b></font></td><td width="10" height="31" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="17" height="31" align="right" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="96" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td><td width="18" height="31" align="center"><font size="2"><b>&#160;</b></font></td><td width="106" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Balance Sheet Location</b></font></td><td width="11" height="31" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&# 160;</b></font></td><td width="16" height="31" align="right" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="96" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td></tr><tr><td width="264" height="34" align="left"><font size="2"><b>Derivatives designated as hedging instruments </b></font></td><td width="106" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="10" height="34" align="left"><font size="2">&#160;</font></td><td width="17" height="34" align="right"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&am p;#160;</font></td><td width="18" height="34" align="left"><font size="2">&#160;</font></td><td width="106" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="11" height="34" align="left"><font size="2">&#160;</font></td><td width="16" height="34" align="right"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="264" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">Foreign exchange contracts</font></td><td width="106" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">Prepaid expenses and other current assets</font></td><td width="10" height="51" align="left" style="background-colo r: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">98&#160;</font></td><td width="18" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="106" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">Other accrued expenses</font></td><td width="11" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">52&#160;</font></td& gt;</tr><tr><td width="264" height="17" align="left"><font size="2">Interest rate contracts</font></td><td width="106" height="17" align="left"><font size="2">Other assets</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="17" height="17" align="right"><font size="2">&#160;</font></td><td width="96" height="17" align="right"><font size="2">6&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="106" height="17" align="left"><font size="2">&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">&#160;</font></td><td width="96" height="17" align="left"><font size="2">& amp;#160;</font></td></tr><tr><td width="264" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">Foreign exchange contracts</font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">Other assets</font></td><td width="10" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="right" style="border-bottom: 1px solid #000000;background-color: #C0C0C0;"><font size="2">64&#160;</font></td><td width="18" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size= "2">Other long-term liabilities</font></td><td width="11" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="right" style="border-bottom: 1px solid #000000;background-color: #C0C0C0;"><font size="2">10&#160;</font></td></tr><tr><td width="264" height="35" align="left"><font size="2"><b>Total derivatives designated as hedging instruments </b></font></td><td width="106" height="35" align="left"><font size="2">&#160;</font></td><td width="10" height="35" align="left"><font size="2">&#160;</font></td><td width="17" height="35" align="right"><font size="2">$</font></td><td width="96" height="35" align="rig ht" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2"><b>168&#160;</b></font></td><td width="18" height="35" align="left"><font size="2"><b>&#160;</b></font></td><td width="106" height="35" align="left"><font size="2">&#160;</font></td><td width="11" height="35" align="left"><font size="2">&#160;</font></td><td width="16" height="35" align="right"><font size="2">$</font></td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2"><b>62&#160;</b></font></td></tr><tr><td width="264" height="18" align="left"><font size="2">&#160;</font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="17" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="18" height="18" align="left"><font size="2">&#160;</font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="264" height="34" align="left" style="background-color: #C0C0C0;"><font size="2"><b>Derivatives not designated a s hedging instruments </b></font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="10" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="18" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="11" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width ="16" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td></tr><tr><td width="264" height="51" align="left"><font size="2">Foreign exchange contracts</font></td><td width="106" height="51" align="left"><font size="2">Prepaid expenses and other current assets</font></td><td width="10" height="51" align="left"><font size="2">&#160;</font></td><td width="17" height="51" align="right"><font size="2">$</font></td><td width="96" height="51" align="right" style="border-bottom: 1px solid #000000;"><font size="2">1&#160;</font></td><td width="18" height="51" align="left"><font size="2">&#160;</font></td><td width="106" height="51" align="left">< ;font size="2">Other accrued expenses</font></td><td width="11" height="51" align="left"><font size="2">&#160;</font></td><td width="16" height="51" align="right"><font size="2">$</font></td><td width="96" height="51" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="264" height="35" align="left" style="background-color: #C0C0C0;"><font size="2"><b>Total derivatives not designated as hedging instruments </b></font></td><td width="106" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="10" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="35" align="right" style="background-color: #C0C0C0;"><font size="2">$</font& gt;</td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;background-color: #C0C0C0;"><font size="2"><b>1&#160;</b></font></td><td width="18" height="35" align="left" style="background-color: #C0C0C0;"><font size="2"><b>&#160;</b></font></td><td width="106" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="11" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="35" align="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;background-color: #C0C0C0;"><font size="2"><b>&#160;-&#160;</b></font></td>& lt;/tr><tr><td width="264" height="18" align="left"><font size="2">&#160;</font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="17" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2"><b>&#160;</b></font></td><td width="18" height="18" align="left"><font size="2"><b>&#160;</b></font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">&#160;</font></td><td widt h="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="264" height="18" align="left"><font size="2"><b>Total derivatives</b></font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="17" height="18" align="right"><font size="2">$</font></td><td width="96" height="18" align="right" style="border-bottom: 3px double #000000;"><font size="2"><b>169&#160;</b></font></td><td width="18" height="18" align="left"><font size="2"><b>&#160;</b></font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="11" height="18" align="lef t"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">$</font></td><td width="96" height="18" align="right" style="border-bottom: 3px double #000000;"><font size="2"><b>62&#160;</b></font></td></tr></table></div><div><font size="2"><p>Concentrations of Credit Risk<br/><br/>Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist principally of interest-bearing investments, forward exchange derivative contracts and trade accounts receivable.<br/><br/>The Company maintains cash and cash equivalents, investments and certain other financial instruments (including forward exchange contracts) with various major financial institutions. The Company performs periodic evaluations of the relative credit standings of these financial institutions and limits the amount of credit ex posure with any one institution.<br/><br/>Concentrations of credit risk with respect to trade accounts receivable are limited due to the large number of customers and their dispersion across many geographic areas. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. However, a significant amount of trade receivables are with national healthcare systems in many countries. Although the Company does not currently foresee a credit risk associated with these receivables, repayment is dependent upon the financial stability of the economies of those countries. As of July 31, 2009 and April 24, 2009, no customer represented more than 10 percent of the outstanding accounts receivable.<br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 11 &#8211; Inventories<br/><br/>Inventories are stated at the lower of cost or market, with cost determined on a first-in, first-out basis. Inventory balances are as&#160;follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td rowspan="2" width="530" height="31" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="16" height="31" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="15" align="center"><font size="2"><b>July 31, </b></font></td><td width="14" height="15" align="left"><font size="2"> ;&#160;</font></td><td colspan="2" width="84" height="15" align="center"><font size="2"><b>April 24,</b></font></td></tr><tr><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="84" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td></tr><tr><td width="530" height="17" align="left"><font size="2">Finished goods</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width=" 65" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">884&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="65" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">854&#160;</font></td></tr><tr><td width="530" height="17" align="left"><font size="2">Work in process</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">&#160;</font></td><td width="65" height="17" align="right"><font size="2">262&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;< /font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="65" height="17" align="right"><font size="2">251&#160;</font></td></tr><tr><td width="530" height="17" align="left"><font size="2">Raw materials</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="65" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">346&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="65" height="17" ali gn="right" style="border-bottom: 1px solid #000000;"><font size="2">321&#160;</font></td></tr><tr><td width="530" height="18" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Total</font></td><td width="16" height="18" align="left"><font size="2">&#160;</font></td><td width="18" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="65" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">1,492&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="65" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">1,426&#160;</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 12 &#8211; Goodwill and Other Intangible Assets<br/><br/>The changes in the carrying amount of goodwill for the three months ended July 31, 2009 are as follows:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="623" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="76" height="17" align="center"><font size="2"><b>July 31, </b></font></td></tr><tr><td width="623" height="17" align="left"><font size="2"><b>(in millions)</b></fo nt></td><td width="14" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="76" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td></tr><tr><td width="623" height="17" align="left"><font size="2"><b>Balance at April 24, 2009</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">8,195&#160;</font></td></tr><tr><td width="623" height="17" align="left"><font size="2">Purchase accounting adjustments, net</font></td><td width="14" height="17" align="le ft"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(5)</font></td></tr><tr><td width="623" height="17" align="left"><font size="2">Currency adjustment, net</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">36&#160;</font></td></tr><tr><td width="623" height="18" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="14" height="18" align="left"><font size="2">&am p;#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">8,226&#160;</font></td></tr></table></div><div><font size="2"><p>Intangible assets, excluding goodwill, as of July 31, 2009 and April 24, 2009 are as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="326" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="3" width="9" height="50" align="center"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Purchased</b></font>< /td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" align="center"><font size="2"><b>Trademarks</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="63" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="63" height="17" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="326" height="16" align="left"><font size="2">&#160;</font></td><td colspan= "2" width="101" height="16" align="center"><font size="2"><b>Technology and</b></font></td><td width="14" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="16" align="center"><font size="2"><b>and</b></font></td><td width="13" height="16" align="left"><font size="2">&#160;</font></td><td width="19" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td width="63" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td width="9" height="16" align="left"><font size="2">&#160;</font></td><td width="19" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td width="63" height="16" align="left"><font size="2"><b>&#160;</b></font>& lt;/td></tr><tr><td width="326" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Patents</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Tradenames</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Other</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" ali gn="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Total</b></font></td></tr><tr><td width="326" height="17" align="left"><font size="2"><b>As of July 31, 2009:</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;< /font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">Amortizable intangible assets</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td ><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td>< ;td width="63" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Original cost</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="82" height="17" align="right"><font size="2">3,057&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">373&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left">< font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">236&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">3,666&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Accumulated amortization</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(855)</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(226)</font></td><td width="13" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(177)</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63 " height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(1,258)</font></td></tr><tr><td width="326" height="18" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Carrying value</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="82" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,202&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td wid th="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">147&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">59&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,408& amp;#160;</font></td></tr><tr><td width="326" height="18" align="left"><font size="2">&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="82" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="63" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td& gt;<td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="63" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="63" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2"><b>As of April 24, 2009:</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td& gt;<td width="82" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td>< /tr><tr><td width="326" height="17" align="left"><font size="2">Amortizable intangible assets</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">& #160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Original cost</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="82" height="17" align="right"><font size="2">3,057&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" heig ht="17" align="right"><font size="2">373&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">238&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">3,668&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Accumulated amortization</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="borde r-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(801)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(217)</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(173)</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(1,191)</font></td></tr><tr><td width="326" height="18" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Carrying value</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="82" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,256&#160;</font></td><td width="14" height="18" align="left"&g t;<font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">156&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">65&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000; border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,477&#160;</font></td></tr></table></div><div><font size="2"><p>Amortization expense for the three months ended July 31, 2009 and July 25, 2008 was $78 million and $66 million, respectively.<br/>&#160;<br/>Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets is as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="563" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="31" height="34" align="left"><font size="2">&#160;</font></td><td colspan="2" width="11 9" height="17" align="center"><font size="2"><b>Amortization</b></font></td></tr><tr><td width="563" height="17" align="left"><font size="2"><b>Fiscal Year</b></font></td><td colspan="2" width="119" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Expense</b></font></td></tr><tr><td width="563" height="17" align="left"><font size="2">Remaining 2010</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">230&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">201 1&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">294&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2012&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">268&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2013&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="1 9" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">252&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2014&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">243&#160;</font></td></tr><tr><td width="563" height="17" align="left"><font size="2">Thereafter</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="1 7" align="right" style="border-bottom: 1px solid #000000;"><font size="2">1,121&#160;</font></td></tr><tr><td width="563" height="18" align="left"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,408&#160;</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 13 &#8211; Warranty Obligation<br/>&#160;<br/>The Company offers a warranty on various products. The Company estimates the costs that may be incurred under its warranties and records a liability in the amount of such costs at the time the product is sold. Factors that affect the Company&#8217;s warranty liability include the number of units sold, historical and anticipated rates of warranty claims and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. The amount of the reserve recorded is equal to the costs to repair or otherwise satisfy the claim. The Company includes the covered costs associated with field actions, if any, in warranty expense. <br/> ;<br/>During the three months ended July 31, 2009, the Company recorded a $16 million warranty provision related to the July 2009 supplier-related Paradigm Quick-set infusion set field action in its Diabetes business. See the &#8220;Net Sales&#8221; section of management&#8217;s discussion and analysis for additional information. <br/>&#160;<br/>Changes in the Company&#8217;s product warranties during the three months ended July 31, 2009 and July 25, 2008 consisted of the&#160;following:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="414" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="249" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months end ed</b></font></td></tr><tr><td rowspan="2" width="414" height="34" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="64" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="119" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="11" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="119" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td colspan="2" width="119" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="11" height="1 7" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="414" height="17" align="left"><font size="2"><b>Balance at the beginning of the period </b></font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">35&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font> </td><td width="100" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">43&#160;</font></td></tr><tr><td width="414" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Warranty claims provision </font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">26&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">9&#160;</font></td></tr><tr><td width="414" height="17" align="left" ><font size="2">&#160;&#160;&#160;&#160;&#160;Settlements made </font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(16)</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(7)</font></td></tr><tr><td width="414" height="18" align="left"><font size="2"><b>Balance at the end of the period </b> ;</font></td><td width="64" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">45&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">45&#160;</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 14 &#8211; Interest Expense/(Income), net<br/>&#160;<br/>Interest income and interest expense for the three months ended July 31, 2009 and July 25, 2008 are as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="476" height="17" align="center"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="242" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="476" height="22" align="left"> <font size="2"><b>(in millions)</b></font></td><td width="10" height="22" align="center"><font size="2">&#160;</font></td><td colspan="2" width="117" height="22" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="8" height="22" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="117" height="22" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 25, 2008</b></font></td></tr><tr><td width="476" height="17" align="left"><font size="2">Interest income</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="bor der-top: 1px solid #000000;"><font size="2">$</font></td><td width="98" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(38)</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="98" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(52)</font></td></tr><tr><td width="476" height="17" align="left"><font size="2">Interest expense</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="98" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">104&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="98" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">99&#160;</font></td></tr><tr><td width="476" height="18" align="left"><font size="2">Interest expense, net</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="98" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">66&#160;< ;/font></td><td width="8" height="18" align="left" style="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="98" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">47&#160;</font></td></tr><tr><td width="476" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="98" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width ="8" height="18" align="left" style="border-top: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="98" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td colspan="7" width="728" height="33" align="left"><font size="2">Interest expense, net for the three months ended July 25, 2008 has been retrospectively adjusted for the impact of the adoption of FSP APB No. 14-1. See Note 3 for additional information.</font></td></tr><tr><td width="476" height="13" align="left"><font size="2">&#160;</font></td><td width="10" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2">&#160; </font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td><td width="8" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2">&#160;</font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td></tr><tr><td colspan="13" width="728" height="37" align="left"><font size="2">Interest income includes interest earned on the Company's cash and cash equivalents, short- and long-term investments and the net realized gain or loss on the sale or impairment of AFS debt securities. See Note 7 for further discussion of these items. </font></td></tr><tr><td width="476" height="13" align="left"><font size="2">&#160;</font></td><td width="10" height="13" align="left"><font size="2">&#160;</font>< ;/td><td width="19" height="13" align="left"><font size="2">&#160;</font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td><td width="8" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2">&#160;</font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td></tr><tr><td colspan="13" width="728" height="36" align="left"><font size="2">Interest expense includes the expense associated with the interest that the Company pays on its outstanding borrowings, including short- and long-term instruments, and the amortization of debt issuance costs and debt discounts.</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 15 &#8211; Income Taxes<br/>&#160;<br/>During the three months ended July 31, 2009, the Company recorded a $7 million benefit associated with Irish research and development credit claims, finalization of certain foreign tax returns and changes to uncertain tax position reserves. These tax adjustments are operational in nature and are recorded in provision for income taxes on the condensed consolidated statements of earnings. <br/><br/>During the three months ended July 31, 2009, the Company&#8217;s gross unrecognized tax benefits increased from $431 million to $471 million. In addition, the Company has accrued interest and penalties of $120 million as of July 31, 2009. If all of the Company&#8217;s unrecognized tax benefits were recognized, approximately $402 million would impact the Company&#8217;s effective tax rate. The Company continues to record the liability for unrecognized tax benefits as a long-term liability as it does not expect significant payments to occur or the total amount of unrecognized tax benefits to change significantly over the next twelve months. The Company will continue to recognize interest and penalties related to income tax matters in the provision for income taxes in the condensed consolidated statements of earnings and record the liability in the current or long-term accrued income taxes in the condensed consolidated balance sheets, as appropriate.<br/>&#160;<br/>As of July 31, 2009, there have been no changes to significant unresolved matters with the U.S. Internal Revenue Service or foreign tax authorities from what was previously disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended April 24, 2009. <br/></p></font></div></ body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 16 &#8211; Earnings Per Share<br/>&#160;<br/>Basic earnings per share is computed based on the weighted average number of common shares outstanding. Diluted earnings per share is computed based on the weighted average number of common shares outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan.<br/><br/>I n the first quarter of fiscal year 2010, the Company adopted FSP EITF No. 03-6-1. See Note 3 for additional information regarding the adoption of FSP EITF No. 03-6-1. <br/><br/>Presented below is a reconciliation between basic and diluted earnings per share:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="510" height="17" align="center"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="209" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="510" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="12" height="34" align="center"><font size="2">&#160;</font> </td><td colspan="2" width="95" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="31" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="510" height="17" align="left"><font size="2"><b>(shares in millions)</b></font></td><td colspan="2" width="95" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #00000 0;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="510" height="17" align="left"><font size="2"><b>Numerator: </b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="76" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td w idth="510" height="17" align="left"><font size="2">Net earnings</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="76" height="17" align="right"><font size="2">445&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">723&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2"><b>Denominator:</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</fon t></td><td width="76" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Basic &#8211; weighted average shares outstanding</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right"><font size="2">&#160;1,112.6&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td widt h="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">1,125.2&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Effect of dilutive securities:</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left">&l t;font size="2">Employee stock options</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right"><font size="2">0.3&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">4.9&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Employee restricted stock and restricted stock units</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#16 0;</font></td><td width="76" height="17" align="right"><font size="2">1.2&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">0.7&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Other</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="76" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;0.5&#160;</font></td><td width="31" height="17" align="left"><font size="2"& gt;&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">0.9&#160;</font></td></tr><tr><td width="510" height="22" align="left"><font size="2">Diluted &#8211; weighted average shares outstanding</font></td><td width="12" height="22" align="left"><font size="2">&#160;</font></td><td width="19" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;</font></td><td width="76" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,114.6&#160;</font></td><td width="31" height="22" align="left"><font size ="2">&#160;</font></td><td width="19" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,131.7&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="76" height="17" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Basic earnings per share</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="76" height="17" align="right"><font size="2">0.40&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">0.64&#160;</font></td></tr> <tr><td width="510" height="17" align="left"><font size="2">Diluted earnings per share</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="76" height="17" align="right"><font size="2">&#160;0.40&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">&#160;0.64&#160;</font></td></tr></table></div><div><font size="2"><p>The calculation of weighted average diluted shares outstanding excludes options for approximately 64&#160;million and 22 million common shares for the three months ended July 31, 2009 and July 25 , 2008, respectively, as the exercise price of those options was greater than the average market price for the period, resulting in an anti-dilutive effect on diluted earnings per share. For the three months ended July 31, 2009 and July 25, 2008, common share equivalents related to the Company&#8217;s $4.400 billion of Senior Convertible Notes were anti-dilutive as the market price of the Company&#8217;s stock was below the conversion price of the Senior Convertible Notes and, therefore, were excluded from the calculation of weighted average diluted shares.</p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 17 &#8211; Comprehensive Income and Accumulated Other Comprehensive (Loss)/Income<br/>&#160;<br/>In addition to net earnings, comprehensive income includes changes in foreign currency translation adjustments (including the change in current exchange rates, or spot rates, of net investment hedges), unrealized gains and losses on foreign exchange derivative contracts qualifying and designated as cash flow hedges, net changes in retirement obligation funded status and unrealized gains and losses on AFS marketable securities. Comprehensive income for the three months ended July 31, 2009 and July 25, 2008 was $441 million and $801 million,&#160;respectively.<br/>&#160;<br/>Presented below is a summary of activity for each component o f accumulated other comprehensive (loss)/income:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="209" height="74" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="78" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Unrealized Gain/(Loss) on Investments</b></font></td><td width="16" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="71" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Cumulative Translation Adjustments</b></font></td><td width="16" height="74" align="left"><font size="2">&#160;</font></td><td colsp an="2" width="79" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Net Change in Retirement Obligations</b></font></td><td width="11" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Unrealized Gain/(Loss) on Foreign Exchange Derivatives</b></font></td><td width="15" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="89" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Accumulated Other Comprehensive Income/(Loss)</b></font></td></tr><tr><td width="209" height="17" align="left"><font size="2"><b>Balance April 24, 2009</b></font></td><td width="13" height="17" align="left"> <font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="59" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(95)</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="52" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">62&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(398)</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="53" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">228&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="70" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(202)</font></td></tr><tr><td width="209" height="34" align="left"><font size="2">Impact of Adoption of FSP FAS Nos. 115-2 and 124-2</font></td><td width="13" height="34" align="left"><font size="2">&#16 0;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="59" height="34" align="right"><font size="2">&#160;(3)</font></td><td width="16" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="52" height="34" align="right"><font size="2">&#160;-&#160;</font></td><td width="16" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="60" height="34" align="right"><font size="2">&#160;-&#160;</font></td><td width="11" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size= "2">&#160;</font></td><td width="53" height="34" align="right"><font size="2">&#160;-&#160;</font></td><td width="15" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="70" height="34" align="right"><font size="2">(3)</font></td></tr><tr><td width="209" height="17" align="left"><font size="2">Period Change</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="59" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">50&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="52" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">179&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(7)</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="53" height="17" align="right" style="border-b ottom: 1px solid #000000;"><font size="2">(227)</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="70" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(5)</font></td></tr><tr><td width="209" height="18" align="left"><font size="2"><b>Balance July 31, 2009</b></font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="59" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">& amp;#160;(48)</font></td><td width="16" height="18" align="left" style="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="52" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;241&#160;</font></td><td width="16" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(405)</font></td><td width="11" height="18" align="left" s tyle="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="53" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1&#160;</font></td><td width="15" height="18" align="left" style="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="70" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">(210)</font></td></tr></table></div><div><font size="2"><p>Translation adjus tments are not adjusted for income taxes as substantially all translation adjustments relate to permanent investments in non-U.S. subsidiaries. The tax benefit on the unrealized loss on foreign exchange derivatives for the three months ended July 31, 2009 was $113 million. The tax expense on the unrealized gain on investments for the three months ended July 31, 2009 was $28 million. The tax benefit on the net change in retirement obligations was not material for the three months ended July 31, 2009. See Note 7 for additional information regarding the adoption of FSP SFAS Nos. 115-2 and 124-2. <br/></p></font></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 18 &#8211; Stock-Based Compensation<br/>The Company follows the provisions in FASB SFAS No. 123 (revised 2004), &#8220;Share-Based Payment&#8221; (SFAS No. 123(R)). Under the fair value recognition provisions of SFAS No. 123(R), the Company measures stock-based compensation cost at the grant date based on the fair value of the award and recognizes the compensation expense over the requisite service period, which is generally the vesting period. The Company elected the modified-prospective method of adopting SFAS No. 123(R), under which prior periods were not retroactively restated. The provisions of SFAS No. 123(R) apply to awards granted after the April 29, 2006 effective date. Stock-based compensation expense for the non-vested portion of awards granted prior to the effective date is being recognized over the remaining service period using the fair-value based compensation cost estimated for FASB SFAS No. 123, &#8220;Accounting for Stock-Based Compensation,&#8221; pro forma disclosures.<br/>The following table presents the components and classification of stock-based compensation expense recognized for the three months ended July 31, 2009 and July 25, 2008:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="515" height="17" align="center"><font size="2">&#160;</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="174" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="5 15" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="11" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="8" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="515" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width= "8" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Stock options</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">33&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height ="17" align="right" style="border-top: 1px solid #000000;"><font size="2">33&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Restricted stock awards</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">24&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">17&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Employee stock purchase plan</font></td><td width="11 " height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">5&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">5&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Total stock-based compensation expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td w idth="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">62&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">55&#160;</font></td></tr><tr><td width="515" height="23" align="left"><font size="2">&#160;</font></td><td width="11" height="23" align="left"><font size="2">&#160;</font></td><td width="19" heigh t="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="8" height="23" align="left"><font size="2">&#160;</font></td><td width="19" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Cost of products sold</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right">< font size="2">7&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">7&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Research and development expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">15&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" heig ht="17" align="right"><font size="2">13&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Selling, general and administrative expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">40&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">35&#160;</font></td>< /tr><tr><td width="515" height="17" align="left"><font size="2">Total stock-based compensation expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">62&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">55&#160;</font></t d></tr><tr><td width="515" height="17" align="left"><font size="2">&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Income tax benefits</font></td> <td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(19)</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(15)</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align= "left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Total stock-based compensation expense, net of tax</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 3px double #000000;"><font size="2">$</font></td&g t;<td width="64" height="17" align="right" style="border-bottom: 3px double #000000;"><font size="2">43&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-bottom: 3px double #000000;"><font size="2">40&#160;</font></td></tr></table></div></body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 19 &#8211; Retirement Benefit Plans<br/>&#160;<br/>The Company sponsors various retirement benefit plans, including defined benefit pension plans (pension benefits), post-retirement medical plans (post-retirement benefits), defined contribution savings plans and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. The net periodic benefit cost of the pension and post-retirement medical plans include the following components for the three months ended July 31, 2009 and July 25, 2008:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="190" height="17" align="center"><font size="2">& amp;#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>U.S. Pension Benefits</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="157" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Non-U.S. Pension Benefits</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Post-Retirement Benefits</b></font></td></tr><tr><td width="190" height="17" align="center"><font size="2">&#160;</font ></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="157" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="190" height="17" al ign="left"><font size="2">&#160;</font></td><td rowspan="2" width="12" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="13" height="17" align="left" style="border-top: 1px solid #000000;"& gt;<font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="190" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="72" height="17" align="center" style= "border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="12" height="17" align="left"><font size="2" >&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="190" height="18" align="left"><font size="2">Service cost</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;15&#160;</font></td><td width=" 12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;18&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align= "right" style="border-top: 1px solid #000000;"><font size="2">&#160;8&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;3&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Interest cost</font></td><td width= "12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;17&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;15&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;5&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font ></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;6&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;4&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;3&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Expected return on plan assets</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(25)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(24)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(6)</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width=" 12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(6)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(2)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(3)</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Amortization of net actuarial loss</font></td><td width="12" height="17" align="left"><font size="2"> &#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" s tyle="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width ="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Net periodic benefit cost</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2" >&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;10&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;6&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;8&#160;</font></td><td width="12" height="17" align="left"&g t;<font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;5&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Special termination benefits</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align=" right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&# 160;-&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;2&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000 ;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="190" height="35" align="left"><font size="2">Total cost for period</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;14&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"> <font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;10&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;6&#160;</font></td><td width="13" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;8&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;7&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;4&#160;</font></td></ tr><tr><td width="190" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="l eft" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width= "12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr></table></div><div><font size="2"><p>As a result of the fiscal year 2009 restructuring initiative that began in the fourth quarter of fiscal year 2009, the Company has recognized special termination benefits in the three months ended July 31, 2009 related to employees electing to accept early retirement packages provided under the restructuring initiatives. The incremental expense from these special termination benefits is reflected in the table&#160;above. See Note 6 for additional information regarding the fiscal year 2009 restructuring initiative. <br/></p></font></div>< /body></html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 20 &#8211; Contingencies<br/>&#160;<br/>The Company is involved in a number of legal actions. The outcomes of these legal actions are not within the Company&#8217;s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost revenues. In accordance with SFAS No. 5, &#8220;Accounting for Contingencies&#8221; (SFAS No. 5), the Company records a liability in the consolidated financial statements for these actions when a loss is known or considered probable and the amount can be reasonably estimated. I f the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. While it is not possible to predict the outcome for most of the matters discussed, the Company believes it is possible that costs associated with them could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position or cash flows. <br/>Litigation with Wyeth and Cordis Corporation<br/>On February 22, 2008, Wyeth and Cordis Corporation (Cordis) filed a lawsuit against the Company and its subsidiary, Medtronic AVE, Inc., in U.S. District Court for the District of New Jersey, alleging that Medtronic&#8217;s Endeavor drug-eluting stent infringes t hree U.S. &#8220;Morris&#8221; patents alleged to be owned by Wyeth and exclusively licensed to Cordis. The Company is indemnified for the claims made by Wyeth and Cordis. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Litigation with Abbott Cardiovascular Systems Inc.<br/>On July 27, 2009, Medtronic announced global resolution of all outstanding intellectual property litigation with Abbott. The terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. Both parties also agreed to a cross-license of the disputed patents within the defined field. The $444 million pre-tax settlement amount includes a $400 million payment to be made to Abbott and a $42 million success payment to be made to evYsio. In addition, a $2 million payment is to be made to evYsio in connection with an amendment to the parties&#8217; existing agreement in order to expand the scope of the definition of the license field from evYsio. In the first quarter of fiscal year 2010, the Company recorded an expense in the amount of $444 million relating to the matter.<br/>Litigation with DePuy Spine<br/>On January 26, 2001, DePuy Spine (formerly DePuy/AcroMed), a subsidiary of Johnson &amp; Johnson, and Biedermann Motech GmbH (collectively, DePuy) filed suit in U.S. District Court for the District of Massachusetts alleging that Medtronic&#8217;s subsidiary, Medtronic Sofamor Danek USA, Inc. (MSD), was infringing a patent relating to a design for a thoracolumbar multi-axial screw (MAS). DePuy subsequently supplemented its allegations to claim that MSD&#8217;s M10, M8 and Vertex screws infringe the patent. On April 17, 2003 and February 26, 2004, the District Court ruled on summary judgment that the M10, M8 and Vertex screws do no t infringe. On October 1, 2004, a jury found that MAS screws, which MSD no longer sells in the U.S., infringe under the doctrine of equivalents. The jury awarded damages of $21 million and on February 9, 2005, the Court entered judgment against MSD, including prejudgment interest, in the aggregate amount of $24 million. In the third quarter of fiscal year 2005, the Company recorded an expense equal to the $24 million judgment in the matter. DePuy appealed the Court&#8217;s decisions that the M10, M8 and Vertex screws do not infringe, and MSD appealed the jury&#8217;s verdict that the MAS screws infringe valid claims of the patent. On November 20, 2006, the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the District Court that the M10 and M8 screws do not infringe, affirmed the jury&#8217;s verdict and damage award on the MAS screws, affirmed the decision that the Vertex screws do not literally infringe, but remanded the case, ruling that there is a triable issue of fact as to whether the Vertex screws infringe under the doctrine of equivalents. On remand, DePuy further supplemented its allegations to claim that an additional product, the Vertex Max screws, also infringe. On March 20, 2007, the District Court declined to stay execution of the judgment relating to the MAS product. On March 30, 2007, the judgment plus accrued interest was paid under protest. On September 27, 2007, a jury found that the Vertex and Vertex Max screws infringe under the doctrine of equivalents and awarded $226 million in damages to DePuy, and the District Court entered judgment against Medtronic on December 12, 2007. Thereafter, the District Court ruled on all post-trial motions, increasing the award to DePuy to an estimated amount of $272 million. The District Court also granted a permanent injunction against Medtronic that prohibits Medtronic from making, using and selling Vertex and Vertex Max polyaxial screws in the U.S.; however, Medtronic&#8217;s Vertex Select multi-axial screw is not affe cted by the injunction. Medtronic appealed to the U.S. Court of Appeals for the Federal Circuit. DePuy cross-appealed. On June 1, 2009, the Court of Appeals for the Federal Circuit affirmed the determination of infringement and award of lost profits, but reversed the remaining elements of the damages awarded. The court remanded the case to the District Court for the calculation of post-judgment interest on damages of $149 million. In the fourth quarter of fiscal year 2009, the Company recorded an expense in the amount of $178 million relating to the matter. The District Court entered a final judgment, including pre- and post-judgment interest in the aggregate amount of $179 million on June 29, 2009. Medtronic satisfied the judgment with a payment of $179 million to DePuy on June 30, 2009.<br/>Marquis/Maximo/InSync Matters<br/>On February 10, 2005, Medtronic voluntarily began to advise physicians about the possibility that a specific battery shorting mechanism might manifest itself in a subset o f implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). These included certain Marquis VR/DR and Maximo VR/DR ICDs and certain InSync I/II/III CRT-D devices. Subsequent to this voluntary field action, a number of lawsuits were filed against the Company alleging a variety of claims, including individuals asserting claims of personal injury and third party payors alleging entitlement to reimbursement. Many of these lawsuits were settled, and in the third quarter of fiscal year 2008, the Company recorded an expense of $123 million relating to the settlement in accordance with SFAS No. 5 as the potential loss was both probable and reasonably estimable. The Company paid substantially all of the $123 million in the first quarter of fiscal year 2009. One third party payor , Kinetic Knife, dismissed its original action without prejudice and subsequently filed a putative class action relating to the same subject matter. Medtronic removed the action to federal co urt in the District of Minnesota and filed a motion to dismiss, which is pending. In addition, class action product liability suits pending in Canada are consolidated in the Ontario Superior Court of Justice. That court certified a class proceeding on December 6, 2007 and denied Medtronic&#8217;s leave to appeal certification on May 15, 2008. The class was certified to include individual implant recipients and their family members. In addition, the subrogated claims of the provincial health insurers to recover costs incurred in providing medical services to the implant class are claimed in the class proceeding. Pretrial proceedings are underway. The Company has not recorded an expense related to damages for the remaining suits because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Sprint Fidelis Product Liability Matters<br/>On October 15, 2007, the Company voluntarily suspended worldwide distribution of its Sprint Fidelis (Fidelis) family of defibr illation leads. The leads are used to deliver therapy in patients with ICDs, but are generally not used in pacemaker patients. The U.S. Food and Drug Administration (FDA) subsequently classified the Company&#8217;s action as a Class I recall. As of August 1, 2009, approximately 1,350 lawsuits regarding the Fidelis leads have been filed against the Company, including approximately 37 putative class action suits reflecting a total of approximately 2,400 individual personal injury cases. In general, the suits allege claims of product liability, warranty, negligence, unjust enrichment, emotional distress and consumer protection violations. One lawsuit includes a claim by an individual purporting to act as a surrogate for the Center for Medicare and Medicaid Services, and one lawsuit has been brought by a third party payor as a putative class action suit. In addition, one putative class action has been filed in the Ontario Superior Court of Justice in Canada. Approximately 485 of the lawsuits have been filed in state court, generally alleging similar causes of action. Of those state court actions, approximately 470 are consolidated before a single judge in Hennepin County District Court in the state of Minnesota. Oral arguments on Medtronic&#8217;s motion to dismiss the Minnesota cases were heard on September 4, 2009. The federal court cases have been consolidated for pretrial proceedings before a single federal judge in the U.S. District Court for the District of Minnesota pursuant to the Multi-District Litigation (MDL) rules. On January 5, 2009, the MDL court entered an order dismissing with prejudice the master consolidated complaint for individuals and the master consolidated complaint for third party payors on grounds of federal preemption. On May 12, 2009, the MDL court denied plaintiffs&#8217; request to file a motion for reconsideration of the dismissals and plaintiffs&#8217; motion seeking permission to amend the master consolidated complaint. The court dismissed with prejudice 229 cases tha t adopted the master consolidated complaint and stayed all other cases pending further order of the court. Plaintiffs in the 229 cases filed a notice of appeal to the Eighth Circuit Court of Appeals on May 29, 2009. The Company has not recorded an expense related to damages in connection with the matter because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Shareholder Related Matters<br/>On November 8, 2007, Stanley Kurzweil filed a putative class action complaint against the Company and certain of its officers in the U.S. District Court for the District of Minnesota, alleging violations of Section 10(b) of the Securities Exchange Act of 1934 (the Exchange Act) and Rule 10b-5 thereunder. The complaint is brought on behalf of persons or entities who purchased securities of Medtronic during the period of June 25, 2007 through October 15, 2007. The complaint alleges that &#8220;materially false and misleading&#8221; representations were made as to the market acceptance and use of the Fidelis defibrillator leads to artificially inflate Medtronic&#8217;s stock price. Pursuant to court order, the caption of the case was changed to Medtronic, Inc., Securities Litigation, and a consolidated putative class action complaint was filed on April 18, 2008. On March 10, 2009, the court entered an order dismissing the complaint with prejudice and denying plaintiffs leave to amend. Plaintiffs&#8217; motion to alter the judgment was denied on May 29, 2009. Plaintiffs have filed an appeal to the Eighth Circuit Court of Appeals.<br/><br/>On November 29 and December 14, 2007 respectively, Feivel Gottlieb and Alan Weinberg filed shareholder derivative actions in Hennepin County District Court in the state of Minnesota against both the Company and certain of its officers and directors, alleging breach of fiduciary duty, waste of corporate assets and other claims arising from the same subject matter as the consolidated class action complaint. On July 28, 2008, the state court stayed these actions pending final resolution of the related consolidated class action complaint. <br/><br/>On January 9, 2009, Richard Gulbrandsen filed a similar shareholder derivative action against both the Company and certain of its officers, directors and employees in Hennepin County District Court in the state of Minnesota, alleging breach of fiduciary duty and other claims arising from the same subject matter as the Markewich putative class action complaint. On April 9, 2009, the court stayed the action until resolution of the Markewich matter pursuant to a stipulation of the parties. On July 10, 2009, the case was dismissed without prejudice pursuant to stipulation of the parties.<br/><br/>In addition, on August 11, 2008, Mark Brown filed a complaint against the Company and certain directors, officers and other company personnel in the U.S. District Court for the District of Minnesota, alleging violations of the Employee Retirement Income Security A ct of 1974 arising from the same subject matter as the consolidated putative class complaint. The complaint was filed on behalf of a putative class of participants in and beneficiaries of the Medtronic, Inc. Savings and Investment Plan, whose individual accounts held shares of Company stock at any time from February 15, 2007 to November 19, 2007. On December 29, 2008, the plaintiff amended the complaint to add similar allegations relating to alleged off-label promotion of INFUSE Bone Graft and to amend the class to include participants in the plan from February 15, 2007 to December 12, 2008. The defendants&#8217; motion to dismiss was granted on May 26, 2009. Plaintiffs have filed an appeal to the Eighth Circuit Court of Appeals.<br/><br/>On December 11, 2008, the Minneapolis Firefighters&#8217; Relief Association filed a putative class action complaint against the Company and two of its officers in the U.S. District Court for the District of Minnesota, alleging violations of Section 10( b) of the Exchange Act and Rule 10b-5 thereunder. The complaint is brought on behalf of persons or entities who purchased securities of Medtronic from November 19, 2007 through November 17, 2008. The complaint alleges that the defendants made false and misleading public statements concerning the INFUSE Bone Graft product which artificially inflated Medtronic&#8217;s stock price during the period. On May 28, 2009, the court order appointed a lead plaintiff and lead counsel. On August 1, 2009, plaintiffs filed a consolidated putative class action complaint making similar allegations but expanding the class to include those persons or entities who purchased securities of Medtronic from November 20, 2006 to November 17, 2008. <br/><br/>On February 24, 2009, Christin Wright filed a complaint against the Company and certain directors, officers and other company personnel in the United States District Court for the District of Minnesota, alleging violations of the Employee Retirement Income Secur ity Act of 1974. The complaint was filed purportedly on behalf of a putative class comprised of participants and beneficiaries of the Medtronic, Inc. Savings and Investment Plan, whose individual accounts held shares of company stock at any time from June 28, 2006 to November 18, 2008. The plaintiff claims the defendants breached fiduciary duties by allegedly failing to properly disclose the September 2008 settlement of the litigation with Fastenetix, LLC and the October 2008 settlement of the Cordis litigation. Medtronic&#8217;s motion to dismiss the complaint is scheduled for hearing on October 19, 2009.<br/>The Company has not recorded an expense related to damages in connection with these shareholder related matters because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Mirowski<br/>Medtronic is a licensee to the RE 38,119 patent (&#8216;119 Patent) and RE 38,897 patent (&#8216;897 Patent) owned by Mirowski Family Ventures, LLC (M irowski) relating to the treatment of hemodynamic dysfunction. Medtronic and Mirowski dispute the application of the &#8216;119 and &#8216;897 Patents to certain Medtronic cardiac resynchronization products. The parties entered into a tolling agreement deferring and conditioning any litigation of the dispute upon conditions precedent. The tolling agreement expired on October 1, 2007. In subsequent notices, Mirowski identified certain claims of the two patents that Mirowski asserts Medtronic is using. On December 17, 2007, Medtronic filed an action in U.S. District Court in Delaware seeking a declaration that none of its products infringe any valid claims of either the &#8216;119 or &#8216;897 Patents. If certain conditions are fulfilled, the &#8216;119 and/or &#8216;897 Patents are determined to be valid and the Medtronic products are found to infringe the &#8216;119 and/or &#8216;897 Patents, Medtronic will be obligated to pay royalties to Mirowski based upon sales of certain CRT-D products. A trial date has not been set. As of July 31, 2009, the amount of disputed royalties and interest related to CRT-D products is $105 million. This amount has not been accrued because the outcome is not currently probable under SFAS No. 5. <br/><br/>In addition, Medtronic is a licensee to the 4,407,288 Patent (&#8216;288 Patent) owned by Mirowski relating to ICDs. Until November 2001, Medtronic accrued and paid royalties under the license based on a percentage of ICD sales. Medtronic and Mirowski dispute the application of the &#8216;288 Patent to certain Medtronic ICD products. In November 2001, Medtronic ceased paying royalties and entered into an agreement with Mirowski to pay putative royalties into an interest-bearing escrow account through the expiration of the &#8216;288 Patent in December of 2003. As of July 31, 2009, the current balance in the interest-bearing escrow account is $86 million. The parties also entered into a tolling agreement deferring and conditi oning any litigation of the obligation to pay royalties upon certain conditions precedent. If these conditions are fulfilled and the &#8216;288 Patent determined to be invalid or Medtronic&#8217;s products found not to infringe, the escrowed funds will be released to Medtronic. <br/>In the normal course of business, the Company periodically enters into agreements that require it to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising out of the Company&#8217;s products or the negligence of its personnel or claims alleging that its products infringe third-party patents or other intellectual property. The Company&#8217;s maximum exposure under these indemnification provisions cannot be estimated, and the Company has not accrued any liabilities within the consolidated financial statements. Historically, the Company has not experienced significant losses on these types of indemnifications.</p></font></div></body>&l t;/html> <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 21 &#8211; Segment and Geographic Information<br/>&#160;<br/>Segment information:<br/>&#160;<br/>The Company functions in seven operating segments, consisting of CRDM, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control.<br/><br/>Each of the Company&#8217;s operating segments have similar economic characteristics, technology, manufacturing processes, customers, distribution and marketing strategies, regulatory environments and shared infrastructures. Net sales by operating segment are as&#160;follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="536" height="17" align="ce nter"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="188" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="7" height="17" align="center"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="12" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="96" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="9" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" w idth="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="96" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"&g t;<font size="2">Cardiac Rhythm Disease Management</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="82" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;1,337&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">1,303&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font s ize="2">Spinal</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;915&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">859&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">CardioVascular </font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17 " align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;689&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">631&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Neuromodulation</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;373&#160;</ font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">348&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Diabetes</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;295&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font si ze="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">269&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Surgical Technologies</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;227&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">202&#160;</font></td><td width="7 " height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Physio-Control</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;97&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">94&#160;</font></td><td width="7" hei ght="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="18" align="left"><font size="2"><b>Total Net Sales</b></font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="14" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="82" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,933&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #0 00000;border-bottom: 3px double #000000;"><font size="2">3,706&#160;</font></td><td width="7" height="18" align="left"><font size="2">&#160;</font></td></tr></table></div><div><font size="2"><p>In December 2006, the Company announced its intention to pursue a spin-off of Physio-Control into an independent, publicly traded company. However, as discussed in the &#8220;Other Matters&#8221; section of the management&#8217;s discussion and analysis, the Company announced, in January 2007, a voluntary suspension of U.S. shipments of Physio-Control products manufactured at its facility in Redmond, Washington in order to address quality system issues. The Company continues to work with the FDA to address the quality system issues that must be resolved in order to resume unrestricted distribution of its external defibrillators. As a result of this issue, the Company&#8217;s plans to pursue a spin-off of Physio-C ontrol are on hold for at least through the end of fiscal year 2010. As additional information, Physio-Control&#8217;s income/(loss) before interest and income taxes for the three months ended July 31, 2009 and July 25, 2008 was $8 million and $(5) million, respectively.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="547" height="17" align="left"><font size="2"><i>Geographic information</i></font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160; </font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">&#160;</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Net sales to external customers by geography are as follows:</font></td ><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">&#160;</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font&g t;</td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="22" align="center"><font size="2">&#160;</font></td><td width="47" height="22" align="center"><font size="2">&#160;</font></td><td colspan="5" width="153" height="22" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="547" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="47" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="69" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="547" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="69" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font> </td></tr><tr><td width="547" height="17" align="left"><font size="2">United States</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="53" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;2,391&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="50" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">2,249&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Europe</font></td>& lt;td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="53" height="17" align="right"><font size="2">968&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="50" height="17" align="right"><font size="2">949&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Asia Pacific</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="53" height="17" align="right"><font size="2">453&#160 ;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="50" height="17" align="right"><font size="2">386&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Other Foreign</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="53" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">121&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px s olid #000000;"><font size="2">&#160;</font></td><td width="50" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">122&#160;</font></td></tr><tr><td width="547" height="18" align="left"><font size="2"><b>Total Net Sales</b></font></td><td width="47" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="53" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,933&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="50" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,706&#160;</font></td></tr></table></div></body></html> EX-101.SCH 4 mdt-20090731.xsd 00100 - Document - Document Information link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements of Earnings (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00105 - Document - Entity Information link:presentationLink link:calculationLink link:definitionLink 00601 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00602 - Disclosure - New Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00604 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 00606 - Disclosure - Restructuring Charges link:presentationLink link:calculationLink link:definitionLink 00607 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 00608 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00609 - Disclosure - Financing Arrangements link:presentationLink link:calculationLink link:definitionLink 00611 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00612 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00613 - Disclosure - Warranty Obligation link:presentationLink link:calculationLink link:definitionLink 00614 - Disclosure - Interest Expense (Income), net link:presentationLink link:calculationLink link:definitionLink 00615 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00616 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 00617 - Disclosure - Comprehensive Income and Accumulated Other Comprehensive (Loss) Income link:presentationLink link:calculationLink link:definitionLink 00618 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 00619 - Disclosure - Retirement Benefit Plans link:presentationLink link:calculationLink link:definitionLink 00620 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 00621 - Disclosure - Segment and Geographic Information link:presentationLink link:calculationLink link:definitionLink 00610 - Disclosure - Derivatives and Foreign Exchange Risk Management link:presentationLink link:calculationLink link:definitionLink 00603 - Disclosure - Retrospective Adoption of Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00605 - Disclosure - Certain Litigation Charges link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 mdt-20090731_cal.xml EX-101.DEF 6 mdt-20090731_def.xml EX-101.LAB 7 mdt-20090731_lab.xml Accumulated other comprehensive loss Accumulated depreciation Accumulated depreciation Acquisitions, net of cash acquired Acquisitions, net of cash acquired Allowances for accounts receivable Statement of Financial Position [Abstract] Amortization of discount on senior convertible notes Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Interest paid Accounts receivable Accounts receivable Accounts payable and accrued liabilities Accounts payable and accrued liabilities [N] Inventories Inventories Change in short-term borrowings, net Change in operating assets and liabilities, net of effect of acquisitions Contingencies [Text Block] Common stock-par value $0.10 Comprehensive Income and Accumulated Other Comprehensive (Loss)/Income [Text Block] Cost of products sold Current liabilities Total current liabilities Total current liabilities Short-term borrowings Long-term debt Financing Arrangements [Text Block] Deferred income taxes Derivatives and Foreign Exchange Risk Management [Text Block] Diluted earnings per share Effect of exchange rate changes on cash and cash equivalents Stock-based compensation Impairment of Intangible Assets (Excluding Goodwill) Income Statement [Abstract] Income Taxes [Text Block] Income taxes paid Income tax receivable Other intangible assets, net Inventories, Net Inventories Investments [Abstract] Liabilities and Shareholders' Equity Liabilities and shareholders' equity Total liabilities and shareholders' equity Total liabilities Liabilities Long-term investments Financing Activities Net cash (used in) provided by financing activities Net cash (used in) provided by financing activities Investing Activities Net cash used in investing activities Net cash used in investing activities Operating Activities Net cash provided by operating activities Net cash provided by operating activities Net earnings Net earnings Net change in cash and cash equivalents Net change in cash and cash equivalents Retrospective Adoption of Accounting Pronouncements [Text Block] Other expense, net Other expense, net Basis of Presentation [Text Block] Other operating assets and liabilities Other operating assets and liabilities Prepaid expenses and other current assets Other investing activities, net Other investing activities, net Dividends to shareholders Dividends to shareholders Retirement Benefit Plans [Text Block] Issuance of common stock Warranty Obligation [Text Block] Property, plant and equipment Property, plant and equipment [Abstract] Property, plant and equipment, net Property, plant and equipment, net Provision for doubtful accounts Purchases of marketable securities Purchases of marketable securities Additions to property, plant and equipment Additions to property, plant and equipment Accounts receivable, less allowances of $63 and $61, respectively Payments on long-term debt Payments on long-term debt Repurchase of common stock Repurchase of common stock Restructuring Charges [Abstract] Restructuring charges Restructuring Charges [Text Block] Retained earnings Sales and maturities of marketable securities Net sales Inventories [Text Block] Short-term investments Segment and Geographic Information [Text Block] Selling, general, and administrative expense Shareholders' equity Goodwill and Other Intangible Assets [Text Block] Current assets Total current assets Total current assets Diluted weighted average shares outstanding Basic weighted average shares outstanding Research and development expense Total assets Total assets Other accrued expenses Other long-term liabilities Cash dividends declared per common share Long-term deferred tax assets, net Stock-Based Compensation [Text Block] Deferred tax assets, net Long-term deferred tax liabilities, net Assets Fair Value Measurements [Text Block] Basic earnings per share Excess tax benefit from exercise of stock-based awards Excess tax beneft from exercise of stock-based awards, operating activities Excess tax benefit from exercise of stock-based awards Preferred stock, par value Other assets Earnings before income taxes Earnings before income taxes Common stock, par value Total shareholders' equity Total shareholders' equity Provision for income taxes Preferred stock-par value $1.00 Costs and expenses Earnings Per Share [Text Block] Accrued income taxes Long-term accrued income taxes Depreciation and amortization Accounts payable Commitments and contingencies (Note 20) Adjustment to reconcile net earnings to net cash provided by operating activities Amendment Description Amendment Flag Current Fiscal Year End Date Document Period End Date Document Type Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Purchased in process research and development charges The amount of purchased research and development assets that are acquired in a business combination or in a transaction other than a business combination have no alternative future use and are therefore written off in the period of acquisition. Certain litigation charges Amount related to material litigation charges recognized in the period in the statement of earnings. Excludes the amount of expense provided in the period for legal fees. Acquisitions [Text Block] Description of a business acquisition (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. This disclosure also includes a description of the amount written off in the period of purchased research and development assets that are acquired in a business combination or in a transaction other than a business combination that have no alternative future use. Acquisitions and In Process Research and Development Charges [Text Block] Interest expense (income), net Net amount of interest expense or income. Interest expense includes the expense associated with the interest paid on outstanding borrowings, including short- and long-term instruments, and the amortization of debt issuance costs and debt discounts. Interest income includes interest earned on cash and cash equivalents, short- and long-term investments and the net realized gains or losses on the sale of available-for-sale securities. Interest expense, net Supplemental Cash Flow Information Long-term accrued compensation and retirement benefits This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans, the aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer), and the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer). Interest Expense (Income), net [Text Block] Discloses the gross amounts of interest income and expense recognized during the period. Interest Expense/(Income), net [Text Block] Total Costs and Expenses Total costs and expenses Total costs of sales and expenses for the period. Accrued compensation Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the current portion of the liability for the underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans. Investments [Text Block] This item represents the entire disclosure related to investments in debt and equity securities with readily determinable fair values, equity method investments in common stock, and investments accounted for under the cost-method. Entity Information Basis of Presentation [Abstract] New Accounting Pronouncements [Abstract] Acquisitions [Abstract] Fair Value Measurements [Abstract] Financing Arrangements [Abstract] Inventories [Abstract] Goodwill and Other Intangible Assets [Abstract] Warranty Obligation [Abstract] Interest Expense (Income), net [Abstract] Income Taxes [Abstract] Comprehensive Income and Accumulated Other Comprehensive (Loss) Income [Abstract] Stock-Based Compensation [Abstract] Retirement Benefit Plans [Abstract] Contingencies [Abstract] Segment and Geographic Information [Abstract] Condensed Consolidated Balance Sheets [Parenthetical] [Abstract] Derivatives and Foreign Exchange Risk Management [Abstract] Retrospective Adoption of Accounting Pronouncements [Abstract] Certain Litigation Charges [Abstract] Certain Litigation Charges [Text Block] This element represents the complete disclosure related to certain litigation charges. Certain litigation charges are amounts related to material litigation recognized in the statement of earnings. Certain litigation (payments) receipts Net amount related to material litigation paid or received in the period. Excludes amount paid in the period for legal fees. Certain litigation payments Document Information Goodwill Statement of Cash Flows [Abstract] New Accounting Pronouncements [Text Block] For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the new pronouncement, the date that adoption is required and the date that the entity plans to adopt, if earlier; (2) discuss the methods of adoption allowed by the pronouncement and the method expected to be utilized by the entity, if determined; (3) discuss the impact that adoption of the pronouncement is expected to have on the financial statements of the entity, unless such impact is not known or reasonably estimable (in which case, a statement to that effect should be made) and; (4) disclose the potential impact of other significant matters that the entity believes might result from the adoption of the pronounce ment (for example, technical violations of debt covenant agreements and planned or intended changes in business practices.) Description of New Accounting Pronouncements Not Yet Adopted Earnings Per Share [Abstract] Cash and Cash Equivalents Period Increase (Decrease) [Abstract] EX-101.PRE 8 mdt-20090731_pre.xml XML 9 R19.xml IDEA: Warranty Obligation 1.0.0.3 false Warranty Obligation false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_WarrantyObligationAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_ProductWarrantyDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 13 &#8211; Warranty Obligation<br/>&#160;<br/>The Company offers a warranty on various products. The Company estimates the costs that may be incurred under its warranties and records a liability in the amount of such costs at the time the product is sold. Factors that affect the Company&#8217;s warranty liability include the number of units sold, historical and anticipated rates of warranty claims and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. The amount of the reserve recorded is equal to the costs to repair or otherwise satisfy the claim. The Company includes the covered costs associated with field actions, if any, in warranty expense. <br/><br/>During the three months ended July 31, 2009, the Company recorde d a $16 million warranty provision related to the July 2009 supplier-related Paradigm Quick-set infusion set field action in its Diabetes business. See the &#8220;Net Sales&#8221; section of management&#8217;s discussion and analysis for additional information. <br/>&#160;<br/>Changes in the Company&#8217;s product warranties during the three months ended July 31, 2009 and July 25, 2008 consisted of the&#160;following:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="414" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="249" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td rowspan="2" width="414" height="34" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="64" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="119" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="11" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="119" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td colspan="2" width="119" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td>&l t;td colspan="2" width="119" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="414" height="17" align="left"><font size="2"><b>Balance at the beginning of the period </b></font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">35&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="17" align="right" style="border-top: 1 px solid #000000;"><font size="2">43&#160;</font></td></tr><tr><td width="414" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Warranty claims provision </font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">26&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">9&#160;</font></td></tr><tr><td width="414" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;S ettlements made </font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(16)</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(7)</font></td></tr><tr><td width="414" height="18" align="left"><font size="2"><b>Balance at the end of the period </b></font></td><td width="64" height="18" align="left"><f ont size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">45&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">45&#160;</font></td></tr></table></div></body></html> Note 13 &#8211; Warranty Obligation&#160;The Company offers a warranty on various products. The Company estimates the costs that may be incurred under its false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 10 R11.xml IDEA: Certain Litigation Charges 1.0.0.3 false Certain Litigation Charges false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_CertainLitigationChargesAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 mdt_CertainLitigationChargesTextBlock mdt false na duration string This element represents the complete disclosure related to certain litigation charges. Certain litigation charges are... false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 5 &#8211; Certain Litigation Charges<br/><br/>The Company classifies material litigation reserves recognized as certain litigation charges. During the three months ended July 31, 2009, the Company recorded certain litigation charges of $444 million related to the global resolution of all outstanding intellectual property litigation with Abbott Laboratories (Abbott). The terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. Both parties also agreed to a cross-license of the disputed patents within the defined field. The $444 million settlement amount includes a $400 million payment to be made to Abbott and a $42 million success payment to be made to evYsio Medical Devices, LLC (evYsi o). In addition, a $2 million payment is to be made to evYsio in connection with an amendment to the parties&#8217; existing agreement in order to expand the scope of the definition of the license field from evYsio.<br/><br/>During the three months ended July 25, 2008, there were no certain litigation charges.</p></font></div></body></html> Note 5 &#8211; Certain Litigation ChargesThe Company classifies material litigation reserves recognized as certain litigation charges. During the three months false false This element represents the complete disclosure related to certain litigation charges. Certain litigation charges are amounts related to material litigation recognized in the statement of earnings. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 11 R10.xml IDEA: Acquisitions 1.0.0.3 false Acquisitions false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_AcquisitionsAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 mdt_AcquisitionsAndInProcessResearchAndDevelopmentChargesTextBlock mdt false na duration string Description of a business acquisition (or series of individually immaterial business combinations) completed during the... false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 4 &#8211; Acquisitions<br/>&#160;<br/>During the first quarter of fiscal year 2010, the Company adopted SFAS No. 141(R), &#8220;Business Combinations&#8221; (SFAS No. 141(R)). SFAS No. 141(R) replaced SFAS No. 141, &#8220;Business Combinations.&#8221; SFAS No. 141(R) establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interests in the acquiree and the goodwill acquired. SFAS No. 141(R) retains the underlying purchase method of accounting for acquisitions, but incorporates a number of changes. These changes include the capitalization of purchased in-process research and development (IPR&amp;D), expensing of acquisition related costs and the recognition of conting ent purchase price consideration at fair value at the acquisition date. In addition, changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period will be recognized in earnings rather than as an adjustment to the cost of the acquisition. This accounting treatment for taxes is applicable to acquisitions consummated both prior to and subsequent to the adoption of SFAS No. 141(R). The adoption of SFAS No. 141(R) did not change the requirement to expense IPR&amp;D immediately with respect to asset acquisitions. With the exception of deferred tax asset valuation allowances and acquired income tax uncertainties related to previous acquisitions, this statement will be applied prospectively to business combinations consummated after fiscal year 2009. The adoption of SFAS No. 141(R) did not have a material impact on our condensed consolidated financial statements during the three months ended July 31, 2009. <br/><br/>When th e Company acquires another company or a group of assets, the purchase price is allocated, as applicable, among IPR&amp;D, other identifiable intangible assets, net tangible assets and goodwill, if any, as required by U.S. GAAP. Goodwill represents the excess of the aggregate purchase price over the fair value of net assets, including IPR&amp;D, of acquired businesses. The values assigned to IPR&amp;D and other identifiable intangible assets are based on valuations that have been prepared using methodologies and valuation techniques consistent with those used by independent appraisers. These techniques include estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values utilizing an appropriate risk-adjusted rate of return (discount rate). The discount rate used is determined at the time of the acquisition in accordance with accepted valuation methods. For IPR&amp;D, these methodologies include consideration of the risk of the p roject not achieving commercial feasibility and include a factor that takes into account the uncertainty surrounding the successful development of the IPR&amp;D.<br/>&#160;<br/>At the time of acquisition, the Company plans that all acquired IPR&amp;D will reach technological feasibility, but there can be no assurance that the commercial viability of these products will actually be achieved. The nature of the efforts to develop the acquired technologies into commercially viable products consists principally of planning, designing and conducting clinical trials necessary to obtain regulatory approvals. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, and patent issuance, validity and litigation, if any. If commercial viability were not achieved, the Company would likely look to other alternative uses for the same technol ogy.<br/><br/>Fiscal Year 2010<br/><br/>There were no significant acquisitions during the three months ended July 31, 2009.<br/><br/>Fiscal Year 2009<br/>&#160;</p></font></div><div><font size="2"><p>Restore Medical Acquisition<br/>&#160;<br/>In July 2008, the Company acquired Restore Medical, Inc. (Restore). Restore&#8217;s Pillar Palatal Implant System provides the Company with a minimally invasive, implantable medical device used to treat the soft palate component of sleep breathing disorders, including mild to moderate obstructive sleep apnea and snoring. The Company accounted for the acquisition as a business combination. Restore shareholders received $1.60 per share in cash for each share of Restore common stock they owned. Total consideration for the transaction, net of cash acquired, was approximately $29 million. In connection with the acquisition of Restore, the Company acquired $17 million of te chnology-based intangible assets with an average estimated useful life of 10 years, $8 million of net tangible assets and $5 million of goodwill. The goodwill is not deductible for tax purposes. The pro forma impact of the Restore acquisition was not significant to the results of the Company for the three months ended July 25, 2008. The results of operations have been included in the Company&#8217;s consolidated statements of earnings since the date of acquisition.<br/><br/>Contingent Consideration<br/>&#160;<br/>Certain of the Company&#8217;s business combinations or purchases of intellectual property involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones and/or various other favorable operating conditions. While it is not certain if and/or when these payments will be made, the Company has developed an estimate of the potential contingent consideration for each of its acquisitions with an ou tstanding potential obligation. At July 31, 2009, the estimated potential amount of future contingent consideration that the Company is expected to make associated with all business combinations or purchases of intellectual property is approximately $399 million. The milestones associated with the contingent consideration must be reached in future periods ranging from fiscal years 2010 to 2016 in order for the consideration to be paid.<br/><br/></p></font></div></body></html> Note 4 &#8211; Acquisitions&#160;During the first quarter of fiscal year 2010, the Company adopted SFAS No. 141(R), &#8220;Business Combinations&#8221; (SFAS false false Description of a business acquisition (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. This disclosure also includes a description of the amount written off in the period of purchased research and development assets that are acquired in a business combination or in a transaction other than a business combination that have no alternative future use. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 12 R8.xml IDEA: New Accounting Pronouncements 1.0.0.3 false New Accounting Pronouncements false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_NewAccountingPronouncementsAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 mdt_NewAccountingPronouncementsTextBlock mdt false na duration string For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the... false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 2 &#8211; New Accounting Pronouncements<br/><br/>In December 2008, the FASB issued FSP Statement of Financial Accounting Standards (SFAS) No. 132(R)-1, &#8220;Employers&#8217; Disclosures About Postretirement Benefit Plan Assets&#8221; (FSP SFAS No. 132(R)-1). FSP SFAS No. 132(R)-1 requires increased disclosures about an entity&#8217;s postretirement benefit plan assets. Specifically, FSP SFAS No. 132(R)-1 requires an entity to disclose information regarding its investment policies and strategies, its categories of plan assets, its fair value measurements of plan assets and any significant concentrations of risk in plan assets. FSP SFAS No. 132(R)-1 is effective for the Company beginning in the first quarter of fiscal year 2010 but only requires the revised annual disclosures on a prospective basis. The Co mpany will provide the additional disclosures necessary to the consolidated financial statements beginning in the Company&#8217;s fiscal year 2010 Annual Report on Form 10-K.<br/><br/>In June 2009, the FASB issued SFAS No. 168, &#8220;The FASB Accounting Standards Codification&#8482; and the Hierarchy of Generally Accepted Accounting Principles&#8221; (SFAS No. 168). SFAS No. 168 replaces SFAS No. 162, &#8220;The Hierarchy of Generally Accepted Accounting Principles,&#8221; and establishes the FASB Accounting Standards Codification (the Codification) as the source of authoritative accounting principles to be applied by nongovernmental entities in the preparation of financial statements. In addition, SFAS No. 168 explicitly recognizes rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws as authoritative GAAP for SEC registrants. On the effective date of SFAS No. 168, all nongrandfathered, non-SEC accou nting literature not included in the Codification is deemed nonauthoritative. SFAS No. 168 will be effective for the Company beginning in the second quarter of fiscal year 2010. Upon adoption, the Company will reference GAAP by using the numbering system prescribed by the Codification. As the Codification was not intended to change existing GAAP, it will not have any impact on the Company&#8217;s consolidated financial statements. <br/><br/></p></font></div></body></html> Note 2 &#8211; New Accounting PronouncementsIn December 2008, the FASB issued FSP Statement of Financial Accounting Standards (SFAS) No. 132(R)-1, false false For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the new pronouncement, the date that adoption is required and the date that the entity plans to adopt, if earlier; (2) discuss the methods of adoption allowed by the pronouncement and the method expected to be utilized by the entity, if determined; (3) discuss the impact that adoption of the pronouncement is expected to have on the financial statements of the entity, unless such impact is not known or reasonably estimable (in which case, a statement to that effect should be made) and; (4) disclose the potential impact of other significant matters that the entity believes might result from the adoption of the pronouncement (for example, technical violations of debt covenant agreements and planned or intended changes in business practices.) No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 13 R22.xml IDEA: Earnings Per Share 1.0.0.3 false Earnings Per Share false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 us-gaap_EarningsPerShareAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_EarningsPerShareTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 16 &#8211; Earnings Per Share<br/>&#160;<br/>Basic earnings per share is computed based on the weighted average number of common shares outstanding. Diluted earnings per share is computed based on the weighted average number of common shares outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan.<br/><br/>In the first quarter of fiscal year 2010, the Company adopted FSP EI TF No. 03-6-1. See Note 3 for additional information regarding the adoption of FSP EITF No. 03-6-1. <br/><br/>Presented below is a reconciliation between basic and diluted earnings per share:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="510" height="17" align="center"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="209" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="510" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="12" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="95" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="31" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="510" height="17" align="left"><font size="2"><b>(shares in millions)</b></font></td><td colspan="2" width="95" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></f ont></td></tr><tr><td width="510" height="17" align="left"><font size="2"><b>Numerator: </b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="76" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Net ear nings</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="76" height="17" align="right"><font size="2">445&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">723&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2"><b>Denominator:</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right">< font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Basic &#8211; weighted average shares outstanding</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right"><font size="2">&#160;1,112.6&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160; </font></td><td width="64" height="17" align="right"><font size="2">1,125.2&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Effect of dilutive securities:</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Employee stock options</font></td>&l t;td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="right"><font size="2">0.3&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">4.9&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Employee restricted stock and restricted stock units</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="76" height="17" align="righ t"><font size="2">1.2&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">0.7&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Other</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="76" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;0.5&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">0.9&#160;</font></td></tr><tr><td width="510" height="22" align="left"><font size="2">Diluted &#8211; weighted average shares outstanding</font></td><td width="12" height="22" align="left"><font size="2">&#160;</font></td><td width="19" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;</font></td><td width="76" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,114.6&#160;</font></td><td width="31" height="22" align="left"><font size="2">&#160;</font></td><td width="19" height= "22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="22" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,131.7&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="76" height="17" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font size="2">Basic earnings per share</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="76" height="17" align="right"><font size="2">0.40&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">0.64&#160;</font></td></tr><tr><td width="510" height="17" align="left"><font s ize="2">Diluted earnings per share</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="76" height="17" align="right"><font size="2">&#160;0.40&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">&#160;0.64&#160;</font></td></tr></table></div><div><font size="2"><p>The calculation of weighted average diluted shares outstanding excludes options for approximately 64&#160;million and 22 million common shares for the three months ended July 31, 2009 and July 25, 2008, respectively, as the exercise price of those options was gr eater than the average market price for the period, resulting in an anti-dilutive effect on diluted earnings per share. For the three months ended July 31, 2009 and July 25, 2008, common share equivalents related to the Company&#8217;s $4.400 billion of Senior Convertible Notes were anti-dilutive as the market price of the Company&#8217;s stock was below the conversion price of the Senior Convertible Notes and, therefore, were excluded from the calculation of weighted average diluted shares.</p></font></div></body></html> Note 16 &#8211; Earnings Per Share&#160;Basic earnings per share is computed based on the weighted average number of common shares outstanding. Diluted false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 14 R18.xml IDEA: Goodwill and Other Intangible Assets 1.0.0.3 false Goodwill and Other Intangible Assets false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_GoodwillAndOtherIntangibleAssetsAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 12 &#8211; Goodwill and Other Intangible Assets<br/><br/>The changes in the carrying amount of goodwill for the three months ended July 31, 2009 are as follows:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="623" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="76" height="17" align="center"><font size="2"><b>July 31, </b></font></td></tr><tr><td width="623" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="14" height="17" align="center"><font size="2">&a mp;#160;</font></td><td colspan="2" width="76" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td></tr><tr><td width="623" height="17" align="left"><font size="2"><b>Balance at April 24, 2009</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">8,195&#160;</font></td></tr><tr><td width="623" height="17" align="left"><font size="2">Purchase accounting adjustments, net</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height=" 17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(5)</font></td></tr><tr><td width="623" height="17" align="left"><font size="2">Currency adjustment, net</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">36&#160;</font></td></tr><tr><td width="623" height="18" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border- top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">8,226&#160;</font></td></tr></table></div><div><font size="2"><p>Intangible assets, excluding goodwill, as of July 31, 2009 and April 24, 2009 are as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="326" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="3" width="9" height="50" align="center"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Purchased</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;< /font></td><td colspan="2" width="82" height="17" align="center"><font size="2"><b>Trademarks</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="63" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="63" height="17" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="326" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="16" align="center"><font size="2"><b>Technology a nd</b></font></td><td width="14" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="16" align="center"><font size="2"><b>and</b></font></td><td width="13" height="16" align="left"><font size="2">&#160;</font></td><td width="19" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td width="63" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td width="9" height="16" align="left"><font size="2">&#160;</font></td><td width="19" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td width="63" height="16" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="326" height="17" align="left"><font s ize="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Patents</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Tradenames</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Other</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="82" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>T otal</b></font></td></tr><tr><td width="326" height="17" align="left"><font size="2"><b>As of July 31, 2009:</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">& amp;#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">Amortizable intangible assets</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</f ont></td><td width="82" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font> </td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Original cost</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="82" height="17" align="right"><font size="2">3,057&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">373&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"> ;<font size="2">236&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">3,666&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Accumulated amortization</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(855)</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font>< /td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(226)</font></td><td width="13" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(177)</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size=" 2">(1,258)</font></td></tr><tr><td width="326" height="18" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Carrying value</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="82" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,202&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3p x double #000000;"><font size="2">147&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">59&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,408&#160;</font></td></tr><tr><td width="326" height="18" ali gn="left"><font size="2">&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="82" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="63" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"&g t;<font size="2">&#160;</font></td><td width="63" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="63" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2"><b>As of April 24, 2009:</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;</fo nt></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">Amo rtizable intangible assets</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td><td width="9" height="17" align="left"><font size= "2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="63" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Original cost</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="82" height="17" align="right"><font size="2">3,057&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">373&#160;</font></td><t d width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">238&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="63" height="17" align="right"><font size="2">3,668&#160;</font></td></tr><tr><td width="326" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Accumulated amortization</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td> <td width="82" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(801)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(217)</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(173)</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19 " height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="63" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(1,191)</font></td></tr><tr><td width="326" height="18" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Carrying value</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="82" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,256&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" a lign="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">156&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">65&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td>< ;td width="63" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">2,477&#160;</font></td></tr></table></div><div><font size="2"><p>Amortization expense for the three months ended July 31, 2009 and July 25, 2008 was $78 million and $66 million, respectively.<br/>&#160;<br/>Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets is as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="563" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="31" height="34" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="17" align="center"><font size="2"><b>Amortization</b>< ;/font></td></tr><tr><td width="563" height="17" align="left"><font size="2"><b>Fiscal Year</b></font></td><td colspan="2" width="119" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Expense</b></font></td></tr><tr><td width="563" height="17" align="left"><font size="2">Remaining 2010</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">230&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2011&#160;</font></td><td width="31" height="17" align="left"><fon t size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">294&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2012&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">268&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2013&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td>&l t;td width="100" height="17" align="right"><font size="2">252&#160;</font></td></tr><tr><td width="563" height="17" align="right"><font size="2">2014&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="100" height="17" align="right"><font size="2">243&#160;</font></td></tr><tr><td width="563" height="17" align="left"><font size="2">Thereafter</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">1,121 &#160;</font></td></tr><tr><td width="563" height="18" align="left"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,408&#160;</font></td></tr></table></div></body></html> Note 12 &#8211; Goodwill and Other Intangible AssetsThe changes in the carrying amount of goodwill for the three months ended July 31, 2009 are as false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 15 R12.xml IDEA: Restructuring Charges 1.0.0.3 false Restructuring Charges false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 us-gaap_RestructuringChargesAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 6 &#8211; Restructuring Charges<br/>&#160;<br/>Fiscal Year 2009 Initiative<br/>&#160;<br/>In the fourth quarter of fiscal year 2009, the Company recorded a $34 million restructuring charge, which consisted of employee termination costs of $29 million and asset write-downs of $5 million. As part of the Company&#8217;s &#8220;One Medtronic&#8221; strategy, the Company continues to pursue opportunities to streamline the organization and standardize or centralize certain functional activities which are not unique to individual businesses. In connection with these efforts to create &#8220;One Medtronic,&#8221; this initiative is designed to streamline operations, by further consolidating manufacturing and eliminating certain non-core product lines, and to further align resources around the Company&#8217;s higher growth opportunities. This initiative impacts most businesses and certain corporate functions. Of the $5 million of asset write-downs, $3 million relates to inventory write-offs and production-related asset impairments and therefore was recorded within cost of products sold in the consolidated statement of earnings. The employee termination costs of $29 million consist of severance and the associated costs of continued medical benefits and outplacement services.<br/><br/>As a continuation of the fiscal year 2009 initiative, in the first quarter of fiscal year 2010, the Company incurred $72 million of incremental restructuring charges, which consisted of employee termination costs of $62 million and asset write-downs of $10 million. Of the $10 million of asset write-downs, $7 million relates to inventory write-offs and production-related asset impairments and therefore was recorded within cost of products sold in the condensed consolidated statement of earnings. Incl uded in the $62 million restructuring charge is $9 million of incremental defined benefit pension and post-retirement related expenses for those employees who accepted early retirement packages. These costs are not included in the table summarizing restructuring costs below because they are associated with costs that are accounted for under the pension and post-retirement rules. For further discussion on the incremental defined benefit pension and post-retirement related expenses, see Note 19. <br/>&#160;<br/>As of the end of the first quarter of fiscal year 2010, the Company has identified approximately 1,500 positions for elimination which will be achieved through early retirement packages offered to employees, voluntary separation and involuntary separation. Of these 1,500 positions, approximately 500 positions have been eliminated as of July 31, 2009. The restructuring initiatives are scheduled to be substantially complete by the end of the first quarter of fiscal year 2011.<br />&#160;<br/>A summary of the activity related to the fiscal year 2009 initiative is presented below:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="217" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="8" width="419" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fiscal Year 2009 Initiative</b></font></td></tr><tr><td rowspan="3" width="217" height="42" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="3" width="64" height="42" align="center"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size= "2"><b>Employee</b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Termination</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Asset</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2"><b>&#160;</b></font></td><td width="100" height="14" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Costs</b></font></td><td width="31" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Write-downs</b></font></td><td width="31" height="16" al ign="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Total</b></font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at April 25, 2008</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Restructuring charges</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">29&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;< /font></td><td width="19" height="20" align="right"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">5&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">34&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Payments/write-downs</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2"> (1)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(5)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(6)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at April 24, 2009</b></font></td><td width="64" height="20" align="left"><font size="2">&# 160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">28&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">28&am p;#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Restructuring charges</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">53&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">10&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="righ t"><font size="2">63&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Payments/write-downs</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(19)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(10)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height=" 20" align="right"><font size="2">(29)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">62&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;borde r-bottom: 3px double #000000;"><font size="2">0&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">62&#160;</font></td></tr></table></div><div><font size="2"><p>Global Realignment Initiative<br/>&#160;<br/>In the fourth quarter of fiscal year 2008, the Company began a global realignment initiative which focused on shifting resources to those areas where the Company has the greatest opportunities for growth and streamlining operations to drive operating leverage. The global realignment initiative impacted most businesses and certain corporate function s. Within the Company&#8217;s Cardiac Rhythm Disease Management (CRDM) business, the Company reduced research and development infrastructure by closing a facility outside the U.S., reprioritizing research and development projects to focus on the core business and consolidating manufacturing operations to drive operating leverage. Within the Company&#8217;s Spinal business, the Company reorganized and consolidated certain activities where Medtronic&#8217;s existing infrastructure, resources and systems could be leveraged to obtain greater operational synergies. The global realignment initiative was also designed to further consolidate manufacturing of CardioVascular products, streamline distribution of products in select businesses and to reduce general and administrative costs in the Company&#8217;s corporate functions. <br/><br/>In the first quarter of fiscal year 2010, the Company recorded a $8 million reversal of excess reserves primarily as a result of favorable severance nego tiations as well as a higher than expected percentage of employees identified for elimination finding positions elsewhere in the Company. This $8 million reversal of excess reserves was partially offset by a $5 million charge the Company recorded in the first quarter of fiscal year 2010 related to the further write-down of a non-inventory related asset resulting from the continued decline in the international real estate market. <br/><br/>As of the end of the first quarter of fiscal year 2009, the Company had identified approximately 900 positions for elimination which were to be achieved through both voluntary and involuntary separation. Of the 900 positions identified, approximately 760 have been eliminated as of July 31, 2009. The restructuring initiatives are scheduled to be substantially complete by the end of the second quarter of fiscal year 2010.<br/>&#160;<br/>A summary of the activity related to the global realignment initiative is presented below:<br/></p> ;</font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="217" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="8" width="419" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Global Realignment Initiative</b></font></td></tr><tr><td rowspan="3" width="217" height="42" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="3" width="64" height="42" align="center"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Employee</b></font></td><td width="31" height="12" align="left" style="border-top: 1 px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="119" height="12" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="31" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="12" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="14" align="center"><font size="2"><b>Termination</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="14" align="center"><font size ="2"><b>Asset</b></font></td><td width="31" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2"><b>&#160;</b></font></td><td width="100" height="14" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Costs</b></font></td><td width="31" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Write-downs</b></font></td><td width="31" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="119" height="16" align="ce nter" style="border-bottom: 1px solid #000000;"><font size="2"><b>Total</b></font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at April 24, 2009</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">15&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;-&#160;</font ></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;"><font size="2">15&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Restructuring charges</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;< /font></td><td width="100" height="20" align="right"><font size="2">&#160;5&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">5&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Reversal of excess accrual</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(8)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"> ;<font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(8)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Payments/write-downs</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(3)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" heigh t="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(5)</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left"><font size="2">&#160;</font></td><td width="100" height="20" align="right"><font size="2">(8)</font></td></tr><tr><td width="217" height="20" align="left"><font size="2">Currency adjustment, net</font></td><td width="64" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td><td width=" 31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="100" height="20" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td></tr><tr><td width="217" height="20" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="64" height="20" align="left"><font size="2">&#160;< /font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">5&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="20" align="left"><font size="2">&#160;</font></td><td width="19" height="20" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double # 000000;"><font size="2">$</font></td><td width="100" height="20" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">5&#160;</font></td></tr></table></div></body></html> Note 6 &#8211; Restructuring Charges&#160;Fiscal Year 2009 Initiative&#160;In the fourth quarter of fiscal year 2009, the Company recorded a $34 million false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 16 R3.xml IDEA: Condensed Consolidated Statements of Earnings (Unaudited) 1.0.0.3 false Condensed Consolidated Statements of Earnings (Unaudited) (USD $) In Millions, except Per Share data false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 2 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 us-gaap_IncomeStatementAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 3 1 us-gaap_SalesRevenueNet us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 true true 3933000000 3933 false false 2 true true 3706000000 3706 false false No definition available. No authoritative reference available. false 4 1 us-gaap_CostsAndExpensesAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 5 2 us-gaap_CostOfGoodsAndServicesSold us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 966000000 966 false false 2 false true 855000000 855 false false No definition available. No authoritative reference available. false 6 2 us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 370000000 370 false false 2 false true 324000000 324 false false No definition available. No authoritative reference available. false 7 2 us-gaap_SellingGeneralAndAdministrativeExpense us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 1368000000 1368 false false 2 false true 1318000000 1318 false false No definition available. No authoritative reference available. false 8 2 us-gaap_RestructuringCharges us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 62000000 62 false false 2 false true 96000000 96 false false No definition available. No authoritative reference available. false 9 2 mdt_CertainLitigationCharges mdt false debit duration monetary Amount related to material litigation charges recognized in the period in the statement of earnings. Excludes the amount of... false false false false false false false false false 1 false true 444000000 444 false false 2 false true 0 0 false false Amount related to material litigation charges recognized in the period in the statement of earnings. Excludes the amount of expense provided in the period for legal fees. No authoritative reference available. false 10 2 us-gaap_NonoperatingIncomeExpense us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true 96000000 96 false false 2 false true 151000000 151 false false No definition available. No authoritative reference available. false 11 2 mdt_InterestExpenseIncomeNet mdt false debit duration monetary Net amount of interest expense or income. Interest expense includes the expense associated with the interest paid on... false false false false false false false false false 1 false true 66000000 66 false false 2 false true 47000000 47 false false Net amount of interest expense or income. Interest expense includes the expense associated with the interest paid on outstanding borrowings, including short- and long-term instruments, and the amortization of debt issuance costs and debt discounts. Interest income includes interest earned on cash and cash equivalents, short- and long-term investments and the net realized gains or losses on the sale of available-for-sale securities. No authoritative reference available. false 12 2 mdt_TotalCostsAndExpenses mdt false debit duration monetary Total costs of sales and expenses for the period. false false false false false false false false false 1 false true 3372000000 3372 false false 2 false true 2791000000 2791 false false Total costs of sales and expenses for the period. No authoritative reference available. true 13 1 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true 561000000 561 false false 2 false true 915000000 915 false false No definition available. No authoritative reference available. true 14 1 us-gaap_IncomeTaxExpenseBenefit us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 116000000 116 false false 2 false true 192000000 192 false false No definition available. No authoritative reference available. false 15 1 us-gaap_NetIncomeLoss us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 true true 445000000 445 false false 2 true true 723000000 723 false false No definition available. No authoritative reference available. true 16 1 us-gaap_EarningsPerShareBasic us-gaap true na duration decimal No definition available. false false false false false false false false true 1 true true 0.40 0.40 false false 2 true true 0.64 0.64 false false No definition available. No authoritative reference available. false 17 1 us-gaap_EarningsPerShareDiluted us-gaap true na duration decimal No definition available. false false false false false false false false true 1 true true 0.40 0.40 false false 2 true true 0.64 0.64 false false No definition available. No authoritative reference available. false 18 1 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic us-gaap true na duration shares No definition available. false false false false false false false false false 1 false true 1112600000 1112.6 false false 2 false true 1125200000 1125.2 false false No definition available. No authoritative reference available. false 19 1 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding us-gaap true na duration shares No definition available. false false false false false false false false false 1 false true 1114600000 1114.6 false false 2 false true 1131700000 1131.7 false false No definition available. No authoritative reference available. false 20 1 us-gaap_CommonStockDividendsPerShareDeclared us-gaap true na duration decimal No definition available. false false false false false false false false true 1 true true 0.205 0.205 false false 2 true true 0.188 0.188 false false No definition available. No authoritative reference available. false false 2 19 false Millions HundredThousands NoRounding false true XML 17 R14.xml IDEA: Fair Value Measurements 1.0.0.3 false Fair Value Measurements false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_FairValueMeasurementsAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_FairValueDisclosuresTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 8 &#8211; Fair Value Measurements<br/>&#160;&#160;<br/>Assets and Liabilities That Are Measured at Fair Value on a Recurring Basis<br/>&#160;<br/>For the Company, effective April 26, 2008, fair value under SFAS No.&#160;157 &#8220;Fair Value Measurements&#8221; (SFAS No. 157), is principally applied to financial assets and liabilities such as marketable equity securities and debt securities that are classified and accounted for as available-for-sale, and derivative instruments. Derivatives include cash flow hedges, freestanding derivative forward contracts, net investment hedges and interest rate swaps. These items were previously and will continue to be marked-to-market at each reporting period; however, the definition of fair value is now applied using SFAS No.&#160;157. The informat ion in the following paragraphs and tables primarily addresses matters relative to these financial assets and liabilities. Separately, there were no material fair value measurements with respect to nonfinancial assets or liabilities that are recognized or disclosed at fair value in the Company&#8217;s financial statements on a recurring basis subsequent to the effective date of SFAS No.&#160;157.<br/>&#160;<br/>The following tables provide information by level for assets and liabilities that are measured at fair value, as defined by SFAS No.&#160;157, on a recurring basis.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="215" height="17" align="center"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2 "><b>Fair Value</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center"><font size="2"><b>Fair Value Measurements</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>at</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Using Inputs Considered as</b></font></td></tr><tr><td width="215" height="17" align="left"&g t;<font size="2"><b>(in millions)</b></font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 1</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="3" width="123" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 2</b></font></td><td wi dth="19" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 3</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Assets:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" styl e="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Corporate debt securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;847&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;22&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="1 7" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;807&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;18&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Auction rate securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right">& lt;font size="2">&#160;152&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" heigh t="17" align="right"><font size="2">&#160;152&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Mortgage backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;623&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td w idth="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;586&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;37&#160;</font></td></tr><tr><td width="215" height="19" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Government and agency securities</font></td><td width="4" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td> ;<td width="85" height="19" align="right"><font size="2">&#160;1,085&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;186&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;899&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2"> ;&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Certificates of deposit</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;34&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font si ze="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;34&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Other asset backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><fon t size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;274&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;257&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height ="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;17&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Marketable equity securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;18&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;18&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative assets</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;169&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;163&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;">< ;font size="2">&#160;6&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total assets</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px so lid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,202&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;389&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,589&#160;</font>< ;/td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;224&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">&#160;</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td>< td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Liabilities:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td wi dth="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative liabilities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align= "left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font> ;</td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total liabilities</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><f ont size="2">&#160;62&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;62&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="18" align="left"><font s ize="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="215" height="17" align="center"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>Fair Value</b></font></td><td width="31" height="17" align="center"><font size ="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center"><font size="2"><b>Fair Value Measurements</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;</font></td><td width="4" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>at</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="9" width="381" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Using Inputs Considered as</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="4" height="17" align="cent er"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>April 24, 2009</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 1</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="3" width="123" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 2</b></font></td><td width="19" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160; </b></font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Level 3</b></font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Assets:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" s tyle="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr>< td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Corporate debt securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;805&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;8&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><fon t size="2">&#160;771&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">&#160;26&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Auction rate securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;119&#160;</font></td><td width="31" height="17" align="left"><fo nt size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;119&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Mortgage backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;746&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height= "17" align="right"><font size="2">&#160;709&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;37&#160;</font></td></tr><tr><td width="215" height="19" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Government and agency securities</font></td><td width="4" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;697&#160;</font></td>< ;td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;174&#160;</font></td><td width="31" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;523&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="left"><font size="2">&#160;</font></td><td width="19" height="19" align="right"><font size="2">&#160;</font></td><td width="85" height="19" align="right"><font size="2">&#160;-&#1 60;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Certificates of deposit</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;2&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160; </font></td><td width="85" height="17" align="right"><font size="2">&#160;2&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Other asset backed securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#1 60;278&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;255&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"&g t;<font size="2">&#160;23&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Marketable equity securities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;12&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;12&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative assets</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td ><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;436&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;436&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size= "2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total assets</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,095&#160;</font></td>&l t;td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;630&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,260&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width=" 19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;205&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">&#160;</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160 ;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font ></td><td width="85" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">Liabilities:</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" a lign="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="215" height="17" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Derivative liabilities</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height= "17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td wid th="19" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="215" height="18" align="left"><font size="2">Total liabilities</font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="18" align="left"><font size=" 2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;31&#160;</font></td><td width="31" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left"><font size="2">&#160;& lt;/font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;-&#160;</font></td></tr></table></div><div><font size="2"><p>Level 3 Valuation Techniques<br/>&#160;<br/>Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. Level 3 financial assets also include certain investment securities for which there is limited market activity such that the determination of fair value requires significant judgment or estimation. Level 3 investment securities primarily include certain corporate debt securities, a uction rate securities, certain mortgage backed securities and certain asset backed securities for which there was a decrease in the observability of market pricing for these investments. At July 31, 2009, these securities were valued primarily using broker pricing models that incorporate transaction details such as contractual terms, maturity, timing and amount of future cash flows, as well as assumptions about liquidity and credit valuation adjustments of marketplace participants at July 31, 2009.<br/>&#160;<br/>The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the table above that used significant unobservable inputs (Level 3).<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="512" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="213" height="17" al ign="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="512" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="5" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 25, 2008</b></font></td></tr><tr><td width="512" height="17" align="left"><font size="2"><b>Beginning Balance</b></font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">205&#160;</font></td><td width="5" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="85" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">448&#160;</font></td></tr><tr><td width="512" height="17" align="left"><font size="2">Total realized losses and other-than temporary impairment losses included in earnings</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(4)</font></td> ;<td width="5" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(3)</font></td></tr><tr><td width="512" height="17" align="left"><font size="2">Total unrealized gains/(losses) included in other comprehensive income</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;45&#160;</font></td><td width="5" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(7)</font></td></tr& gt;<tr><td width="512" height="17" align="left"><font size="2">Net purchases, issuances, and settlements</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(22)</font></td><td width="5" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;(152)</font></td></tr><tr><td width="512" height="18" align="left"><font size="2"><b>Ending Balance</b></font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" styl e="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;224&#160;</font></td><td width="5" height="18" align="right"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;286&#160;</font></td></tr></table></div><div><font size="2"><p>Realized gains or losses included in earnings are included in interest expense, net in the condensed consolidated statement of earnings.<br/>&#160;<br/>Assets and Liabilities that are Measured at Fair Value on a Nonrecurring Basis<br/>&#160;<br/>The Company had no financial assets or liabilities that are measured on a nonrecurring basis subsequent to their initial recognition during the three months ended July 31, 2009.&#160;<br/><br/>Non-financial assets such as goodwill, intangible assets and property, plant and equipment are measured at fair value when there is an indicator of impairment and recorded at fair value only when impairment is recognized. No impairments existed as of July 31, 2009.<br/><br/>Financial Instruments Not Measured at Fair Value<br/><br/>The estimated fair value of the Company&#8217;s long-term debt at July 31, 2009 was $6.728 billion compared with a carrying value of $6.725 billion and at April 24, 2009 an estimated fair value of $6.375 billion compared with a carrying value of $6.665 billion. Fair value was estimated using quoted market prices. The fair values and carrying values consider the terms of the related debt and exclude the impacts of debt discounts and derivative/hedging activity.<br/></p></font></div></body> </html> Note 8 &#8211; Fair Value Measurements&#160;&#160;Assets and Liabilities That Are Measured at Fair Value on a Recurring Basis&#160;For the Company, effective false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 18 R15.xml IDEA: Financing Arrangements 1.0.0.3 false Financing Arrangements false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_FinancingArrangementsAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_DebtDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 9 &#8211; Financing Arrangements<br/>&#160;<br/>Senior Convertible Notes<br/>&#160;<br/>In April 2006, the Company issued $2.200 billion of 1.500 percent Senior Convertible Notes due 2011 and $2.200 billion of 1.625 percent Senior Convertible Notes due 2013 (collectively, the Senior Convertible Notes). The Senior Convertible Notes were issued at par and pay interest in cash semi-annually in arrears on April&#160;15 and October&#160;15 of each year. The Senior Convertible Notes are unsecured unsubordinated obligations and rank equally with all other unsecured and unsubordinated indebtedness. <br/><br/>Concurrent with the issuance of the Senior Convertible Notes, the Company purchased call options on its common stock in private transactions. The call options allow the Company to receive shares of the Company&#8217;s common stock and/or cash from counterparties equal to the amounts of common stock and/or cash related to the excess conversion value that it would pay to the holders of the Senior Convertible Notes upon conversion.<br/><br/>In separate transactions, the Company sold warrants to issue shares of the Company&#8217;s common stock at an exercise price of $76.56 per share in private transactions. Pursuant to these transactions, warrants for 41 million shares of the Company&#8217;s common stock may be settled over a specified period beginning in July 2011 and warrants for 41 million shares of the Company&#8217;s common stock may be settled over a specified period beginning in July 2013.<br/><br/>In June 2008, the FASB issued EITF Issue No. 07-5, &#8220;Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity&#8217;s Own Stock&#8221; (EITF No. 07-5). EITF No. 07-5 provides guidance for determining whether an equi ty-linked financial instrument (or embedded feature) is indexed to an entity's own stock and classified in shareholders&#8217; equity or whether it should be bifurcated and classified as a separate asset or liability and marked-to-market through earnings. The Company adopted EITF No. 07-5 in the first quarter of fiscal year 2010. In applying EITF No. 07-5, the Company concluded that the purchased call options and sold warrants were indexed to its own stock and should continue to be classified in shareholders&#8217; equity; thus consistent with prior periods, EITF Issue No. 00-19, &#8220;Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock&#8221; (EITF No. 00-19) would still apply. <br/><br/>Under EITF No. 00-19, the notes are accounted for as a combined instrument because the conversion spread meets the requirements of EITF No. 00-19, including the provisions contained in paragraphs 12&#8211;32 of EITF No. 00-1 9. Accordingly, the &#8220;conversion spread&#8221; is not separated as a derivative.<br/><br/>EITF No. 00-19 provides that contracts are initially classified as equity if (1)&#160;the contract requires physical settlement or net-share settlement, or (2)&#160;the contract gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The settlement terms of the Company&#8217;s purchased call options and sold warrant contracts provide for net cash settlement for the particular contract or net share settlement, depending on the method of settlement, as discussed above, which is at the option of the Company. Based on the guidance from EITF&#160;No. 00-19 and SFAS No.&#160;133, &#8220;Accounting for Derivative Instruments and Hedging Activities&#8221; (SFAS No. 133), the purchased call option contracts were recorded as a reduction of equity and the warrants were recorded as an addition to equity as o f the trade date. SFAS No.&#160;133 states that a reporting entity shall not consider contracts to be derivative instruments if the contract issued or held by the reporting entity is both indexed to its own stock and classified in shareholders&#8217; equity in its statement of financial position. The Company concluded the purchased call option contracts and the warrant contracts should be accounted for in shareholders&#8217; equity.<br/><br/>Effective April 25, 2009, the Company accounts for the Senior Convertible Notes in accordance with FSP APB No. 14-1. FSP APB No. 14-1 requires the proceeds from the issuance of the Senior Convertible Notes to be allocated between a liability component (issued at a discount) and an equity component. The resulting debt discount is amortized over the period the Senior Convertible Notes are expected to be outstanding as additional non-cash interest expense. This change in accounting for the Senior Convertible Notes has been applied to the Company&a mp;#8217;s prior period financial statements on a retrospective basis, as required by FSP APB No. 14-1. For additional information on the impact of this change to the Company&#8217;s financial statements, refer to Note 3.<br/><br/>The following table provides equity and debt information for the Senior Convertible Notes under FSP APB No. 14-1. <br/>&#160;</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2011</b></font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font s ize="2"><b>Senior Convertible Notes due 2013</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td rowspan="2" width="341" height="31" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="15" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>April 24,</b></font></td><td rowspan="2" width="16" height="31" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="1 5" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="15" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="15" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>April 24,</b></font></td><td width="19" height="15" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="16" align="left"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>200 9&#160;</b></font></td><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="19" height="16" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Carrying amount of the equity component</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">420&a mp;#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">420&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">547&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">$</font></td>< ;td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">547&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center">< ;font size="2">&#160;</font></td><td width="71" height="17" align="right"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td width="71" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Principal amount of the Senior Convertible Notes</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font> ;</td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">&#160;2,200&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><fo nt size="2">Unamortized discount</font></td><td width="12" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(157)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(181)</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" ali gn="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(318)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;(338)</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Net carrying amount</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #00000 0;"><font size="2">&#160;2,043&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;2,019&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,882&#160;</font></td><td width="14" height="17" al ign="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1,862&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font> </td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="16" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="71" height="18" align="right" style="border-top: 3px double #000000;"><font size="2" >&#160;</font></td><td width="19" height="18" align="right"><font size="2">&#160;</font></td></tr><tr><td colspan="12" width="717" height="55" align="left"><font size="2">At July 31, 2009, the unamortized balance of the debt discount will be amortized over the remaining life of the Senior Convertible Notes, which is approximately 2 years for the 2011 Senior Convertible Notes and 4 years for the 2013 Senior Convertible Notes. The following table provides interest rate and interest expense amounts related to the Senior Convertible Notes.</font></td><td width="19" height="55" align="left"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size=" 2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="71" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#1 60;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2011</b></font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Senior Convertible Notes due 2013</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="341" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000 ;"><font size="2"><b>Three months ended</b></font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="180" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td rowspan="2" width="341" height="34" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td co lspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td rowspan="2" width="16" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="14" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2 "><b>2009&#160;</b></font></td><td width="14" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="19" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="341" height="17" align="left"><font s ize="2">Effective interest rate</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">5.97&#160;</font></td><td width="14" height="17" align="left"><font size="2">%</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">5.97&#160;</font></td><td width="16" height="17" align="left"><font size="2">%</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px soli d #000000;"><font size="2">&#160;6.03&#160;</font></td><td width="14" height="17" align="left"><font size="2">%</font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="71" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;6.03&#160;</font></td><td width="19" height="17" align="right"><font size="2">%</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Interest cost related to contractual interest coupon</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">9&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td ><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">8&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">10&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">9&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr><tr><td width="341" height="17" align="left"><font size="2">Interest cost related to amortizat ion of the discount</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">23&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">21&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font></td><td width="71" height="17" align="right"><font size="2">21&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">$</font> </td><td width="71" height="17" align="right"><font size="2">18&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td></tr></table></div><div><font size="2"><p>Senior Notes<br/>&#160;<br/>In March 2009, the Company issued three tranches of Senior Notes (New Senior Notes) with the aggregate face value of $1.250 billion. The first tranche consisted of $550 million of 4.500 percent Senior Notes due 2014, the second tranche consisted of $400 million of 5.600 percent Senior Notes due 2019 and the third tranche consisted of $300 million of 6.500 percent Senior Notes due 2039. The first tranche was issued at par, the second tranche was issued at a discount which resulted in an effective interest rate of 5.609 percent and the third tranche was issued at a discount which resulted in an effective interest rate of 6.519 percent. Interest on each series of New Senior Note s is payable semi-annually, on March 15 and September 15 of each year, commencing September 15, 2009. The New Senior Notes are unsecured senior obligations of the Company and rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which the New Senior Notes were issued contain customary covenants. The Company used the net proceeds from the sale of the New Senior Notes for repayment of a portion of its commercial paper and for general corporate uses.<br/><br/>In September 2005, the Company issued two tranches of Senior Notes with the aggregate face value of $1.000 billion. The first tranche consisted of $400 million of 4.375 percent Senior Notes due 2010 and the second tranche consisted of $600 million of 4.750 percent Senior Notes due 2015. Each tranche was issued at a discount which resulted in an effective interest rate of 4.433 percent and 4.760 percent for the five and ten year Senior Notes, respectively. Interest on each series of Senior Not es is payable semi-annually, on March 15 and September 15 of each year. The Senior Notes are unsecured unsubordinated obligations of the Company and rank equally with all other unsecured and unsubordinated indebtedness of the Company. The indentures under which Senior Notes were issued contain customary covenants. The Company used the net proceeds from the sale of the Senior Notes for repayment of a portion of its commercial paper.<br/>&#160;<br/>In June 2009, the Company entered into two five year interest rate swap agreements with notional amounts of $150 million each. These interest rate swap agreements were designated as fair value hedges of the changes in fair value of a portion of the Company&#8217;s fixed-rate $550 million Senior Notes due 2014. On the first interest rate swap agreement, the Company pays variable interest equal to the one-month London Interbank Offered Rate (LIBOR) plus 134 basis points and it receives a fixed interest rate of 4.50 percent. For the second interest rate swap agreement, the Company pays variable interest equal to the one-month LIBOR plus 137.25 basis points and it receives a fixed interest rate of 4.50 percent. The outstanding market value of these swap agreements was a $6 million unrealized gain at July 31, 2009 which is recorded in long-term debt with the offset recorded in other assets on the condensed consolidated balance sheet.<br/>&#160;<br/>Contingent Convertible Debentures<br/>&#160;<br/>As of July 31, 2009 and April 24, 2009, the Company has $15 million remaining in aggregate principal amount of 1.250 percent Contingent Convertible Debentures, Series B due 2021 (the Debentures) outstanding. Interest is payable semi-annually. Each Debenture is convertible into shares of common stock at an initial conversion price of $61.81 per share; however, the Debentures are not convertible before their final maturity unless the closing price of our common stock reaches 110 percent of the conversion price for 20 trading days during a consecutive 30 trading day period.&#160; Upon conversion of the Debentures, the Company will pay holders cash equal to the lesser of the principal amount of the Debentures or their conversion value, and shares of the Company&#8217;s common stock to the extent the conversion value exceeds the principal amount of the Debentures. The Company may be required to repurchase the remaining debentures at the option of the holders in September 2011 or 2016. For put options exercised by the holders of the Debentures, the purchase price is equal to the principal amount of the applicable debenture plus any accrued and unpaid interest thereon to the repurchase date. If the put option is exercised, the Company will pay holders the repurchase price solely in cash. The Company can redeem the debentures for cash at any time.<br/>&#160;<br/>Commercial Paper<br/>&#160;<br/>The Company maintains a commercial paper program that allows the Company to have a maximum of $2.250 billion in commercial paper outstanding, with maturities up to 364&#160;days from the date of issuance. As of July 31, 2009 and April 24, 2009, outstanding commercial paper totaled $506 million and $385 million, respectively. During the three months ended July 31, 2009, the weighted average original maturity of the commercial paper outstanding was approximately 46 days, and the weighted average interest rate was 0.25 percent. The issuance of commercial paper reduces the amount of credit available under our existing lines of credit.<br/><br/>Bank Borrowings&#160;&#160;&#160;<br/><br/>Bank borrowings consist primarily of borrowings from non-U.S. banks at interest rates considered favorable by management and where natural hedges can be gained for foreign exchange purposes.<br/>&#160;<br/>Lines of Credit<br/>&#160;<br/>The Company has existing unsecured lines of credit of approximately $2.839 billion with various banks at July 31, 2009. The existin g lines of credit include a five-year $1.750 billion syndicated credit facility dated December&#160;20, 2006 that will expire on December 20, 2011 (Credit Facility). The Credit Facility provides backup funding for the commercial paper program and may also be used for general corporate&#160;purposes. The Credit Facility provides the Company with the ability to increase its capacity by an additional $500 million at any time during the life of the five-year term of the agreement.<br/><br/>As of July 31, 2009 and April 24, 2009, the Company has unused lines of credit and commercial paper capacity of approximately $2.681 billion and $2.799 billion, respectively. <br/>&#160;<br/>Interest rates on these borrowings are determined by a pricing matrix, based on the Company&#8217;s long-term debt ratings, assigned by Standard and Poor&#8217;s Ratings Group and Moody&#8217;s Investors Service. Facility fees are payable on the credit facilities and are determined in the sa me manner as the interest rates.</p></font></div></body></html> Note 9 &#8211; Financing Arrangements&#160;Senior Convertible Notes&#160;In April 2006, the Company issued $2.200 billion of 1.500 percent Senior Convertible false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 19 R24.xml IDEA: Stock Based Compensation 1.0.0.3 false Stock Based Compensation false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_StockBasedCompensationAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 18 &#8211; Stock-Based Compensation<br/>The Company follows the provisions in FASB SFAS No. 123 (revised 2004), &#8220;Share-Based Payment&#8221; (SFAS No. 123(R)). Under the fair value recognition provisions of SFAS No. 123(R), the Company measures stock-based compensation cost at the grant date based on the fair value of the award and recognizes the compensation expense over the requisite service period, which is generally the vesting period. The Company elected the modified-prospective method of adopting SFAS No. 123(R), under which prior periods were not retroactively restated. The provisions of SFAS No. 123(R) apply to awards granted after the April 29, 2006 effective date. Stock-based compensation expense for the non-vested portion of awards granted prior to the effective date is being recognized over the remaining s ervice period using the fair-value based compensation cost estimated for FASB SFAS No. 123, &#8220;Accounting for Stock-Based Compensation,&#8221; pro forma disclosures.<br/>The following table presents the components and classification of stock-based compensation expense recognized for the three months ended July 31, 2009 and July 25, 2008:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="515" height="17" align="center"><font size="2">&#160;</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="174" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="515" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="11" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="8" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="515" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Stock options</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">33&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">33&#160;</font& gt;</td></tr><tr><td width="515" height="17" align="left"><font size="2">Restricted stock awards</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">24&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">17&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Employee stock purchase plan</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" he ight="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">5&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">5&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Total stock-based compensation expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000 ;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">62&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">55&#160;</font></td></tr><tr><td width="515" height="23" align="left"><font size="2">&#160;</font></td><td width="11" height="23" align="left"><font size="2">&#160;</font></td><td width="19" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font& gt;</td><td width="64" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="8" height="23" align="left"><font size="2">&#160;</font></td><td width="19" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="64" height="23" align="right" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Cost of products sold</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">7&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="64" height="17" align="right"><font size="2">7&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Research and development expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">15&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">13&#160;</font></td></tr><tr>&l t;td width="515" height="17" align="left"><font size="2">Selling, general and administrative expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">40&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">35&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Total stock-based co mpensation expense</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">62&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">55&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">&#160;& lt;/font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Income tax benefits</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td>< td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(19)</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(15)</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td>& lt;td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="515" height="17" align="left"><font size="2">Total stock-based compensation expense, net of tax</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-bottom: 3px double #000000;"><font size ="2">43&#160;</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-bottom: 3px double #000000;"><font size="2">40&#160;</font></td></tr></table></div></body></html> Note 18 &#8211; Stock-Based CompensationThe Company follows the provisions in FASB SFAS No. 123 (revised 2004), &#8220;Share-Based Payment&#8221; (SFAS No. false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 20 R20.xml IDEA: Interest Expense (Income), net 1.0.0.3 false Interest Expense (Income), net false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_InterestExpenseIncomeNetAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 mdt_InterestExpenseIncomeNetTextBlock mdt false na duration string Discloses the gross amounts of interest income and expense recognized during the period. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 14 &#8211; Interest Expense/(Income), net<br/>&#160;<br/>Interest income and interest expense for the three months ended July 31, 2009 and July 25, 2008 are as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="476" height="17" align="center"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="242" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="476" height="22" align="left"><font size="2"><b>(in millions)</b></font></ td><td width="10" height="22" align="center"><font size="2">&#160;</font></td><td colspan="2" width="117" height="22" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="8" height="22" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="117" height="22" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 25, 2008</b></font></td></tr><tr><td width="476" height="17" align="left"><font size="2">Interest income</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font>< /td><td width="98" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(38)</font></td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="98" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(52)</font></td></tr><tr><td width="476" height="17" align="left"><font size="2">Interest expense</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="98" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">104&#160;</font></ td><td width="8" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="98" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">99&#160;</font></td></tr><tr><td width="476" height="18" align="left"><font size="2">Interest expense, net</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="98" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">66&#160;</font></td><td width="8" height="18" align="left" style="b order-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="98" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">47&#160;</font></td></tr><tr><td width="476" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="98" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="8" height="18" align="left" style="border-top: 3px solid #C0C0C0;"> ;<font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="98" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td colspan="7" width="728" height="33" align="left"><font size="2">Interest expense, net for the three months ended July 25, 2008 has been retrospectively adjusted for the impact of the adoption of FSP APB No. 14-1. See Note 3 for additional information.</font></td></tr><tr><td width="476" height="13" align="left"><font size="2">&#160;</font></td><td width="10" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2">&#160;</font></td><td width="98" height="13" align="left">& lt;font size="2">&#160;</font></td><td width="8" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2">&#160;</font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td></tr><tr><td colspan="13" width="728" height="37" align="left"><font size="2">Interest income includes interest earned on the Company's cash and cash equivalents, short- and long-term investments and the net realized gain or loss on the sale or impairment of AFS debt securities. See Note 7 for further discussion of these items. </font></td></tr><tr><td width="476" height="13" align="left"><font size="2">&#160;</font></td><td width="10" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2" >&#160;</font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td><td width="8" height="13" align="left"><font size="2">&#160;</font></td><td width="19" height="13" align="left"><font size="2">&#160;</font></td><td width="98" height="13" align="left"><font size="2">&#160;</font></td></tr><tr><td colspan="13" width="728" height="36" align="left"><font size="2">Interest expense includes the expense associated with the interest that the Company pays on its outstanding borrowings, including short- and long-term instruments, and the amortization of debt issuance costs and debt discounts.</font></td></tr></table></div></body></html> Note 14 &#8211; Interest Expense/(Income), net&#160;Interest income and interest expense for the three months ended July 31, 2009 and July 25, 2008 are as false false Discloses the gross amounts of interest income and expense recognized during the period. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 21 R4.xml IDEA: Condensed Consolidated Balance Sheets (Unaudited) 1.0.0.3 false Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Millions false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 2 $ false false 4 2 us-gaap_AssetsCurrentAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 5 3 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 true true 1022000000 1022 false false 2 true true 1271000000 1271 false false No definition available. No authoritative reference available. false 6 3 us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 522000000 522 false false 2 false true 405000000 405 false false No definition available. No authoritative reference available. false 7 3 us-gaap_ReceivablesNetCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 3113000000 3113 false false 2 false true 3123000000 3123 false false No definition available. No authoritative reference available. false 8 3 us-gaap_InventoryNet us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 1492000000 1492 false false 2 false true 1426000000 1426 false false No definition available. No authoritative reference available. false 9 3 us-gaap_DeferredTaxAssetsNetCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 600000000 600 false false 2 false true 605000000 605 false false No definition available. No authoritative reference available. false 10 3 us-gaap_OtherAssetsCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 535000000 535 false false 2 false true 622000000 622 false false No definition available. No authoritative reference available. false 11 3 us-gaap_AssetsCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 7284000000 7284 false false 2 false true 7452000000 7452 false false No definition available. No authoritative reference available. true 12 2 us-gaap_PropertyPlantAndEquipmentAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 13 3 us-gaap_PropertyPlantAndEquipmentGross us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 5057000000 5057 false false 2 false true 4887000000 4887 false false No definition available. No authoritative reference available. false 14 3 us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true -2724000000 -2724 false false 2 false true -2608000000 -2608 false false No definition available. No authoritative reference available. false 15 3 us-gaap_PropertyPlantAndEquipmentNet us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 2333000000 2333 false false 2 false true 2279000000 2279 false false No definition available. No authoritative reference available. true 16 2 us-gaap_Goodwill us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 8226000000 8226 false false 2 false true 8195000000 8195 false false No definition available. No authoritative reference available. false 17 2 us-gaap_IntangibleAssetsNetExcludingGoodwill us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 2408000000 2408 false false 2 false true 2477000000 2477 false false No definition available. No authoritative reference available. false 18 2 us-gaap_LongTermInvestments us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 3037000000 3037 false false 2 false true 2769000000 2769 false false No definition available. No authoritative reference available. false 19 2 us-gaap_OtherAssetsNoncurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 286000000 286 false false 2 false true 416000000 416 false false No definition available. No authoritative reference available. false 20 2 us-gaap_Assets us-gaap true debit instant monetary No definition available. false false false false false false false false false 1 false true 23574000000 23574 false false 2 false true 23588000000 23588 false false No definition available. No authoritative reference available. true 22 2 us-gaap_LiabilitiesCurrentAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 23 3 us-gaap_DebtCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 658000000 658 false false 2 false true 522000000 522 false false No definition available. No authoritative reference available. false 24 3 us-gaap_AccountsPayableCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 373000000 373 false false 2 false true 382000000 382 false false No definition available. No authoritative reference available. false 25 3 mdt_AccruedCompensation mdt false credit instant monetary Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for... false false false false false false false false false 1 false true 662000000 662 false false 2 false true 901000000 901 false false Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the current portion of the liability for the underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans. No authoritative reference available. false 26 3 us-gaap_AccruedIncomeTaxesCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 123000000 123 false false 2 false true 130000000 130 false false No definition available. No authoritative reference available. false 27 3 us-gaap_OtherLiabilitiesCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 1316000000 1316 false false 2 false true 1212000000 1212 false false No definition available. No authoritative reference available. false 28 3 us-gaap_LiabilitiesCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 3132000000 3132 false false 2 false true 3147000000 3147 false false No definition available. No authoritative reference available. true 29 2 us-gaap_LongTermDebtAndCapitalLeaseObligations us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 6307000000 6307 false false 2 false true 6253000000 6253 false false No definition available. No authoritative reference available. false 30 2 mdt_LongTermAccruedCompensationAndRetirementBenefits mdt false credit instant monetary This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the... false false false false false false false false false 1 false true 351000000 351 false false 2 false true 329000000 329 false false This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans, the aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer), and the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer). No authoritative reference available. false 31 2 us-gaap_AccruedIncomeTaxesNoncurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 485000000 485 false false 2 false true 475000000 475 false false No definition available. No authoritative reference available. false 32 2 us-gaap_DeferredTaxLiabilitiesNoncurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 62000000 62 false false 2 false true 115000000 115 false false No definition available. No authoritative reference available. false 33 2 us-gaap_OtherLiabilitiesNoncurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 93000000 93 false false 2 false true 87000000 87 false false No definition available. No authoritative reference available. false 34 2 us-gaap_Liabilities us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 10430000000 10430 false false 2 false true 10406000000 10406 false false No definition available. No authoritative reference available. true 35 2 us-gaap_CommitmentsAndContingencies2009 us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 - - false false 2 false false 0 0 - - false false No definition available. No authoritative reference available. false 36 2 us-gaap_StockholdersEquityAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 37 3 us-gaap_PreferredStockValue us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 0 0 false false 2 false true 0 0 false false No definition available. No authoritative reference available. false 38 3 us-gaap_CommonStockValue us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 111000000 111 false false 2 false true 112000000 112 false false No definition available. No authoritative reference available. false 39 3 us-gaap_RetainedEarningsAccumulatedDeficit us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 13243000000 13243 false false 2 false true 13272000000 13272 false false No definition available. No authoritative reference available. false 40 3 us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true -210000000 -210 false false 2 false true -202000000 -202 false false No definition available. No authoritative reference available. false 41 3 us-gaap_StockholdersEquity us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 false true 13144000000 13144 false false 2 false true 13182000000 13182 false false No definition available. No authoritative reference available. true 42 2 us-gaap_LiabilitiesAndStockholdersEquity us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 true true 23574000000 23574 false false 2 true true 23588000000 23588 false false No definition available. No authoritative reference available. true false 2 38 false Millions UnKnown UnKnown false true XML 22 R27.xml IDEA: Segment and Geographic Information 1.0.0.3 false Segment and Geographic Information false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_SegmentAndGeographicInformationAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_SegmentReportingDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 21 &#8211; Segment and Geographic Information<br/>&#160;<br/>Segment information:<br/>&#160;<br/>The Company functions in seven operating segments, consisting of CRDM, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control.<br/><br/>Each of the Company&#8217;s operating segments have similar economic characteristics, technology, manufacturing processes, customers, distribution and marketing strategies, regulatory environments and shared infrastructures. Net sales by operating segment are as&#160;follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="536" height="17" align="center"><font size="2">&#160;</font></td><td width= "12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="188" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="7" height="17" align="center"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="12" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="96" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="9" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;"&g t;<font size="2"><b>July 25, </b></font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="96" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Cardiac Rhythm Disease Management</font></td& gt;<td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="82" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;1,337&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">1,303&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Spinal</font></td><td width="12" height="17" align= "left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;915&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">859&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">CardioVascular </font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td>< ;td width="82" height="17" align="right"><font size="2">&#160;689&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">631&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Neuromodulation</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;373&#160;</font></td><td width="9" height="17" align="left"><font size ="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">348&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Diabetes</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;295&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" ali gn="right"><font size="2">269&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="536" height="17" align="left"><font size="2">Surgical Technologies</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right"><font size="2">&#160;</font></td><td width="82" height="17" align="right"><font size="2">&#160;227&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">202&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font>< ;/td></tr><tr><td width="536" height="17" align="left"><font size="2">Physio-Control</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="14" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="82" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;97&#160;</font></td><td width="9" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">94&#160;</font></td><td width="7" height="17" align="left"><font size="2">&#160;</font></td& gt;</tr><tr><td width="536" height="18" align="left"><font size="2"><b>Total Net Sales</b></font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="14" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="82" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,933&#160;</font></td><td width="9" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">3,706&# 160;</font></td><td width="7" height="18" align="left"><font size="2">&#160;</font></td></tr></table></div><div><font size="2"><p>In December 2006, the Company announced its intention to pursue a spin-off of Physio-Control into an independent, publicly traded company. However, as discussed in the &#8220;Other Matters&#8221; section of the management&#8217;s discussion and analysis, the Company announced, in January 2007, a voluntary suspension of U.S. shipments of Physio-Control products manufactured at its facility in Redmond, Washington in order to address quality system issues. The Company continues to work with the FDA to address the quality system issues that must be resolved in order to resume unrestricted distribution of its external defibrillators. As a result of this issue, the Company&#8217;s plans to pursue a spin-off of Physio-Control are on hold for at least through the end of fiscal year 2010. As addi tional information, Physio-Control&#8217;s income/(loss) before interest and income taxes for the three months ended July 31, 2009 and July 25, 2008 was $8 million and $(5) million, respectively.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="547" height="17" align="left"><font size="2"><i>Geographic information</i></font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><fon t size="2">&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">&#160;</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Net sales to external customers by geography are as follows:</font></td><td width="47" height="17" align="left"><font size="2">&# 160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">&#160;</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="53" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2"& gt;&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="50" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="547" height="22" align="center"><font size="2">&#160;</font></td><td width="47" height="22" align="center"><font size="2">&#160;</font></td><td colspan="5" width="153" height="22" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="547" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="47" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="69" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="547" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="69" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="547" height="17" align="left"&g t;<font size="2">United States</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="53" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;2,391&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="50" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">2,249&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Europe</font></td><td width="47" height="17" align="left"><font size="2">&#160;& lt;/font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="53" height="17" align="right"><font size="2">968&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="50" height="17" align="right"><font size="2">949&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Asia Pacific</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="53" height="17" align="right"><font size="2">453&#160;</font></td><td width="12" height="17" align="left"><fo nt size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="50" height="17" align="right"><font size="2">386&#160;</font></td></tr><tr><td width="547" height="17" align="left"><font size="2">Other Foreign</font></td><td width="47" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="53" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">121&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td>< td width="50" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">122&#160;</font></td></tr><tr><td width="547" height="18" align="left"><font size="2"><b>Total Net Sales</b></font></td><td width="47" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="53" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,933&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td widt h="50" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,706&#160;</font></td></tr></table></div></body></html> Note 21 &#8211; Segment and Geographic Information&#160;Segment information:&#160;The Company functions in seven operating segments, consisting of CRDM, false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 23 R16.xml IDEA: Derivatives and Foreign Exchange Risk Management 1.0.0.3 false Derivatives and Foreign Exchange Risk Management false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_DerivativesAndForeignExchangeRiskManagementAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 10 &#8211; Derivatives and Foreign Exchange Risk Management<br/><br/>The Company uses operational and economic hedges, as well as forward exchange derivative contracts to manage the impact of foreign exchange rate changes on earnings and cash flows. In order to reduce the uncertainty of foreign exchange rate movements, the Company enters into derivative instruments, primarily forward exchange contracts, to manage its exposure related to foreign exchange rate changes. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets, liabilities, net investments and probable commitments. At inception of the forward contract, the derivative is designated as either a freestanding derivative, net investment hedge or cash flow hedge. Principal currencies hedged are the Eur o and the Japanese Yen. The Company does not enter into forward exchange derivative contracts for speculative purposes. The gross notional amount of these contracts outstanding at July 31, 2009 and April 24, 2009 was $5.656 billion and $5.296 billion, respectively. The aggregate foreign currency gains/(losses) were $39 million and $(64) million for the three months ended July 31, 2009 and July 25, 2008, respectively. These gains/(losses) represent the net impact to the condensed consolidated statements of earnings for the derivative instruments presented below offset by remeasurement gains/(losses) on foreign currency denominated assets and liabilities.<br/><br/>The information that follows explains the various types of derivatives and financial instruments used by the Company, how and why the Company uses such instruments, how such instruments are accounted for and how such instruments impact the Company&#8217;s condensed consolidated balance sheets and statements of earnings. <br/>< ;br/>Freestanding Derivative Forward Contracts<br/><br/>Freestanding derivative forward contracts are used to offset the Company&#8217;s exposure to the change in value of certain foreign currency denominated assets and liabilities. These derivatives are not designated as hedges, and therefore, changes in the value of these forward contracts are recognized currently in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities. The cash flows from these contracts are reported as operating activities in the consolidated statements of cash flows. The gross notional amount of these contracts, not designated as hedging instruments, outstanding at July 31, 2009 was $1.266 billion. <br/><br/>The amount of losses and location of the losses in the condensed consolidated statement of earnings related to derivative instruments not designated as hedging instruments for the three months ended July 31, 2009 were as follows: & lt;br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="287" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="11" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="11" height="17" align="left"><font size="2"><i>&#160;</i></font></td><td width="177" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="11" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="16" height="17" align="left"><font size="2"><b>&#160;</b></font></td><td width="178" height="17" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="287" heigh t="30" align="left" style="border-bottom: 1px solid #000000;"><font size="2"><b>Derivatives Not Designated as Hedging Instruments under SFAS No. 133</b></font></td><td width="11" height="30" align="center"><font size="2"><b>&#160;</b></font></td><td width="11" height="30" align="center"><font size="2"><b>&#160;</b></font></td><td width="177" height="30" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Location</b></font></td><td width="11" height="30" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="194" height="30" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Amount</b></font></td></tr><tr><td width="287" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2" >Foreign exchange contracts</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="177" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">Other expense, net</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="178" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(95)</font></td></tr></table></div><div><font size="2"><p>Net Investment Hedges<br/><br/>Net investment hedges are used to hedge the long-term investment (equity) in foreign operations. For hedges th at meet effectiveness requirements, the net gains/(losses) related to changes in the current rates, or spot rates, are recorded as a cumulative translation adjustment, a component of accumulated other comprehensive (loss)/ income (AOCI) on the consolidated balance sheets. Net gains/(losses) associated with changes in forward rates of the contracts are reflected in other expense, net in the consolidated statements of earnings. Recognition in earnings of amounts previously recorded as a cumulative translation adjustment is limited to circumstances such as complete or substantially complete liquidation of the long-term investment (equity) in foreign operations. The cash flows from these contracts are reported as investing activities in the consolidated statements of cash flows. As of July 31, 2009, there were no open net investment hedge contracts. For the three months ended July 31, 2009, there were no reclassifications of the effective portion of net investment hedges out of AOCI into income; therefore, consi stent with the fourth quarter of fiscal year 2009, $27 million in gains remained in cumulative translation within AOCI.<br/><br/></p></font></div><div><font size="2"><p>Cash Flow Hedges<br/><br/>Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions, denominated in a foreign currency that will take place in the future. For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. No gains or losses relating to ineffectiveness of cash flow hedges were recognized in earnings during the three months ended July 31, 2009 and July 25, 2008. No components of the hedge contracts were excluded in the measurement of hedge ineffectiveness and no hedge s were derecognized or discontinued during the three months ended July 31, 2009 and July 25, 2008. The cash flows from these contracts are reported as operating activities in the consolidated statements of cash flows. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at July 31, 2009 was $4.090 billion and will mature within the subsequent 36-month period.<br/><br/>The amount of gains/(losses) and location of the gains/(losses) in the condensed consolidated statement of earnings and other comprehensive income (OCI) related to derivative instruments designated as cash flow hedges for the three months ended July 31, 2009 are as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="156" height="45" align="left"><font size="2"><b>(in millions)</b></font></td><td width="11" height="45" align="center"><font size="2">< ;b>&#160;</b></font></td><td width="16" height="45" align="right"><font size="2">&#160;</font></td><td width="194" height="45" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Gross Losses Recognized in OCI on Effective Portion of Derivative</b></font></td><td width="10" height="45" align="right"><font size="2">&#160;</font></td><td width="10" height="45" align="right"><font size="2">&#160;</font></td><td colspan="4" width="309" height="45" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effective Portion of Gains on Derivative Reclassified from AOCI into Income</b></font></td></tr><tr><td width="156" height="49" align="left" style="border-bottom: 1px solid #000000;"><font size="2"><b>Derivatives in SFAS No. 133 Cash Flow Hedging Relationships</b ></font></td><td width="11" height="49" align="center"><font size="2"><b>&#160;</b></font></td><td width="16" height="49" align="center"><font size="2">&#160;</font></td><td width="194" height="49" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Amount</b></font></td><td width="10" height="49" align="center"><font size="2"><b>&#160;</b></font></td><td width="10" height="49" align="center"><font size="2"><b>&#160;</b></font></td><td width="141" height="49" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Location</b></font></td><td width="11" height="49" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></ font></td><td width="16" height="49" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="141" height="49" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Amount</b></font></td></tr><tr><td width="156" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">Foreign exchange contracts</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">$</font></td><td width="194" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(340)</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td width="141" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">Other expense, net</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">$</font></td><td width="141" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">23&#160;</font></td></tr><tr><td width="156" height="17" align="center"><font size="2">&#160;</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">&#160;</font></td><td width="194" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</fo nt></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td width="10" height="17" align="center"><font size="2">&#160;</font></td><td width="141" height="17" align="center"><font size="2">Cost of products sold</font></td><td width="11" height="17" align="center"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">&#160;</font></td><td width="141" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">8&#160;</font></td></tr><tr><td width="156" height="18" align="left"><font size="2"><b>Total</b></font></td><td width="11" height="18" align="center"><font size="2"><b>&#160;</b></font></td><td width="16" height="18" align="right"><font size="2">$</f ont></td><td width="194" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(340)</font></td><td width="10" height="18" align="center"><font size="2">&#160;</font></td><td width="10" height="18" align="center"><font size="2">&#160;</font></td><td width="141" height="18" align="center"><font size="2">&#160;</font></td><td width="11" height="18" align="center"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">$</font></td><td width="141" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">31&#160;</font></td></tr></table></div><div><font size="2"><p>As of July 31, 2009, the Company had a balance of $1 million i n after-tax net unrealized gains associated with cash flow hedging instruments recorded in AOCI. The Company expects that $4 million in losses of this balance will be reclassified into the consolidated statement of earnings over the next twelve months.<br/><br/>Fair Value Hedges<br/><br/>For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivatives as well as the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in current earnings.<br/><br/>Interest rate derivative instruments designated as fair value hedges are designed to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, the Company agrees to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.<br/><br/> As of July 31, 2009, the Company had interest rate swaps designated as fair value hedges of underlying fixed rate obligations. In June 2009, the Company entered into two fixed-to-floating interest rate swap agreements with an aggregate notional amount of $300 million designated as fair value hedges of the fixed interest rate obligation under the existing $550 million, 5 year, 4.50 percent New Senior Notes that were issued in March 2009. These fair value hedges are 100 percent effective and, thus, there is no net impact on earnings. As a result, the market value of these interest rate swap agreements is a $6 million unrealized gain at July 31, 2009 which is recorded as an increase in long-term debt with the offset recorded as an increase in other assets on the condensed consolidated balance sheet. The gross notional amount of these contracts, designated as fair value hedges outstanding at July 31, 2009 was $300 million.<br/><br/></p></font></div><div><font size="2">&l t;p>During the three months ended July 31, 2009 and July 25, 2008, the Company did not have any ineffective fair value hedging instruments. In addition, the Company did not recognize any gains or losses during the three months ended July 31, 2009 and July 25, 2008 on firm commitments that no longer qualify as fair value hedges. <br/><br/>Balance Sheet Presentation<br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br/>The following table summarizes the location and fair value amounts of derivative instruments reported in the condensed consolidated balance sheet as of July 31, 2009. The fair value amounts are presented on a gross basis and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not, and are further segregated by type of contract within those two categories.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;">&l t;tr><td width="264" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="4" width="229" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Asset Derivatives</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="4" width="229" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Liability Derivatives</b></font></td></tr><tr><td width="264" height="31" align="left"><font size="2"><b>(in millions)</b></font></td><td width="106" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Balance Sheet Location</b></font></td><td width="10" height="31" align="center" s tyle="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="17" height="31" align="right" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="96" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td><td width="18" height="31" align="center"><font size="2"><b>&#160;</b></font></td><td width="106" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Balance Sheet Location</b></font></td><td width="11" height="31" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="16" height="31" align="right" style="border-top: 1 px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="96" height="31" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td></tr><tr><td width="264" height="34" align="left"><font size="2"><b>Derivatives designated as hedging instruments </b></font></td><td width="106" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="10" height="34" align="left"><font size="2">&#160;</font></td><td width="17" height="34" align="right"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="18" height="34" align="left"><font size="2">& ;#160;</font></td><td width="106" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="11" height="34" align="left"><font size="2">&#160;</font></td><td width="16" height="34" align="right"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td width="264" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">Foreign exchange contracts</font></td><td width="106" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">Prepaid expenses and other current assets</font></td><td width="10" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="51" a lign="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">98&#160;</font></td><td width="18" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="106" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">Other accrued expenses</font></td><td width="11" height="51" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="51" align="right" style="background-color: #C0C0C0;"><font size="2">52&#160;</font></td></tr><tr><td width="264" height="17" align="left"><font size="2">Interest r ate contracts</font></td><td width="106" height="17" align="left"><font size="2">Other assets</font></td><td width="10" height="17" align="left"><font size="2">&#160;</font></td><td width="17" height="17" align="right"><font size="2">&#160;</font></td><td width="96" height="17" align="right"><font size="2">6&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="106" height="17" align="left"><font size="2">&#160;</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="16" height="17" align="right"><font size="2">&#160;</font></td><td width="96" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="264" height="34" align="left" styl e="background-color: #C0C0C0;"><font size="2">Foreign exchange contracts</font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">Other assets</font></td><td width="10" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="right" style="border-bottom: 1px solid #000000;background-color: #C0C0C0;"><font size="2">64&#160;</font></td><td width="18" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">Other long-term liabilities</font></td><td width="11" height="34" align="left" s tyle="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="right" style="border-bottom: 1px solid #000000;background-color: #C0C0C0;"><font size="2">10&#160;</font></td></tr><tr><td width="264" height="35" align="left"><font size="2"><b>Total derivatives designated as hedging instruments </b></font></td><td width="106" height="35" align="left"><font size="2">&#160;</font></td><td width="10" height="35" align="left"><font size="2">&#160;</font></td><td width="17" height="35" align="right"><font size="2">$</font></td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">& lt;b>168&#160;</b></font></td><td width="18" height="35" align="left"><font size="2"><b>&#160;</b></font></td><td width="106" height="35" align="left"><font size="2">&#160;</font></td><td width="11" height="35" align="left"><font size="2">&#160;</font></td><td width="16" height="35" align="right"><font size="2">$</font></td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2"><b>62&#160;</b></font></td></tr><tr><td width="264" height="18" align="left"><font size="2">&#160;</font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="17" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="18" height="18" align="left"><font size="2">&#160;</font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr><tr><td width="264" height="34" align="left" style="background-color: #C0C0C0;"><font size="2"><b>Derivatives not designated as hedging instruments </b></font></td><td width="106" height="34" align="left" st yle="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="10" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="96" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="18" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="106" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="11" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="34" align="right" style="background-color: #C0C0C0;"><font size="2">&#160;& lt;/font></td><td width="96" height="34" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td></tr><tr><td width="264" height="51" align="left"><font size="2">Foreign exchange contracts</font></td><td width="106" height="51" align="left"><font size="2">Prepaid expenses and other current assets</font></td><td width="10" height="51" align="left"><font size="2">&#160;</font></td><td width="17" height="51" align="right"><font size="2">$</font></td><td width="96" height="51" align="right" style="border-bottom: 1px solid #000000;"><font size="2">1&#160;</font></td><td width="18" height="51" align="left"><font size="2">&#160;</font></td><td width="106" height="51" align="left"><font size="2">Other accrued expenses</font></td><td width="11" height="51" align="l eft"><font size="2">&#160;</font></td><td width="16" height="51" align="right"><font size="2">$</font></td><td width="96" height="51" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="264" height="35" align="left" style="background-color: #C0C0C0;"><font size="2"><b>Total derivatives not designated as hedging instruments </b></font></td><td width="106" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="10" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="17" height="35" align="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border- bottom: 3px double #000000;background-color: #C0C0C0;"><font size="2"><b>1&#160;</b></font></td><td width="18" height="35" align="left" style="background-color: #C0C0C0;"><font size="2"><b>&#160;</b></font></td><td width="106" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="11" height="35" align="left" style="background-color: #C0C0C0;"><font size="2">&#160;</font></td><td width="16" height="35" align="right" style="background-color: #C0C0C0;"><font size="2">$</font></td><td width="96" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;background-color: #C0C0C0;"><font size="2"><b>&#160;-&#160;</b></font></td></tr><tr><td width="264" height="18" align="left"><font size="2">&#160;< /font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="17" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2"><b>&#160;</b></font></td><td width="18" height="18" align="left"><font size="2"><b>&#160;</b></font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="16" height="18" align="right"><font size="2">&#160;</font></td><td width="96" height="18" align="left" style="border-top: 3px double #000000;"><font size="2"><b& gt;&#160;</b></font></td></tr><tr><td width="264" height="18" align="left"><font size="2"><b>Total derivatives</b></font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="10" height="18" align="left"><font size="2">&#160;</font></td><td width="17" height="18" align="right"><font size="2">$</font></td><td width="96" height="18" align="right" style="border-bottom: 3px double #000000;"><font size="2"><b>169&#160;</b></font></td><td width="18" height="18" align="left"><font size="2"><b>&#160;</b></font></td><td width="106" height="18" align="left"><font size="2">&#160;</font></td><td width="11" height="18" align="left"><font size="2">&#160;</font></td><td width="16" height="18" align="righ t"><font size="2">$</font></td><td width="96" height="18" align="right" style="border-bottom: 3px double #000000;"><font size="2"><b>62&#160;</b></font></td></tr></table></div><div><font size="2"><p>Concentrations of Credit Risk<br/><br/>Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist principally of interest-bearing investments, forward exchange derivative contracts and trade accounts receivable.<br/><br/>The Company maintains cash and cash equivalents, investments and certain other financial instruments (including forward exchange contracts) with various major financial institutions. The Company performs periodic evaluations of the relative credit standings of these financial institutions and limits the amount of credit exposure with any one institution.<br/><br/>Concentrations of credit risk with respect to tr ade accounts receivable are limited due to the large number of customers and their dispersion across many geographic areas. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. However, a significant amount of trade receivables are with national healthcare systems in many countries. Although the Company does not currently foresee a credit risk associated with these receivables, repayment is dependent upon the financial stability of the economies of those countries. As of July 31, 2009 and April 24, 2009, no customer represented more than 10 percent of the outstanding accounts receivable.<br/></p></font></div></body></html> Note 10 &#8211; Derivatives and Foreign Exchange Risk ManagementThe Company uses operational and economic hedges, as well as forward exchange derivative false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 24 R9.xml IDEA: Retrospective Adoption of Accounting Pronouncements 1.0.0.3 false Retrospective Adoption of Accounting Pronouncements false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_RetrospectiveAdoptionOfAccountingPronouncementsAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 3 &#8211; Retrospective Adoption of Accounting Pronouncements<br/><br/>In May 2008, the FASB issued FSP APB No. 14-1. FSP APB No. 14-1 requires the proceeds from the issuance of applicable convertible debt instruments to be allocated between a liability component (issued at a discount) and an equity component. The resulting debt discount is amortized over the period the convertible debt is expected to be outstanding as additional non-cash interest expense. FSP APB No. 14-1 changes the accounting treatment for the Company&#8217;s $2.200 billion of 1.500 percent and $2.200 billion of 1.625 percent Senior Convertible Notes due 2011 and 2013, respectively, which were issued in April 2006 (collectively, the Senior Convertible Notes), and the $15 million remaining balance of the Company&#8217;s Contingent Convertible De bentures due 2021 (the Debentures). <br/><br/>The effect of the adoption of FSP APB No. 14-1 on the Senior Convertible Notes at April 2006 was a debt discount of $967 million and an increase of $614 million, net of tax, to shareholders&#8217; equity. <br/><br/>The resulting debt discount for the Company&#8217;s Debentures is to be amortized over the period from the effective date, January 2005, through the first date holders of the Debentures had the ability to put them back to the Company, September 2006. Therefore, the retrospective adoption of FSP APB No. 14-1 for the Debentures had no impact on results of operations for periods following fiscal year 2007. <br/><br/>In addition, in June 2008, the FASB issued FSP EITF No. 03-6-1. FSP EITF No. 03-6-1 provides that unvested share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and shall be included in the comput ation of earnings per share (EPS) pursuant to the two-class method. The Company adopted FSP EITF No. 03-6-1 in the first quarter of fiscal year 2010 and is required to retrospectively adjust all prior-period EPS data. The resulting impact of the adoption of FSP EITF No. 03-6-1 was to include 3.5 million and 4.3 million of unvested restricted shares in the basic weighted average shares outstanding calculation for the three months ended July 31, 2009 and July 25, 2008, respectively. <br/><br/>The following table illustrates the impact of the adoption of FSP APB No. 14-1 and FSP EITF No. 03-6-1 on certain financial statement line items in the condensed consolidated statement of earnings for the three months ended July 31, 2009:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="245" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" heigh t="17" align="center"><font size="2"><b>Previous</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="127" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="134" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Method</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="127" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP APB No. 14-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="134" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP EITF No. 03-6-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"> <font size="2"><b>As Reported</b></font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Interest expense, net</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;23&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="115" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">43&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style=" border-top: 1px solid #000000;"><font size="2">$</font></td><td width="116" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;66&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Provision for income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;131&#160;</font></td><td width="12" height="17" align="left">&l t;font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(15)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;116&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Net earnings</font></td>< td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;473&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(28)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</fon t></td><td width="83" height="17" align="right"><font size="2">&#160;445&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2"><b>Earnings per share:</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" al ign="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Basic</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.43&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(0.03)</font></td><t d width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.40&#160;</font></td></tr><tr><td width="245" height="17" align="left"><font size="2">Diluted</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.43&#160;</font></td><td width="12" height="17" align="left"><font si ze="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(0.03)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.40&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td cols pan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated balance sheet as of July 31, 2009:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18 " height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Previous</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font>< ;/td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Method</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Reported</b></font></td></tr><tr><td width ="389" height="17" align="left"><font size="2"><b><u>ASSETS</u></b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="b order-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Prepaid expenses and other current assets (debt issuance costs)</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;542&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;(7)</font></td><td width="12" height="17" align="left"><font size="2">& ;#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;535&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax assets, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;103&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(103)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width ="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total assets</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,684&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(110)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2"> &#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,574&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b><u>LIABILITIES AND SHAREHOLDERS' EQUITY</u></b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;& lt;/font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term debt</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,782&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(475)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right" ><font size="2">&#160;6,307&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax liabilities, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;62&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2"& gt;&#160;62&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabilities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;10,843&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(413)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;10,430&#160;</font></td ></tr><tr><td width="389" height="17" align="left"><font size="2">Retained earnings</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,940&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;303&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;13,243&#160;</font></td></tr><tr><td width ="389" height="17" align="left"><font size="2">Total shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,841&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;303&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;13,144&#160;</font></td></tr><tr><td width="389" height="17" align="le ft"><font size="2">Total liabilities and shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,684&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(110)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,574&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated statement of cash flows for the three months ended July 31, 2009:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" al ign="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>Previous </b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Method</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2">& lt;b>As Reported</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>Operating Activities</b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&# 160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net earnings</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;473&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;(28)</font></td><td width="12" height="17" align="lef t"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;445&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Amortization of discount on senior convertible notes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;43&#160;</font></td><td width="12" height="17" align="left"><font size ="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;43&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Deferred income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;83&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(15)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td w idth="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;68&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net cash provided by operating activities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;621&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;621&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="12" width="715" height="32" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 and FSP EITF No. 03-6-1 on certain financial statement line items in the condensed consolidated statement of earnings for the three months ended July 25, 2008:</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"> ;<font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" hei ght="17" align="center"><font size="2"><b>As Originally</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="127" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td colspan="2" width="134" height="17" align="center"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="216" height="17" align="left">& lt;font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Reported</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="127" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP APB No. 14-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="134" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>of FSP EITF No. 03-6-1</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000 000;"><font size="2"><b>As Adjusted</b></font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Interest expense, net</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">9&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="115" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">38&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="bo rder-top: 1px solid #000000;"><font size="2">$</font></td><td width="116" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="83" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;47&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Provision for income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">206&#160;</font></td><td width="12" height="17" align="left"><font size= "2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(14)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;192&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Net earnings</font></td><td width="18 " height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">747&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(24)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;723&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2"><b>Earnings per share:</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Basic</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">0.67&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(0.02)</font></td><td width="12" height="17" align=" left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;(0.01)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.64&#160;</font></td></tr><tr><td width="216" height="17" align="left"><font size="2">Diluted</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">0.66&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td>< ;td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="115" height="17" align="right"><font size="2">&#160;(0.02)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="116" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;0.64&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="9" width="716" height="34" align="left"> ;<font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated balance sheet as of April 24, 2009:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2 ">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>As Originally</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" ali gn="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Reported</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Adjusted</b></font></td></tr><tr><td width="389" height="17" align="left">< font size="2"><b><u>ASSETS</u></b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><f ont size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Prepaid expenses and other current assets (debt issuance costs)</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;630&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;(8)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td wi dth="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;622&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax assets, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;65&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(65)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><fon t size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total assets</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,661&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(73)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td w idth="83" height="17" align="right"><font size="2">&#160;23,588&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b><u>LIABILITIES AND SHAREHOLDERS' EQUITY</u></b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" h eight="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term debt</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,772&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(519)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;6,253&a mp;#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Long-term deferred tax liabilities, net</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;115&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;115&#160;</font>&l t;/td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabilities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;10,810&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(404)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;10,406&#160;</font></td></tr><tr><td width="3 89" height="17" align="left"><font size="2">Retained earnings</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,941&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;331&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;13,272&#160;</font></td></tr><tr><td width="389" height="17" align="left"><f ont size="2">Total shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;12,851&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;331&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;13,182&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Total liabil ities and shareholders' equity</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,661&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(73)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;23,588&#160;</font></td></tr></table></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr&g t;<td colspan="9" width="716" height="34" align="left"><font size="2">The following table illustrates the impact of the adoption of FSP APB No. 14-1 on certain financial statement line items in the condensed consolidated statement of cash flows for the three months ended July 25, 2008:</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="left"><font size="2">&# 160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center"><font size="2"><b>As Originally</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="center"><font size="2"><b>&#160;</b></font></td><td width="18" height="17" align="left"&g t;<font size="2">&#160;</font></td><td width="83" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Reported</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Effect of Change</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="101" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>As Adjusted</b></f ont></td></tr><tr><td width="389" height="17" align="left"><font size="2"><b>Operating Activities</b></font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="83" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net earnings</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;747&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;(24)</font></td><td width="12" height="17" align="left"><font size="2">&#16 0;</font></td><td width="18" height="17" align="right"><font size="2">$</font></td><td width="83" height="17" align="right"><font size="2">&#160;723&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Amortization of discount on senior convertible notes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;38&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font>< /td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;38&#160;</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Deferred income taxes</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;11&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(14)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"& gt;<font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;(3)</font></td></tr><tr><td width="389" height="17" align="left"><font size="2">Net cash provided by operating activities</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;800&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="83" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#1 60;</font></td><td width="83" height="17" align="right"><font size="2">&#160;800&#160;</font></td></tr></table></div></body></html> Note 3 &#8211; Retrospective Adoption of Accounting PronouncementsIn May 2008, the FASB issued FSP APB No. 14-1. FSP APB No. 14-1 requires the proceeds from false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 25 R6.xml IDEA: Condensed Consolidated Statements of Cash Flows (Unaudited) 1.0.0.3 false Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Millions false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 2 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 4 2 us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 5 3 us-gaap_NetIncomeLoss us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 true true 445000000 445 false false 2 true true 723000000 723 false false No definition available. No authoritative reference available. false 6 3 us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 7 4 us-gaap_DepreciationDepletionAndAmortization us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 188000000 188 false false 2 false true 173000000 173 false false No definition available. No authoritative reference available. false 8 4 us-gaap_AmortizationOfDebtDiscountPremium us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 43000000 43 false false 2 false true 38000000 38 false false No definition available. No authoritative reference available. false 9 4 us-gaap_ProvisionForDoubtfulAccounts us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 8000000 8 false false 2 false true 6000000 6 false false No definition available. No authoritative reference available. false 10 4 us-gaap_DeferredIncomeTaxExpenseBenefit us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 68000000 68 false false 2 false true -3000000 -3 false false No definition available. No authoritative reference available. false 11 4 us-gaap_ShareBasedCompensation us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 62000000 62 false false 2 false true 55000000 55 false false No definition available. No authoritative reference available. false 12 4 us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true 0 0 false false 2 false true -11000000 -11 false false No definition available. No authoritative reference available. false 13 4 us-gaap_IncreaseDecreaseInOperatingCapitalAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 14 5 us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true 29000000 29 false false 2 false true 42000000 42 false false No definition available. No authoritative reference available. false 15 5 us-gaap_IncreaseDecreaseInInventories us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -35000000 -35 false false 2 false true -59000000 -59 false false No definition available. No authoritative reference available. false 16 5 us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true -136000000 -136 false false 2 false true -81000000 -81 false false No definition available. No authoritative reference available. false 17 5 us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -1000000 -1 false false 2 false true 110000000 110 false false No definition available. No authoritative reference available. false 18 4 mdt_CertainLitigationCharges mdt false debit duration monetary Amount related to material litigation charges recognized in the period in the statement of earnings. Excludes the amount of... false false false false false false false false false 1 false true 444000000 444 false false 2 false true 0 0 false false Amount related to material litigation charges recognized in the period in the statement of earnings. Excludes the amount of expense provided in the period for legal fees. No authoritative reference available. false 19 4 mdt_CertainLitigationPaymentsReceipts mdt false credit duration monetary Net amount related to material litigation paid or received in the period. Excludes amount paid in the period for legal fees. false false false false false false false false false 1 false true -494000000 -494 false false 2 false true -193000000 -193 false false Net amount related to material litigation paid or received in the period. Excludes amount paid in the period for legal fees. No authoritative reference available. false 20 3 us-gaap_NetCashProvidedByUsedInOperatingActivities us-gaap true na duration monetary No definition available. false false false false false false false false false 1 false true 621000000 621 false false 2 false true 800000000 800 false false No definition available. No authoritative reference available. true 21 2 us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 22 3 us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true 0 0 false false 2 false true -29000000 -29 false false No definition available. No authoritative reference available. false 23 3 us-gaap_PaymentsToAcquirePropertyPlantAndEquipment us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -150000000 -150 false false 2 false true -127000000 -127 false false No definition available. No authoritative reference available. false 24 3 us-gaap_PaymentsToAcquireInvestments us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -1156000000 -1156 false false 2 false true -1103000000 -1103 false false No definition available. No authoritative reference available. false 25 3 us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 860000000 860 false false 2 false true 558000000 558 false false No definition available. No authoritative reference available. false 26 3 us-gaap_PaymentsForProceedsFromOtherInvestingActivities us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -83000000 -83 false false 2 false true 21000000 21 false false No definition available. No authoritative reference available. false 27 3 us-gaap_NetCashProvidedByUsedInInvestingActivities us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true -529000000 -529 false false 2 false true -680000000 -680 false false No definition available. No authoritative reference available. true 28 2 us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 29 3 us-gaap_ProceedsFromRepaymentsOfShortTermDebt us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 148000000 148 false false 2 false true 481000000 481 false false No definition available. No authoritative reference available. false 30 3 us-gaap_RepaymentsOfLongTermDebt us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -6000000 -6 false false 2 false true -300000000 -300 false false No definition available. No authoritative reference available. false 31 3 us-gaap_PaymentsOfDividendsCommonStock us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -228000000 -228 false false 2 false true -211000000 -211 false false No definition available. No authoritative reference available. false 32 3 us-gaap_ProceedsFromIssuanceOrSaleOfEquity us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 36000000 36 false false 2 false true 198000000 198 false false No definition available. No authoritative reference available. false 33 3 us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 0 0 false false 2 false true 11000000 11 false false No definition available. No authoritative reference available. false 34 3 us-gaap_PaymentsForRepurchaseOfCommonStock us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true -344000000 -344 false false 2 false true -175000000 -175 false false No definition available. No authoritative reference available. false 35 3 us-gaap_NetCashProvidedByUsedInFinancingActivities us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true -394000000 -394 false false 2 false true 4000000 4 false false No definition available. No authoritative reference available. true 36 1 us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents us-gaap true debit duration monetary No definition available. false false false false false false false false false 1 false true 53000000 53 false false 2 false true -14000000 -14 false false No definition available. No authoritative reference available. false 37 1 us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false 1 false true -249000000 -249 false false 2 false true 110000000 110 false false No definition available. No authoritative reference available. true 38 1 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false true false false 1 false true 1271000000 1271 false false 2 false true 1060000000 1060 false false No definition available. No authoritative reference available. false 39 1 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false false true false 1 false true 1022000000 1022 false false 2 false true 1170000000 1170 false false No definition available. No authoritative reference available. false 40 1 mdt_SupplementalCashFlowInformation mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 41 2 us-gaap_IncomeTaxesPaidNet us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 false true 68000000 68 false false 2 false true 62000000 62 false false No definition available. No authoritative reference available. false 42 2 us-gaap_InterestPaid us-gaap true credit duration monetary No definition available. false false false false false false false false false 1 true true 58000000 58 false false 2 true true 38000000 38 false false No definition available. No authoritative reference available. false false 2 39 false Millions UnKnown UnKnown false true XML 26 R5.xml IDEA: Condensed Consolidated Balance Sheets (Parenthetical) 1.0.0.3 false Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Millions, except Per Share data false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 2 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_CondensedConsolidatedBalanceSheetsParentheticalAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false No definition available. false 3 1 us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false 1 true true 63000000 63 false false 2 true true 61000000 61 false false No definition available. No authoritative reference available. false 4 1 us-gaap_PreferredStockParOrStatedValuePerShare us-gaap true na instant decimal No definition available. false false false false false false false false true 1 true true 1.00 1.00 false false 2 true true 1.00 1.00 false false No definition available. No authoritative reference available. false 5 1 us-gaap_CommonStockParOrStatedValuePerShare us-gaap true na instant decimal No definition available. false false false false false false false false true 1 true true 0.10 0.10 false false 2 true true 0.10 0.10 false false No definition available. No authoritative reference available. false false 2 4 false Millions UnKnown Hundreds false true XML 27 R23.xml IDEA: Comprehensive Income and Accumulated Other Comprehensive (Loss) Income 1.0.0.3 false Comprehensive Income and Accumulated Other Comprehensive (Loss) Income false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_ComprehensiveIncomeAndAccumulatedOtherComprehensiveLossIncomeAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_ComprehensiveIncomeNoteTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 17 &#8211; Comprehensive Income and Accumulated Other Comprehensive (Loss)/Income<br/>&#160;<br/>In addition to net earnings, comprehensive income includes changes in foreign currency translation adjustments (including the change in current exchange rates, or spot rates, of net investment hedges), unrealized gains and losses on foreign exchange derivative contracts qualifying and designated as cash flow hedges, net changes in retirement obligation funded status and unrealized gains and losses on AFS marketable securities. Comprehensive income for the three months ended July 31, 2009 and July 25, 2008 was $441 million and $801 million,&#160;respectively.<br/>&#160;<br/>Presented below is a summary of activity for each component of accumulated other comprehensive (loss)/income:<br/></p></ font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="209" height="74" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="78" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Unrealized Gain/(Loss) on Investments</b></font></td><td width="16" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="71" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Cumulative Translation Adjustments</b></font></td><td width="16" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="79" height="74" align="center" style="border-bottom: 1px sol id #000000;"><font size="2"><b>Net Change in Retirement Obligations</b></font></td><td width="11" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Unrealized Gain/(Loss) on Foreign Exchange Derivatives</b></font></td><td width="15" height="74" align="left"><font size="2">&#160;</font></td><td colspan="2" width="89" height="74" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Accumulated Other Comprehensive Income/(Loss)</b></font></td></tr><tr><td width="209" height="17" align="left"><font size="2"><b>Balance April 24, 2009</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" h eight="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="59" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(95)</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="52" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">62&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(398)</font></td><td width="11" height="17" ali gn="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="53" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">228&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="70" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(202)</font></td></tr><tr><td width="209" height="34" align="left"><font size="2">Impact of Adoption of FSP FAS Nos. 115-2 and 124-2</font></td><td width="13" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left">&l t;font size="2">&#160;</font></td><td width="59" height="34" align="right"><font size="2">&#160;(3)</font></td><td width="16" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="52" height="34" align="right"><font size="2">&#160;-&#160;</font></td><td width="16" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="60" height="34" align="right"><font size="2">&#160;-&#160;</font></td><td width="11" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="53" height="34" ali gn="right"><font size="2">&#160;-&#160;</font></td><td width="15" height="34" align="left"><font size="2">&#160;</font></td><td width="19" height="34" align="left"><font size="2">&#160;</font></td><td width="70" height="34" align="right"><font size="2">(3)</font></td></tr><tr><td width="209" height="17" align="left"><font size="2">Period Change</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="59" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">50&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17 " align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="52" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">179&#160;</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(7)</font></td><td width="11" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="53" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(227)</font></ td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="70" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">(5)</font></td></tr><tr><td width="209" height="18" align="left"><font size="2"><b>Balance July 31, 2009</b></font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="59" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(48)</font></td><td width="16" height="18" align=" left" style="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="52" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;241&#160;</font></td><td width="16" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(405)</font></td><td width="11" height="18" align="left" style="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160 ;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="53" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;1&#160;</font></td><td width="15" height="18" align="left" style="border-bottom: 3px solid #C0C0C0;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="70" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">(210)</font></td></tr></table></div><div><font size="2"><p>Translation adjustments are not adjusted for income taxes as substantially all translation adjustments relate to permanent investments in non-U.S. subsidiaries. The tax benefit on the unrealized loss on foreign exchange derivatives for the three months ended July 31, 2009 was $113 million. The tax expense on the unrealized gain on investments for the three months ended July 31, 2009 was $28 million. The tax benefit on the net change in retirement obligations was not material for the three months ended July 31, 2009. See Note 7 for additional information regarding the adoption of FSP SFAS Nos. 115-2 and 124-2. <br/></p></font></div></body></html> Note 17 &#8211; Comprehensive Income and Accumulated Other Comprehensive (Loss)/Income&#160;In addition to net earnings, comprehensive income includes changes false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 28 defnref.xml IDEA: XBRL DOCUMENT No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents the complete disclosure related to certain litigation charges. Certain litigation charges are amounts related to material litigation recognized in the statement of earnings. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans, the aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer), and the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the new pronouncement, the date that adoption is required and the date that the entity plans to adopt, if earlier; (2) discuss the methods of adoption allowed by the pronouncement and the method expected to be utilized by the entity, if determined; (3) discuss the impact that adoption of the pronouncement is expected to have on the financial statements of the entity, unless such impact is not known or reasonably estimable (in which case, a statement to that effect should be made) and; (4) disclose the potential impact of other significant matters that the entity believes might result from the adoption of the pronouncement (for example, technical violations of debt covenant agreements and planned or intended changes in business practices.) No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total costs of sales and expenses for the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Discloses the gross amounts of interest income and expense recognized during the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net amount related to material litigation paid or received in the period. Excludes amount paid in the period for legal fees. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net amount of interest expense or income. Interest expense includes the expense associated with the interest paid on outstanding borrowings, including short- and long-term instruments, and the amortization of debt issuance costs and debt discounts. Interest income includes interest earned on cash and cash equivalents, short- and long-term investments and the net realized gains or losses on the sale of available-for-sale securities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the current portion of the liability for the underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amount related to material litigation charges recognized in the period in the statement of earnings. Excludes the amount of expense provided in the period for legal fees. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Description of a business acquisition (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. This disclosure also includes a description of the amount written off in the period of purchased research and development assets that are acquired in a business combination or in a transaction other than a business combination that have no alternative future use. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the entire disclosure related to investments in debt and equity securities with readily determinable fair values, equity method investments in common stock, and investments accounted for under the cost-method. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. XML 29 R21.xml IDEA: Income Taxes 1.0.0.3 false Income Taxes false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_IncomeTaxesAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_IncomeTaxDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 15 &#8211; Income Taxes<br/>&#160;<br/>During the three months ended July 31, 2009, the Company recorded a $7 million benefit associated with Irish research and development credit claims, finalization of certain foreign tax returns and changes to uncertain tax position reserves. These tax adjustments are operational in nature and are recorded in provision for income taxes on the condensed consolidated statements of earnings. <br/><br/>During the three months ended July 31, 2009, the Company&#8217;s gross unrecognized tax benefits increased from $431 million to $471 million. In addition, the Company has accrued interest and penalties of $120 million as of July 31, 2009. If all of the Company&#8217;s unrecognized tax benefits were recognized, approximately $402 million would impact the Company&#8 217;s effective tax rate. The Company continues to record the liability for unrecognized tax benefits as a long-term liability as it does not expect significant payments to occur or the total amount of unrecognized tax benefits to change significantly over the next twelve months. The Company will continue to recognize interest and penalties related to income tax matters in the provision for income taxes in the condensed consolidated statements of earnings and record the liability in the current or long-term accrued income taxes in the condensed consolidated balance sheets, as appropriate.<br/>&#160;<br/>As of July 31, 2009, there have been no changes to significant unresolved matters with the U.S. Internal Revenue Service or foreign tax authorities from what was previously disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended April 24, 2009. <br/></p></font></div></body></html> Note 15 &#8211; Income Taxes&#160;During the three months ended July 31, 2009, the Company recorded a $7 million benefit associated with Irish research and false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 30 R13.xml IDEA: Investments 1.0.0.3 false Investments false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 us-gaap_InvestmentsAbstract us-gaap true na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 mdt_InvestmentsTextBlock mdt false na duration string This item represents the entire disclosure related to investments in debt and equity securities with readily determinable... false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 7 &#8211; Investments<br/><br/>In April 2009, the FASB issued FSP SFAS No. 115-2 and SFAS No. 124-2, &#8220;Recognition and Presentation of Other-Than-Temporary Impairments&#8221; (FSP SFAS Nos. 115-2 and 124-2) which amended the existing guidance on determining whether an impairment for investments in debt securities is other-than-temporary as well as requiring additional annual and interim disclosures. Under FSP SFAS Nos. 115-2 and 124-2, impairment on debt securities will be considered other-than-temporary if the Company (1) intends to sell the security, (2) more likely than not will be required to sell the security before recovering its costs, or (3) does not expect to recover the security&#8217;s fair value versus its amortized cost basis. FSP SFAS Nos. 115-2 and 124-2 further indicates that, depending on wh ich of the above factor(s) causes the impairment to be considered other-than-temporary, (1) the entire shortfall of the security&#8217;s fair value versus its amortized cost basis or (2) only the credit loss portion would be recognized in earnings while the remaining shortfall would be recognized in other comprehensive income. FSP SFAS Nos. 115-2 and 124-2 requires the Company to initially apply the provisions of the standard to previously other-than-temporary impaired debt securities existing as of the date of initial adoption by making a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The cumulative-effect adjustment reclassifies the non-credit portion of a previously other-than-temporarily impaired debt security held as of the date of initial adoption from retained earnings to accumulated other comprehensive income. FSP SFAS Nos. 115-2 and 124-2 was effective for the Company in the first quarter of fiscal year 2010 and resulted in a cumulative-effect adjustment of $3 million as of April 25, 2009.<br/><br/>Information regarding the Company&#8217;s short-term and long-term investments at July 31, 2009 is as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="319" height="14" align="left"><font size="2">&#160;</font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2">&#160;</font></td><td width="64" height="14" align="left"><font size="2"><b>&#160;</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center"><font size="2"><b>Unrealized </b></font></td><td width="12" height="14" align="left">& lt;font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center"><font size="2"><b>Unrealized </b></font></td><td width="14" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2">&#160;</font></td><td width="73" height="14" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="319" height="14" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Cost</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></t d><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Gains</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td><td width="14" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="92" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Corporate debt securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-t op: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;852&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">13&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(18)</font></td><td width="14" height="17" align="left"&g t;<font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="73" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;847&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Auction rate securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;195&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height ="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(43)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;152&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Mortgage backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"> <font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;654&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">8&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(39)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align ="right"><font size="2">&#160;623&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Government and agency securities </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;1,082&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">5&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&a mp;#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(2)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;1,085&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Certificates of deposit</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;34&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width ="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;34&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Other asset backed securities&#160;&#160; </font></td><td width="13" height ="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;280&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;3&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(9)</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td>< td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;274&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Marketable equity securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;12&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;6&#160;</font></td><td width="12" height="17" align= "left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;18&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Cost method, equity method and other investments</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" he ight="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;526&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font ></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="73" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;526&#160;</font></td></tr><tr><td width="319" height="18" align="left"><font size="2">Total short-term and long-term investments</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,635&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></t d><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;35&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(111)</font></td><td width="14" height="18" align="left" style="border-bottom: 3px double #FFFFFF;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000 000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="73" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,559&#160;</font></td></tr></table></div><div><font size="2"><p>Information regarding the Company&#8217;s short-term and long-term investments at April 24, 2009 is as follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="306" height="17" align="left"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2"><b>&#160;</b></font></ td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center"><font size="2"><b>Unrealized </b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center"><font size="2"><b>Unrealized </b></font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="306" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;& lt;/font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Cost</b></font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Gains</b></font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td></tr& gt;<tr><td width="306" height="17" align="left"><font size="2">Corporate debt securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">817&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">8&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">(20)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">805&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Auction rate securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">199&#160;< ;/font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(80)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">119&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font si ze="2">Mortgage backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">789&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">9&#160;</font></td><td width="18" height="17" align="right"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(52)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">746&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Government and agency securities </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">693&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">5&#160;</font ></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(1)</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">697&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Certificates of deposit</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2 ">2&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">2&#160;</font></td></tr><tr><td width="306" heigh t="17" align="left"><font size="2">Other asset backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">297&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">3&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">(22)</font>< ;/td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">278&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Marketable equity securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">12&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">12&#160;</font></td></tr><tr><td width="306" height="17" align="left"><font size="2">Cost method, equity method and other investments</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #0000 00;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">515&#160;</font></td><td width="15" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="18" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width= "17" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">515&#160;</font></td></tr><tr><td width="306" height="18" align="left"><font size="2">Total short-term and long-term investments</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,324&#160;</font></td><td width="15" height="18" ali gn="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">25&#160;</font></td><td width="18" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">(175)</font></td><td width="17" height="18" align="left" style="border-bottom: 3px double #FFFFFF;"><font size="2">&#160;</font></td><td width="19" height="18" ali gn="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;3,174&#160;</font></td></tr></table></div><div><font size="2"><p>The following table shows the gross unrealized losses and fair values of the Company&#8217;s investments in individual securities that have been in a continuous unrealized loss position deemed to be temporary for less than 12 months and for more than 12 months, aggregated by investment category as of July 31, 2009:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="319" height="17" align="left"><font size="2">&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;&l t;/font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td colspan="4" width="159" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Less than 12 months</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="5" width="189" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>More than 12 months</b></font></td></tr><tr><td width="319" height="14" align="left"><font size="2">&#160;</font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td width="19" height="14" align="left"><font size="2">&#160;</font></td><td width="64" height="14" align="left" style="border-top: 1px solid #000000;"><font size="2" ><b>&#160;</b></font></td><td width="12" height="14" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Unrealized </b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>&#160;</b></font></td><td width="14" height="14" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="92" height="14" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>Unrealized</b></font></td></tr><tr><td width="319" height="14" align="left"& gt;<font size="2"><b>(in millions)</b></font></td><td width="13" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td><td width="12" height="14" align="left"><font size="2">&#160;</font></td><td colspan="2" width="83" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Fair Value</b></font></td><td width="14" height="14" align="left"><font size="2">&#160;</font></td><td colspan= "2" width="92" height="14" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Losses</b></font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Corporate debt securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;117&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&am p;#160;(1)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;83&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="73" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;(17)</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Auction rate securities</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font>& lt;/td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;152&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2 ">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;(43)</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Mortgage backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;104&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(5)</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font>< ;/td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;113&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;(34)</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Government and agency securities </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;342&#160;</font></td><td width="12" height= "17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;(2)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="319" height="17" align="left"><font size="2">Other asset backed securities&#160;&#160; </font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="64" height="17" align="right"><font size="2">&#160;51&#160;</font></td><td width="14" h eight="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right"><font size="2">&#160;</font></td><td width="73" height="17" align="right"><font size="2">&#160;(9)</font></td></tr><tr><td width="319" height="18" align="left"><font size="2">Total short-term and long-term investments</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;563&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height ="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(8)</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="64" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;399&#160;</font></td><td width="14" height="18" align="left" style="border-bottom: 3px double #FFFFFF;"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="73" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;(103)</font></td></tr></table></div><div><font size="2"><p>The Company&#8217;s investments in marketable debt securities detailed above are classified and accounted for as available-for-sale and include corporate debt securities, government and agency securities, certificates of deposit and mortgage backed and other asset backed securities including auction rate securities. Market conditions during the first quarter of fiscal year 2010 and subsequent to the Company&#8217;s quarter-end continue to indicate significant uncertainty on the part of investors on the economic outlook for the U.S. and for financial institutions. This uncertainty has created reduced liquidity across the fixed income investment market, including certain securities in which the Company has invested. As a result, some of the Company&#8217;s investments have experienced reduced liquidity including unsuccessful monthly auctions for auction rate security holdings. At July 31, 2009, the Company concluded that the unrealized losses associated with the remaining securities were not other-than-temporary as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell, before recovery of the amortized cost.<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td colspan="13" width="718" height="17" align="left"><font size="2">Activity related to the Company&#8217;s short-term and long-term investment portfolio is as follows:</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2"&g t;&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;& lt;/font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td width="229" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="11" width="425" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="229" height="17" align="center"><font size="2">&#160;</font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="197" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 31, 2009</b></font></td><td width="31" height="17" align="center" st yle="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="5" width="197" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>July 25, 2008</b></font></td></tr><tr><td width="229" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="64" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Debt (a)</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #0000 00;"><font size="2"><b>Equity (b)</b></font></td><td width="31" height="17" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Debt (a)</b></font></td><td width="31" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="83" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Equity (b)</b></font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Proceeds from sales</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="bor der-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;860&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td wid th="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;558&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Gross realized gains </font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td& gt;<td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;14&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"> <font size="2">&#160;1&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Gross realized losses</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #0 00000;"><font size="2">&#160;(1)</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(2)</font></td><td width="31" height="17" align="left"><font size="2 ">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">Impairment losses recognized</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(7)</font></td><td width="31" height="17" align="left"><fo nt size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(3)</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(3)</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;border-bot tom: 1px solid #000000;"><font size="2">$</font></td><td width="64" height="17" align="right" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2">&#160;(2)</font></td></tr><tr><td width="229" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="1 7" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="64" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td></tr><tr><td colspan="8" width="521" height="17" align="left"><font size="2">(a) Includes available-for-sale (AFS) debt secu rities.</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td><td width="31" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="64" height="17" align="left"><font size="2">&#160;</font></td></tr><tr><td colspan="13" width="718" height="17" align="left"><font size="2">(b) Includes marketable equity securities, cost method, equity method and other investments. </font></td></tr></table></div><div><font size="2"><p>The total other-than-temporary impairment losses on AFS debt securities for the three months ended July 31, 2009 was $24 million, of which $17 million was recognized in other comprehensive i ncome resulting in $7 million of charges being recognized in earnings. These charges relate to credit losses on certain mortgage backed securities and auction rate securities. The amount of credit losses represents the difference between the present value of cash flows expected to be collected on these securities and the amortized cost. Based on the Company&#8217;s assessment of the credit quality of the underlying collateral and credit support available to each of the remaining securities in which invested, the Company believes it has recorded all necessary other-than-temporary impairments as the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell before recovery of the amortized cost. For additional discussion, see the &#8220;Liquidity and Capital Resources&#8221; section of management&#8217;s discussion and analysis.&#160;<br/><br/>The following table shows the credit loss portion of other-than-temporary impai rments on debt securities held by the Company as of the dates indicated and the corresponding changes in such amounts:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="548" height="17" align="left"><font size="2">&#160;</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="548" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="104" height="17" align="center"><font size="2"><b>&#160;</b></font></td></tr><tr><td width="548" height="17" align="left"&g t;<font size="2"><b>Balance at April 24, 2009</b></font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">$</font></td><td width="85" height="17" align="right"><font size="2">0&#160;</font></td></tr><tr><td width="548" height="17" align="left"><font size="2">Credit losses remaining in retained earnings upon adoption</font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left"><font size="2">&#160;</font></td><td width="85" height="17" align="right"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="548" height="17" align="left"><font size="2">Credit losses recognized on securities previously not impaired& lt;/font></td><td width="4" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="85" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td></tr><tr><td width="548" height="18" align="left"><font size="2"><b>Balance at July 31, 2009</b></font></td><td width="4" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="85" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;11&#160;</font>< /td></tr></table></div><div><font size="2"><p>The July 31, 2009 balance of AFS debt securities by contractual maturity is shown in the following table at fair value. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows, assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td rowspan="2" width="560" height="32" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="78" height="32" align="center"><font size="2">&#160;</font></td><td colspan="2" width="79" height="19" align="center"><font size="2"><b>July 31 , </b></font></td></tr><tr><td colspan="2" width="79" height="13" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due in one year or less</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width="9" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="70" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;750&#160;</font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due after one year through five years</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width=" 9" height="17" align="right"><font size="2">&#160;</font></td><td width="70" height="17" align="right"><font size="2">&#160;2,064&#160;</font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due after five years through ten years</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width="9" height="17" align="right"><font size="2">&#160;</font></td><td width="70" height="17" align="right"><font size="2">&#160;33&#160;</font></td></tr><tr><td width="560" height="17" align="left"><font size="2">Due after ten years</font></td><td width="78" height="17" align="left"><font size="2">&#160;</font></td><td width="9" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160; </font></td><td width="70" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;168&#160;</font></td></tr><tr><td width="560" height="18" align="left"><font size="2">Total debt securities</font></td><td width="78" height="18" align="left"><font size="2">&#160;</font></td><td width="9" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="70" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">3,015&#160;</font></td></tr></table></div><div><font size="2"><p>As of July 31, 2009 and April 24, 2009, the aggregate carrying amount of equity and other securities without a quoted market price and accounted for using the cost or equity method was $526 million and $515 million, respectively. The total carrying value of these investments is reviewed quarterly for changes in circumstance or the occurrence of events that suggest the Company&#8217;s investment may not be recoverable. The fair value of cost or equity method investments is not adjusted if there are no identified events or changes in circumstances that may have a material adverse effect on the fair value of the investment.<br/>&#160;<br/>Gains and losses recognized on debt instruments are recorded in interest expense, net in the condensed consolidated statements of earnings. Gains and losses recognized on equity instruments are recorded in other expense, net in the condensed consolidated statements of earnings. Gains and losses from the sale of investments are calculated based on the specific identification method.<br/>&#160;<br/></p></font></div></body></html> Note 7 &#8211; InvestmentsIn April 2009, the FASB issued FSP SFAS No. 115-2 and SFAS No. 124-2, &#8220;Recognition and Presentation of Other-Than-Temporary false false This item represents the entire disclosure related to investments in debt and equity securities with readily determinable fair values, equity method investments in common stock, and investments accounted for under the cost-method. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 31 R26.xml IDEA: Contingencies 1.0.0.3 false Contingencies false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_ContingenciesAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_CommitmentsAndContingenciesDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 20 &#8211; Contingencies<br/>&#160;<br/>The Company is involved in a number of legal actions. The outcomes of these legal actions are not within the Company&#8217;s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost revenues. In accordance with SFAS No. 5, &#8220;Accounting for Contingencies&#8221; (SFAS No. 5), the Company records a liability in the consolidated financial statements for these actions when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within t he range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. While it is not possible to predict the outcome for most of the matters discussed, the Company believes it is possible that costs associated with them could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position or cash flows. <br/>Litigation with Wyeth and Cordis Corporation<br/>On February 22, 2008, Wyeth and Cordis Corporation (Cordis) filed a lawsuit against the Company and its subsidiary, Medtronic AVE, Inc., in U.S. District Court for the District of New Jersey, alleging that Medtronic&#8217;s Endeavor drug-eluting stent infringes three U.S. &#8220;Morris&#8221; patents alleged to be owned by Wyeth and exclusiv ely licensed to Cordis. The Company is indemnified for the claims made by Wyeth and Cordis. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Litigation with Abbott Cardiovascular Systems Inc.<br/>On July 27, 2009, Medtronic announced global resolution of all outstanding intellectual property litigation with Abbott. The terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. Both parties also agreed to a cross-license of the disputed patents within the defined field. The $444 million pre-tax settlement amount includes a $400 million payment to be made to Abbott and a $42 million success payment to be made to evYsio. In addition, a $2 million payment is to be made to evYsio in connection with an amendment to the parties&a mp;#8217; existing agreement in order to expand the scope of the definition of the license field from evYsio. In the first quarter of fiscal year 2010, the Company recorded an expense in the amount of $444 million relating to the matter.<br/>Litigation with DePuy Spine<br/>On January 26, 2001, DePuy Spine (formerly DePuy/AcroMed), a subsidiary of Johnson &amp; Johnson, and Biedermann Motech GmbH (collectively, DePuy) filed suit in U.S. District Court for the District of Massachusetts alleging that Medtronic&#8217;s subsidiary, Medtronic Sofamor Danek USA, Inc. (MSD), was infringing a patent relating to a design for a thoracolumbar multi-axial screw (MAS). DePuy subsequently supplemented its allegations to claim that MSD&#8217;s M10, M8 and Vertex screws infringe the patent. On April 17, 2003 and February 26, 2004, the District Court ruled on summary judgment that the M10, M8 and Vertex screws do not infringe. On October 1, 2004, a jury found that MAS screws, which MSD no longer sells in the U.S., infringe under the doctrine of equivalents. The jury awarded damages of $21 million and on February 9, 2005, the Court entered judgment against MSD, including prejudgment interest, in the aggregate amount of $24 million. In the third quarter of fiscal year 2005, the Company recorded an expense equal to the $24 million judgment in the matter. DePuy appealed the Court&#8217;s decisions that the M10, M8 and Vertex screws do not infringe, and MSD appealed the jury&#8217;s verdict that the MAS screws infringe valid claims of the patent. On November 20, 2006, the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the District Court that the M10 and M8 screws do not infringe, affirmed the jury&#8217;s verdict and damage award on the MAS screws, affirmed the decision that the Vertex screws do not literally infringe, but remanded the case, ruling that there is a triable issue of fact as to whether the Vertex screws infringe under the doctrine of equivalents. On remand, DeP uy further supplemented its allegations to claim that an additional product, the Vertex Max screws, also infringe. On March 20, 2007, the District Court declined to stay execution of the judgment relating to the MAS product. On March 30, 2007, the judgment plus accrued interest was paid under protest. On September 27, 2007, a jury found that the Vertex and Vertex Max screws infringe under the doctrine of equivalents and awarded $226 million in damages to DePuy, and the District Court entered judgment against Medtronic on December 12, 2007. Thereafter, the District Court ruled on all post-trial motions, increasing the award to DePuy to an estimated amount of $272 million. The District Court also granted a permanent injunction against Medtronic that prohibits Medtronic from making, using and selling Vertex and Vertex Max polyaxial screws in the U.S.; however, Medtronic&#8217;s Vertex Select multi-axial screw is not affected by the injunction. Medtronic appealed to the U.S. Court of Appeals for the Federal Circuit. DePuy cross-appealed. On June 1, 2009, the Court of Appeals for the Federal Circuit affirmed the determination of infringement and award of lost profits, but reversed the remaining elements of the damages awarded. The court remanded the case to the District Court for the calculation of post-judgment interest on damages of $149 million. In the fourth quarter of fiscal year 2009, the Company recorded an expense in the amount of $178 million relating to the matter. The District Court entered a final judgment, including pre- and post-judgment interest in the aggregate amount of $179 million on June 29, 2009. Medtronic satisfied the judgment with a payment of $179 million to DePuy on June 30, 2009.<br/>Marquis/Maximo/InSync Matters<br/>On February 10, 2005, Medtronic voluntarily began to advise physicians about the possibility that a specific battery shorting mechanism might manifest itself in a subset of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy-d efibrillators (CRT-Ds). These included certain Marquis VR/DR and Maximo VR/DR ICDs and certain InSync I/II/III CRT-D devices. Subsequent to this voluntary field action, a number of lawsuits were filed against the Company alleging a variety of claims, including individuals asserting claims of personal injury and third party payors alleging entitlement to reimbursement. Many of these lawsuits were settled, and in the third quarter of fiscal year 2008, the Company recorded an expense of $123 million relating to the settlement in accordance with SFAS No. 5 as the potential loss was both probable and reasonably estimable. The Company paid substantially all of the $123 million in the first quarter of fiscal year 2009. One third party payor , Kinetic Knife, dismissed its original action without prejudice and subsequently filed a putative class action relating to the same subject matter. Medtronic removed the action to federal court in the District of Minnesota and filed a motion to dismiss, which is pending. In add ition, class action product liability suits pending in Canada are consolidated in the Ontario Superior Court of Justice. That court certified a class proceeding on December 6, 2007 and denied Medtronic&#8217;s leave to appeal certification on May 15, 2008. The class was certified to include individual implant recipients and their family members. In addition, the subrogated claims of the provincial health insurers to recover costs incurred in providing medical services to the implant class are claimed in the class proceeding. Pretrial proceedings are underway. The Company has not recorded an expense related to damages for the remaining suits because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Sprint Fidelis Product Liability Matters<br/>On October 15, 2007, the Company voluntarily suspended worldwide distribution of its Sprint Fidelis (Fidelis) family of defibrillation leads. The leads are used to deliver therapy in patients with ICDs, but are gen erally not used in pacemaker patients. The U.S. Food and Drug Administration (FDA) subsequently classified the Company&#8217;s action as a Class I recall. As of August 1, 2009, approximately 1,350 lawsuits regarding the Fidelis leads have been filed against the Company, including approximately 37 putative class action suits reflecting a total of approximately 2,400 individual personal injury cases. In general, the suits allege claims of product liability, warranty, negligence, unjust enrichment, emotional distress and consumer protection violations. One lawsuit includes a claim by an individual purporting to act as a surrogate for the Center for Medicare and Medicaid Services, and one lawsuit has been brought by a third party payor as a putative class action suit. In addition, one putative class action has been filed in the Ontario Superior Court of Justice in Canada. Approximately 485 of the lawsuits have been filed in state court, generally alleging similar causes of action. Of those state court action s, approximately 470 are consolidated before a single judge in Hennepin County District Court in the state of Minnesota. Oral arguments on Medtronic&#8217;s motion to dismiss the Minnesota cases were heard on September 4, 2009. The federal court cases have been consolidated for pretrial proceedings before a single federal judge in the U.S. District Court for the District of Minnesota pursuant to the Multi-District Litigation (MDL) rules. On January 5, 2009, the MDL court entered an order dismissing with prejudice the master consolidated complaint for individuals and the master consolidated complaint for third party payors on grounds of federal preemption. On May 12, 2009, the MDL court denied plaintiffs&#8217; request to file a motion for reconsideration of the dismissals and plaintiffs&#8217; motion seeking permission to amend the master consolidated complaint. The court dismissed with prejudice 229 cases that adopted the master consolidated complaint and stayed all other cases pending further o rder of the court. Plaintiffs in the 229 cases filed a notice of appeal to the Eighth Circuit Court of Appeals on May 29, 2009. The Company has not recorded an expense related to damages in connection with the matter because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Shareholder Related Matters<br/>On November 8, 2007, Stanley Kurzweil filed a putative class action complaint against the Company and certain of its officers in the U.S. District Court for the District of Minnesota, alleging violations of Section 10(b) of the Securities Exchange Act of 1934 (the Exchange Act) and Rule 10b-5 thereunder. The complaint is brought on behalf of persons or entities who purchased securities of Medtronic during the period of June 25, 2007 through October 15, 2007. The complaint alleges that &#8220;materially false and misleading&#8221; representations were made as to the market acceptance and use of the Fidelis defibrillator leads to artificially inflat e Medtronic&#8217;s stock price. Pursuant to court order, the caption of the case was changed to Medtronic, Inc., Securities Litigation, and a consolidated putative class action complaint was filed on April 18, 2008. On March 10, 2009, the court entered an order dismissing the complaint with prejudice and denying plaintiffs leave to amend. Plaintiffs&#8217; motion to alter the judgment was denied on May 29, 2009. Plaintiffs have filed an appeal to the Eighth Circuit Court of Appeals.<br/><br/>On November 29 and December 14, 2007 respectively, Feivel Gottlieb and Alan Weinberg filed shareholder derivative actions in Hennepin County District Court in the state of Minnesota against both the Company and certain of its officers and directors, alleging breach of fiduciary duty, waste of corporate assets and other claims arising from the same subject matter as the consolidated class action complaint. On July 28, 2008, the state court stayed these actions pending final resolution of the related consolidated class action complaint. <br/><br/>On January 9, 2009, Richard Gulbrandsen filed a similar shareholder derivative action against both the Company and certain of its officers, directors and employees in Hennepin County District Court in the state of Minnesota, alleging breach of fiduciary duty and other claims arising from the same subject matter as the Markewich putative class action complaint. On April 9, 2009, the court stayed the action until resolution of the Markewich matter pursuant to a stipulation of the parties. On July 10, 2009, the case was dismissed without prejudice pursuant to stipulation of the parties.<br/><br/>In addition, on August 11, 2008, Mark Brown filed a complaint against the Company and certain directors, officers and other company personnel in the U.S. District Court for the District of Minnesota, alleging violations of the Employee Retirement Income Security Act of 1974 arising from the same subject matter as the consolidated putative class compl aint. The complaint was filed on behalf of a putative class of participants in and beneficiaries of the Medtronic, Inc. Savings and Investment Plan, whose individual accounts held shares of Company stock at any time from February 15, 2007 to November 19, 2007. On December 29, 2008, the plaintiff amended the complaint to add similar allegations relating to alleged off-label promotion of INFUSE Bone Graft and to amend the class to include participants in the plan from February 15, 2007 to December 12, 2008. The defendants&#8217; motion to dismiss was granted on May 26, 2009. Plaintiffs have filed an appeal to the Eighth Circuit Court of Appeals.<br/><br/>On December 11, 2008, the Minneapolis Firefighters&#8217; Relief Association filed a putative class action complaint against the Company and two of its officers in the U.S. District Court for the District of Minnesota, alleging violations of Section 10(b) of the Exchange Act and Rule 10b-5 thereunder. The complaint is brought on behalf of persons or entities who purchased securities of Medtronic from November 19, 2007 through November 17, 2008. The complaint alleges that the defendants made false and misleading public statements concerning the INFUSE Bone Graft product which artificially inflated Medtronic&#8217;s stock price during the period. On May 28, 2009, the court order appointed a lead plaintiff and lead counsel. On August 1, 2009, plaintiffs filed a consolidated putative class action complaint making similar allegations but expanding the class to include those persons or entities who purchased securities of Medtronic from November 20, 2006 to November 17, 2008. <br/><br/>On February 24, 2009, Christin Wright filed a complaint against the Company and certain directors, officers and other company personnel in the United States District Court for the District of Minnesota, alleging violations of the Employee Retirement Income Security Act of 1974. The complaint was filed purportedly on behalf of a putative class compr ised of participants and beneficiaries of the Medtronic, Inc. Savings and Investment Plan, whose individual accounts held shares of company stock at any time from June 28, 2006 to November 18, 2008. The plaintiff claims the defendants breached fiduciary duties by allegedly failing to properly disclose the September 2008 settlement of the litigation with Fastenetix, LLC and the October 2008 settlement of the Cordis litigation. Medtronic&#8217;s motion to dismiss the complaint is scheduled for hearing on October 19, 2009.<br/>The Company has not recorded an expense related to damages in connection with these shareholder related matters because any potential loss is not currently probable or reasonably estimable under SFAS No. 5.<br/>Mirowski<br/>Medtronic is a licensee to the RE 38,119 patent (&#8216;119 Patent) and RE 38,897 patent (&#8216;897 Patent) owned by Mirowski Family Ventures, LLC (Mirowski) relating to the treatment of hemodynamic dysfunction. Medtronic and Mirowski di spute the application of the &#8216;119 and &#8216;897 Patents to certain Medtronic cardiac resynchronization products. The parties entered into a tolling agreement deferring and conditioning any litigation of the dispute upon conditions precedent. The tolling agreement expired on October 1, 2007. In subsequent notices, Mirowski identified certain claims of the two patents that Mirowski asserts Medtronic is using. On December 17, 2007, Medtronic filed an action in U.S. District Court in Delaware seeking a declaration that none of its products infringe any valid claims of either the &#8216;119 or &#8216;897 Patents. If certain conditions are fulfilled, the &#8216;119 and/or &#8216;897 Patents are determined to be valid and the Medtronic products are found to infringe the &#8216;119 and/or &#8216;897 Patents, Medtronic will be obligated to pay royalties to Mirowski based upon sales of certain CRT-D products. A trial date has not been set. As of July 31, 2009, the amount of dispu ted royalties and interest related to CRT-D products is $105 million. This amount has not been accrued because the outcome is not currently probable under SFAS No. 5. <br/><br/>In addition, Medtronic is a licensee to the 4,407,288 Patent (&#8216;288 Patent) owned by Mirowski relating to ICDs. Until November 2001, Medtronic accrued and paid royalties under the license based on a percentage of ICD sales. Medtronic and Mirowski dispute the application of the &#8216;288 Patent to certain Medtronic ICD products. In November 2001, Medtronic ceased paying royalties and entered into an agreement with Mirowski to pay putative royalties into an interest-bearing escrow account through the expiration of the &#8216;288 Patent in December of 2003. As of July 31, 2009, the current balance in the interest-bearing escrow account is $86 million. The parties also entered into a tolling agreement deferring and conditioning any litigation of the obligation to pay royalties upon certain conditions preceden t. If these conditions are fulfilled and the &#8216;288 Patent determined to be invalid or Medtronic&#8217;s products found not to infringe, the escrowed funds will be released to Medtronic. <br/>In the normal course of business, the Company periodically enters into agreements that require it to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising out of the Company&#8217;s products or the negligence of its personnel or claims alleging that its products infringe third-party patents or other intellectual property. The Company&#8217;s maximum exposure under these indemnification provisions cannot be estimated, and the Company has not accrued any liabilities within the consolidated financial statements. Historically, the Company has not experienced significant losses on these types of indemnifications.</p></font></div></body></html> Note 20 &#8211; Contingencies&#160;The Company is involved in a number of legal actions. The outcomes of these legal actions are not within the Company&#8217;s false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 32 R1.xml IDEA: Document Information 1.0.0.3 false Document Information false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_DocumentInformation mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 dei_DocumentType dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 10-Q 10-Q false false No definition available. No authoritative reference available. false 4 1 dei_DocumentPeriodEndDate dei false na duration date No definition available. false false false false false false false false false 1 false false 0 0 2009-07-31 2009-07-31 false false No definition available. No authoritative reference available. false 5 1 dei_AmendmentFlag dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 false false false false No definition available. No authoritative reference available. false false 1 4 false UnKnown UnKnown UnKnown false true XML 33 R2.xml IDEA: Entity Information 1.0.0.3 false Entity Information (USD $) In Billions, except Share data false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 2 $ false false Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 false 3 $ false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_EntityInformation mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. false 3 1 dei_EntityRegistrantName dei false na duration normalizedstring No definition available. false false false false false false false false false 1 false false 0 0 Medtronic, Inc. Medtronic, Inc. false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 4 1 dei_EntityCentralIndexKey dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 0000064670 0000064670 false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 5 1 dei_CurrentFiscalYearEndDate dei false na duration monthday No definition available. false false false false false false false false false 1 false false 0 0 --04-30 --04-30 false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 6 1 dei_EntityWellKnownSeasonedIssuer dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 Yes Yes false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 7 1 dei_EntityVoluntaryFilers dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 No No false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 8 1 dei_EntityCurrentReportingStatus dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 Yes Yes false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 9 1 dei_EntityFilerCategory dei false na duration na No definition available. false false false false false false false false false 1 false false 0 0 Large Accelerated Filer Large Accelerated Filer false false 2 false false 0 0 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false 10 1 dei_EntityPublicFloat dei false credit instant monetary No definition available. false false false false false false false false false 1 false false 0 0 false false 2 false false 0 0 false false 3 true true 42400000000 42.4 false false No definition available. No authoritative reference available. false 11 1 dei_EntityCommonStockSharesOutstanding dei false na instant shares No definition available. false false false false false false false false false 1 false false 0 0 false false 2 false true 1106803531 1106803531.00 false false 3 false false 0 0 false false No definition available. No authoritative reference available. false false 3 10 false HundredMillions NoRounding UnKnown false true XML 34 FilingSummary.xml IDEA: XBRL DOCUMENT 1.0.0.3 true Sheet 00100 - Document - Document Information Document Information R1.xml false Sheet 00105 - Document - Entity Information Entity Information R2.xml false Sheet 00200 - Statement - Condensed Consolidated Statements of Earnings (Unaudited) Condensed Consolidated Statements of Earnings (Unaudited) R3.xml false Sheet 00300 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Condensed Consolidated Balance Sheets (Unaudited) R4.xml false Sheet 00305 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Condensed Consolidated Balance Sheets (Parenthetical) R5.xml false Sheet 00500 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Condensed Consolidated Statements of Cash Flows (Unaudited) R6.xml false Sheet 00601 - Disclosure - Basis of Presentation Basis of Presentation R7.xml false Sheet 00602 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements R8.xml false Sheet 00603 - Disclosure - Retrospective Adoption of Accounting Pronouncements Retrospective Adoption of Accounting Pronouncements R9.xml false Sheet 00604 - Disclosure - Acquisitions Acquisitions R10.xml false Sheet 00605 - Disclosure - Certain Litigation Charges Certain Litigation Charges R11.xml false Sheet 00606 - Disclosure - Restructuring Charges Restructuring Charges R12.xml false Sheet 00607 - Disclosure - Investments Investments R13.xml false Sheet 00608 - Disclosure - Fair Value Measurements Fair Value Measurements R14.xml false Sheet 00609 - Disclosure - Financing Arrangements Financing Arrangements R15.xml false Sheet 00610 - Disclosure - Derivatives and Foreign Exchange Risk Management Derivatives and Foreign Exchange Risk Management R16.xml false Sheet 00611 - Disclosure - Inventories Inventories R17.xml false Sheet 00612 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets R18.xml false Sheet 00613 - Disclosure - Warranty Obligation Warranty Obligation R19.xml false Sheet 00614 - Disclosure - Interest Expense (Income), net Interest Expense (Income), net R20.xml false Sheet 00615 - Disclosure - Income Taxes Income Taxes R21.xml false Sheet 00616 - Disclosure - Earnings Per Share Earnings Per Share R22.xml false Sheet 00617 - Disclosure - Comprehensive Income and Accumulated Other Comprehensive (Loss) Income Comprehensive Income and Accumulated Other Comprehensive (Loss) Income R23.xml false Sheet 00618 - Disclosure - Stock Based Compensation Stock Based Compensation R24.xml false Sheet 00619 - Disclosure - Retirement Benefit Plans Retirement Benefit Plans R25.xml false Sheet 00620 - Disclosure - Contingencies Contingencies R26.xml false Sheet 00621 - Disclosure - Segment and Geographic Information Segment and Geographic Information R27.xml false Book All Reports All Reports 1 9 0 0 3 117 false false AS_OF_Jul25_2008 4 FROM_Apr26_2008_TO_Apr24_2009 1 AS_OF_Apr24_2009 33 FROM_Apr25_2009_TO_Jul31_2009 79 FROM_Apr26_2008_TO_Jul25_2008 46 AS_OF_Sep03_2009 1 AS_OF_Jul31_2009 36 AS_OF_Apr25_2008 1 AS_OF_Oct24_2008 1 true true EXCEL 35 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls MT,\1X*&Q&N$`````````````````````/@`#`/[_"0`&```````````````# M`````0``````````$````0$```$```#^____```````````"``````$``/__ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_______________________]_____O____W___\$````!0````8````'```` M"`````D````*````"P````P````-````#@````\````0````$0```!(````3 M````%````!4````6````%P```!@````9````&@```!L````<````'0```!X` M```?````(````"$````B````(P```"0````E````)@```"<````H````*0`` M`"H````K````+````"T````N````+P```#`````Q````,@```#,````T```` M-0```#8````W````.````#D````Z````.P```#P````]````/@```#\```!` M````00```$(```!#````1````$4```!&````1P```$@```!)````2@```$L` M``!,````30```$X```!/````4````%$```!2````4P```%0```!5````5@`` M`%<```!8````60```%H```!;````7````%T```!>````7P```&````!A```` M8@```&,```!D````90```&8```!G````:````&D```!J````:P```&P```!M M````;@```&\```!P````<0```'(```!S````=````'4```!V````=P```'@` M``!Y````>@```'L```!\````?0```'X```!_````@````%(`;P!O`'0`(`!% M`&X`=`!R`'D````````````````````````````````````````````````` M```````````6``4`__________\"```````````````````````````````` M`````````'#[]0&0,````GP```*````"A M````H@```*,```"D````I0```*8```"G````J````*D```"J````JP```*P` M``"M````K@```*\```"P````L0```+(```"S````M````+4```"V````MP`` M`+@```"Y````N@```+L```"\````O0```+X```"_````P````,$```#"```` MPP```,0```#%````Q@```,<```#(````R0```,H```#+````S````,T```#. M````SP```-````#1````T@```-,```#4````U0```-8```#7````V````-D` M``#:````VP```-P```#=````W@```-\```#@````X0```.(```#C````Y``` M`.4```#F````YP```.@```#I````Z@```.L```#L````[0```.X```#O```` M\````/$```#R````\P```/0```#U````]@```/<```#X````^0```/H```#[ M````_````/T```#^````_P```/[___\)"!````8%`$88S0?!@```!@(``.$` M`@"P!,$``@```.(```!<`'``!P``&)R;```!@(````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````````````````$(``@"P M!&$!`@```,`!```]`38``0`"``,`!``%``8`!P`(``D`"@`+``P`#0`.``\` M$``1`!(`$P`4`!4`%@`7`!@`&0`:`!L`G``"``X`&0`"````$@`"````$P`" M````KP$"````O`$"````/0`2`/``6@!,+(L:.````````0!8`D```@```(T` M`@```"(``@````X``@`!`+!$T`"``D``$B`"0`(@`C`"P`(P`C`#``+@`P`#`` M7P`I`#L`6P!2`&4`9`!=`%P`*``@`"(`)``B`",`+``C`",`,``N`#``,`!< M`"``*0`>!'$`*@`V``%?`"@`(@`D`"(`*@`@`",`+``C`",`,`!?`"D`.P!? M`"@`(@`D`"(`*@`@`%P`*``@`",`+``C`",`,`!<`"``*0`[`%\`*``B`"0` M(@`J`"``(@`M`"(`7P`I`#L`7P`H`"``0`!?`"``*0`>!%\`*0`M``%?`"@` M*@`@`",`+``C`",`,`!?`"D`.P!?`"@`*@`@`%P`*``@`",`+``C`",`,`!< M`"``*0`[`%\`*``J`"``(@`M`"(`7P`I`#L`7P`H`"``0`!?`"``*0`>!($` M+``^``%?`"@`(@`D`"(`*@`@`",`+``C`",`,``N`#``,`!?`"D`.P!?`"@` M(@`D`"(`*@`@`%P`*``@`",`+``C`",`,``N`#``,`!<`"``*0`[`%\`*``B M`"0`(@`J`"``(@`M`"(`/P`_`%\`*0`[`%\`*``@`$``7P`@`"D`'@1O`"L` M-0`!7P`H`"H`(``C`"P`(P`C`#``+@`P`#``7P`I`#L`7P`H`"H`(`!<`"@` M(``C`"P`(P`C`#``+@`P`#``7``@`"D`.P!?`"@`*@`@`"(`+0`B`#\`/P!? M`"D`.P!?`"@`(`!``%\`(``I`!X$+P"D`!4``20`(P`L`",`(P`P`"X`(P`C M`#L`*``D`",`+``C`",`,``N`",`(P`I`!X$'P"E``T``2,`+``C`",`,``[ M`"@`(P`L`",`(P`P`"D`'@0C`*8`#P`!)``C`"P`(P`C`#``.P`H`"0`(P`L M`",`(P`P`"D`'@0K`*<`$P`!(P`L`",`(P`P`"X`(P`C`#L`*``C`"P`(P`C M`#``+@`C`",`*0#@`!0``````/7_(```````````````P"#@`!0``0```/7_ M(```]```````````02#@`!0``0```/7_(```]```````````02#@`!0``@`` M`/7_(```]```````````02#@`!0``@```/7_(```]```````````02#@`!0` M`````/7_(```]```````````02#@`!0``````/7_(```]```````````02#@ M`!0``````/7_(```]```````````02#@`!0``````/7_(```]``````````` M02#@`!0``````/7_(```]```````````02#@`!0``````/7_(```]``````` M````02#@`!0``````/7_(```]```````````02#@`!0``````/7_(```]``` M````````02#@`!0``````/7_(```]```````````02#@`!0``````/7_(``` M]```````````02#@`!0```````$`(```````````````P"#@`!0``0`K`/7_ M(```^```````````02#@`!0``0`I`/7_(```^```````````02#@`!0``0`L M`/7_(```^```````````02#@`!0``0`J`/7_(```^```````````02#@`!0` M`0`)`/7_(```^```````````02#@`!0`!0````$`(```"```````````P"#@ M`!0`!0````$`*```&```````````P"#@`!0`!0````$`*@``&``````````` MP"#@`!0```````$`*```$```````````P"#@`!0```````D`(``````````` M````P"#@`!0```````D`*```$```````````P"#@`!0```````D`"```$``` M````````P"#@`!0```"D``$`(```!```````````P"#@`!0```"E``$`(``` M!```````````P"#@`!0```"F``$`(```!```````````P"#@`!0```"G``$` M(```!```````````P"#@`!0`!@"E``$`(```#```````````P"#@`!0`!@"F M``$`(```#```````````P""3`@0``(``_Y,"!``0@`/_DP($`!&`!O^3`@0` M$H`$_Y,"!``3@`?_DP($`!2`!?]@`0(```"%`#``0:T!````%`%$`&\`8P!U M`&T`90!N`'0`(`!)`&X`9@!O`'(`;0!A`'0`:0!O`&X`A0`L`)BO`0```!(! M10!N`'0`:0!T`'D`(`!)`&X`9@!O`'(`;0!A`'0`:0!O`&X`A0!&`#^S`0`` M`!\!0P!O`&X`9`!E`&X``'/;`0````L!20!N`'8`90!S`'0`;0!E`&X`=`!S`(4` M-@!FW0$````7`48`80!I`'(`(`!6`&$`;`!U`&4`(`!-`&4`80!S`'4`<@!E M`&T`90!N`'0``!C`&@` M80!N`&<`A0`>`#_C`0````L!20!N`'8`90!N`'0`;P!R`&D`90!S`(4`1@`R MY0$````?`4<`;P!O`&0`=P!I`&P`;``@`&$`;@!D`"``3P!T`&@`90!R`"`` M20!N`'0`80!N`&<`:0!B`&P`90`@`$$`A0`N`"7G`0```!,!5P!A`'(`<@!A M`&X`=`!Y`"``3P!B`&P`:0!G`&$`=`!I`&\`;@"%`"@`&.D!````$`%)`&X` M=`!E`'(`90!S`'0`(`!%`'@`<`!E`&X`0!P`&4`!``!,0`P`"T`40`8``%$ M`&\`8P!U`&T`90!N`'0`(`!0`&4`<@!I`&\`9``@`$4`;@!D`"``1`!A`'0` M90`*``$R`#``,``Y`"T`,``W`"T`,P`Q``X``4$`;0!E`&X`9`!M`&4`;@!T M`"``1@!L`&$`9P`%``%F`&$`;`!S`&4`&@`!10!N`'0`:0!T`'D`(`!)`&X` M9@!O`'(`;0!A`'0`:0!O`&X`(``H`%4`4P!$`"``)``I`!X``4D`;@`@`$(` M:0!L`&P`:0!O`&X`0`@`$,`90!N`'0`<@!A`&P`(`!)`&X`9`!E`'@`(`!+`&4`>0`*``$P`#`` M,``P`#``-@`T`#8`-P`P`!P``4,`=0!R`'(`90!N`'0`(`!&`&D`0`@`%<`90!L`&P`+0!K`&X`;P!W`&X`(`!3`&4` M80!S`&\`;@!E`&0`(`!)`',`0`@`%8`;P!L`'4`;@!T`&$`<@!Y`"``1@!I`&P`90!R`',``@`!3@!O M`!\``44`;@!T`&D`=`!Y`"``0P!U`'(`<@!E`&X`=``@`%(`90!P`&\`<@!T M`&D`;@!G`"``4P!T`&$`=`!U`',`%0`!10!N`'0`:0!T`'D`(`!&`&D`;`!E M`'(`(`!#`&$`=`!E`&<`;P!R`'D`%P`!3`!A`'(`9P!E`"``00!C`&,`90!L M`&4`<@!A`'0`90!D`"``1@!I`&P`90!R`!,``44`;@!T`&D`=`!Y`"``4`!U M`&(`;`!I`&,`(`!&`&P`;P!A`'0`)P`!10!N`'0`:0!T`'D`(`!#`&\`;0!M M`&\`;@`@`%,`=`!O`&,`:P`L`"``4P!H`&$`<@!E`',`(`!/`'4`=`!S`'0` M80!N`&0`:0!N`&<`00`!0P!O`&X`9`!E`&X``!P`&4`;@!S`&4``!P`&4`;@!S`&4`+``!4P!E`&P`;`!I`&X`9P`L`"``9P!E`&X`90!R M`&$`;``L`"``80!N`&0`(`!A`&0`;0!I`&X`:0!S`'0`<@!A`'0`:0!V`&4` M(`!E`'@`<`!E`&X``!P`&4`;@!S`&4```@`&$`0`L`"``<`!L`&$`;@!T`"``80!N`&0`(`!E`'$`=0!I`'`` M;0!E`&X`=``@`%L`00!B`',`=`!R`&$`8P!T`%T`'0`!4`!R`&\`<`!E`'(` M=`!Y`"P`(`!P`&P`80!N`'0`(`!A`&X`9``@`&4`<0!U`&D`<`!M`&4`;@!T M`!@``4$`8P!C`'4`;0!U`&P`80!T`&4`9``@`&0`90!P`'(`90!C`&D`80!T M`&D`;P!N`"(``5``<@!O`'``90!R`'0`>0`L`"``<`!L`&$`;@!T`"``80!N M`&0`(`!E`'$`=0!I`'``;0!E`&X`=``L`"``;@!E`'0`"``!1P!O`&\`9`!W M`&D`;`!L`!P``4\`=`!H`&4`<@`@`&D`;@!T`&$`;@!G`&D`8@!L`&4`(`!A M`',`0!A`&(`;`!E`!0``4$`8P!C`'(`=0!E`&0`(`!C`&\`;0!P`&4` M;@!S`&$`=`!I`&\`;@`4``%!`&,`8P!R`'4`90!D`"``:0!N`&,`;P!M`&4` M(`!T`&$`>`!E`',`%@`!3P!T`&@`90!R`"``80!C`&,`<@!U`&4`9``@`&4` M>`!P`&4`;@!S`&4```%,`&\`;@!G`"T`=`!E M`'(`;0`@`&$`8P!C`'(`=0!E`&0`(`!I`&X`8P!O`&T`90`@`'0`80!X`&4` M0`@ M`&\`<`!E`'(`80!T`&D`;@!G`"``80!C`'0`:0!V`&D`=`!I`&4`@!A`'0`:0!O`&X`-``!00!M`&\`<@!T`&D`>@!A`'0`:0!O`&X`(`!O`&8` M(`!D`&D``!C`&4``!E`'(`8P!I`',`90`@`&\`9@`@`',`=`!O M`&,`:P`M`&(`80!S`&4`9``@`&$`=P!A`'(`9`!S`$D``4,`:`!A`&X`9P!E M`"``:0!N`"``;P!P`&4`<@!A`'0`:0!N`&<`(`!A`',`0!A`&(`;`!E`"``80!N`&0`(`!A`&,` M8P!R`'4`90!D`"``;`!I`&$`8@!I`&P`:0!T`&D`90!S`"8``4\`=`!H`&4` M<@`@`&\`<`!E`'(`80!T`&D`;@!G`"``80!S`',`90!T`',`(`!A`&X`9``@ M`&P`:0!A`&(`:0!L`&D`=`!I`&4`0`@`&8`:0!N`&$`;@!C M`&D`;@!G`"``80!C`'0`:0!V`&D`=`!I`&4``!C`&@`80!N`&<`90`@`'(`80!T`&4`(`!C`&@`80!N`&<` M90!S`"``;P!N`"``8P!A`',`:``@`&$`;@!D`"``8P!A`',`:``@`&4`<0!U M`&D`=@!A`&P`90!N`'0``!T`"``0@!L`&\`8P!K`%T`,@D!#0`-``T`3@!O`'0`90`@`#$` M(``@`$(`80!S`&D`0`@`&$`8P!C`&4`<`!T`&4`9``@`&D`;@`@`'0`:`!E`"`` M50!N`&D`=`!E`&0`(`!3`'0`80!T`&4``!P`&4`;@!S`&4`0!S`"``00!N`&X`=0!A`&P`(`!2`&4`<`!O`'(`=``@`&\` M;@`@`$8`;P!R`&T`(``Q`#``+0!+`"``9@!O`'(`(`!T`&@`90`@`'D`90!A M`'(`(`!E`&X`9`!E`&0`(`!!`'``<@!I`&P`(``R`#0`+``@`#(`,``P`#D` M+@!!`&P`;``@`'``<@!I`&\`<@`@`'``90!R`&D`;P!D`',`(`!P`'(`90!S M`&4`;@!T`&4`9``@`&@`80!V`&4`(`!B`&4`90!N`"``<@!E`'0`<@!O`',` M<`!E`&,`=`!I`'8`90!L`'D`(`!A`&0`:@!U`',`=`!E`&0`(`!F`&\`<@`@ M`'0`:`!E`"``:0!M`'``80!C`'0`(`!O`&8`(`!T`&@`90`@`&$`9`!O`'`` M=`!I`&\`;@`@`&\`9@`@`$8`:0!N`&$`;@!C`&D`80!L`"``00!C`&,`;P!U M`&X`=`!I`&X`9P`@`%,`=`!A`&X`9`!A`'(`9`!S`"``0@!O`&$`<@!D`"`` M*`!&`$$`4P!"`"D`(`!3`'0`80!F`&8`(`!0`&\`0!S`"``40!U`&$`<@!T`&4`<@!L`'D` M(`!2`&4`<`!O`'(`=``@`&\`;@`@`$8`;P!R`&T`,0`P`"T`40`@`&8`;P!R M`"``=`!H`&4`(`!P`&4`<@!I`&\`9``@`&4`;@!D`&4`9``@`$H`=0!L`'D` M,P`Q`"P`(``R`#``,``Y`"X`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`',`(`!F M`&D`0`N`!T``4X`90!W`"``00!C`&,`;P!U`&X`=`!I`&X`9P`@`%`` M<@!O`&X`;P!U`&X`8P!E`&T`90!N`'0`0!E`'(`0!S`"``<`!O`',`=`!R M`&4`=`!I`'(`90!M`&4`;@!T`"``8@!E`&X`90!F`&D`=``@`'``;`!A`&X` M(`!A`',`0!E`&$`<@`@`#(`,``Q`#``(`!B`'4`=``@`&\`;@!L`'D`(`!R M`&4`<0!U`&D`<@!E`',`(`!T`&@`90`@`'(`90!V`&D`0`@`'<`:0!L`&P`(`!P`'(`;P!V`&D`9`!E`"``=`!H M`&4`(`!A`&0`9`!I`'0`:0!O`&X`80!L`"``9`!I`',`8P!L`&\`0!E`&$` M<@`@`#(`,``Q`#``(`!!`&X`;@!U`&$`;``@`%(`90!P`&\`<@!T`"``;P!N M`"``1@!O`'(`;0`@`#$`,``M`$L`+@!)`&X`(`!*`'4`;@!E`"``,@`P`#`` M.0`L`"``=`!H`&4`(`!&`$$`4P!"`"``:0!S`',`=0!E`&0`(`!3`$8`00!3 M`"``3@!O`"X`(``Q`#8`.``L`"``5`!H`&4`(`!&`$$`4P!"`"``00!C`&,` M;P!U`&X`=`!I`&X`9P`@`%,`=`!A`&X`9`!A`'(`9`!S`"``0P!O`&0`:0!F M`&D`8P!A`'0`:0!O`&X`(`!A`&X`9``@`'0`:`!E`"``2`!I`&4`<@!A`'(` M8P!H`'D`(`!O`&8`(`!'`&4`;@!E`'(`80!L`&P`>0`@`$$`8P!C`&4`<`!T M`&4`9``@`$$`8P!C`&\`=0!N`'0`:0!N`&<`(`!0`'(`:0!N`&,`:0!P`&P` M90!S`"``*`!3`$8`00!3`"``3@!O`"X`(``Q`#8`.``I`"X`(`!3`$8`00!3 M`"``3@!O`"X`(``Q`#8`.``@`'(`90!P`&P`80!C`&4`0`@`'(`90!C`&\`9P!N`&D`>@!E`',`(`!R`'4`;`!E M`',`(`!A`&X`9``@`&D`;@!T`&4`<@!P`'(`90!T`&D`=@!E`"``<@!E`&P` M90!A`',`90!S`"``;P!F`"``=`!H`&4`(`!3`&4`8P!U`'(`:0!T`&D`90!S M`"``80!N`&0`(`!%`'@`8P!H`&$`;@!G`&4`(`!#`&\`;0!M`&D`0`@`'4`0`@`#(`,``P M`#@`+``@`'0`:`!E`"``1@!!`%,`0@`@`&D`@!E M`&0`(`!O`'8`90!R`"``=`!H`&4`(`!P`&4`<@!I`&\`9``@`'0`:`!E`"`` M8P!O`&X`=@!E`'(`=`!I`&(`;`!E`"``9`!E`&(`=``@`&D``!P M`&4`8P!T`&4`9``@`'0`;P`@`&(`90`@`&\`=0!T`',`=`!A`&X`9`!I`&X` M9P`@`&$```L`"``=`!O`"``0`N`"``5`!H`&4` M(`!R`&4`0!S`"``1`!E`&(` M90!N`'0`=0!R`&4`0`L`"`` M4P!E`'``=`!E`&T`8@!E`'(`(``R`#``,``V`"X`(`!4`&@`90!R`&4`9@!O M`'(`90`L`"``=`!H`&4`(`!R`&4`=`!R`&\`0!E M`&$`<@`@`#(`,``Q`#``(`!A`&X`9``@`&D`0`@`#,`,0`L`"``,@`P`#``.0`@`&$`;@!D M`"``2@!U`&P`>0`@`#(`-0`L`"``,@`P`#``.``L`"``<@!E`',`<`!E`&,` M=`!I`'8`90!L`'D`+@`@`%0`:`!E`"``9@!O`&P`;`!O`'<`:0!N`&<`(`!T M`&$`8@!L`&4`(`!I`&P`;`!U`',`=`!R`&$`=`!E`',`(`!T`&@`90`@`&D` M;0!P`&$`8P!T`"``;P!F`"``=`!H`&4`(`!A`&0`;P!P`'0`:0!O`&X`(`!O M`&8`(`!&`%,`4``@`$$`4`!"`"``3@!O`"X`(``Q`#0`+0`Q`"``80!N`&0` M(`!&`%,`4``@`$4`20!4`$8`(`!.`&\`+@`@`#``,P`M`#8`+0`Q`"``;P!N M`"``8P!E`'(`=`!A`&D`;@`@`&8`:0!N`&$`;@!C`&D`80!L`"```!E`',`"0`)`#$`,P`Q``D`"0`)`"@`,0`U`"D`"0`)``D`+0`)``D`"0`Q M`#$`-@`-``T`"0!.`&4`=``@`&4`80!R`&X`:0!N`&<`0`@ M`#,`,0`L`"``,@`P`#``.0`Z``T`#0`-``D`4`!R`&4`=@!I`&\`=0!S``D` M"0`)``D`"0`-``T`"0`H`&D`;@`@`&T`:0!L`&P`:0!O`&X``!P`&4`;@!S`&4` M@!E`',`(`!A`&X`9``@`&T`90!A`',`=0!R`&4`0!I`&X`9P`@`'``=0!R`&,`:`!A`',`90`@ M`&T`90!T`&@`;P!D`"``;P!F`"``80!C`&,`;P!U`&X`=`!I`&X`9P`@`&8` M;P!R`"``80!C`'$`=0!I`',`:0!T`&D`;P!N`',`+``@`&(`=0!T`"``:0!N M`&,`;P!R`'``;P!R`&$`=`!E`',`(`!A`"``;@!U`&T`8@!E`'(`(`!O`&8` M(`!C`&@`80!N`&<`90!S`"X`(`!4`&@`90!S`&4`(`!C`&@`80!N`&<`90!S M`"``:0!N`&,`;`!U`&0`90`@`'0`:`!E`"``8P!A`'``:0!T`&$`;`!I`'H` M80!T`&D`;P!N`"``;P!F`"``<`!U`'(`8P!H`&$``!E`',`(`!I`',`(`!A`'``<`!L`&D`8P!A`&(`;`!E`"``=`!O`"`` M80!C`'$`=0!I`',`:0!T`&D`;P!N`',`(`!C`&\`;@!S`'4`;0!M`&$`=`!E M`&0`(`!B`&\`=`!H`"``<`!R`&D`;P!R`"``=`!O`"``80!N`&0`(`!S`'4` M8@!S`&4`<0!U`&4`;@!T`"``=`!O`"``=`!H`&4`(`!A`&0`;P!P`'0`:0!O M`&X`(`!O`&8`(`!3`$8`00!3`"``3@!O`"X`(``Q`#0`,0`H`%(`*0`N`"`` M5`!H`&4`(`!A`&0`;P!P`'0`:0!O`&X`(`!O`&8`(`!3`$8`00!3`"``3@!O M`"X`(``Q`#0`,0`H`%(`*0`@`&0`:0!D`"``;@!O`'0`(`!C`&@`80!N`&<` M90`@`'0`:`!E`"``<@!E`'$`=0!I`'(`90!M`&4`;@!T`"``=`!O`"``90!X M`'``90!N`',`90`@`$D`4`!2`$0`(`!I`&T`;0!E`&0`:0!A`'0`90!L`'D` M(`!W`&D`=`!H`"``<@!E`',`<`!E`&,`=``@`'0`;P`@`&$`0`@`',`=0!R`'(`;P!U`&X`9`!I`&X`9P`@`'0`:`!E`"``!`$-``T`#0!.`&\`=`!E`"``-0`@`"``0P!E`'(`=`!A`&D`;@`@`$P` M:0!T`&D`9P!A`'0`:0!O`&X`(`!#`&@`80!R`&<`90!S`%0`:`!E`"``0P!O M`&T`<`!A`&X`>0`@`&,`;`!A`',`0`@`#,`,0`L`"``,@`P`#``.0`L`"``=`!H M`&4`(`!#`&\`;0!P`&$`;@!Y`"``<@!E`&,`;P!R`&0`90!D`"``8P!E`'(` M=`!A`&D`;@`@`&P`:0!T`&D`9P!A`'0`:0!O`&X`(`!C`&@`80!R`&<`90!S M`"``;P!F`"``)``T`#0`-``@`&T`:0!L`&P`:0!O`&X`(`!R`&4`;`!A`'0` M90!D`"``=`!O`"``=`!H`&4`(`!G`&P`;P!B`&$`;``@`'(`90!S`&\`;`!U M`'0`:0!O`&X`(`!O`&8`(`!A`&P`;``@`&\`=0!T`',`=`!A`&X`9`!I`&X` M9P`@`&D`;@!T`&4`;`!L`&4`8P!T`'4`80!L`"``<`!R`&\`<`!E`'(`=`!Y M`"``;`!I`'0`:0!G`&$`=`!I`&\`;@`@`'<`:0!T`&@`(`!!`&(`8@!O`'0` M=``@`$P`80!B`&\`<@!A`'0`;P!R`&D`90!S`"``*`!!`&(`8@!O`'0`=``I M`"X`(`!4`&@`90`@`'0`90!R`&T`0!M`&4`;@!T`"``=`!O`"``8@!E`"``;0!A`&0` M90`@`'0`;P`@`&4`=@!9`',`:0!O`"``30!E`&0`:0!C`&$`;``@`$0`90!V M`&D`8P!E`',`+``@`$P`3`!#`"``*`!E`'8`60!S`&D`;P`I`"X`(`!)`&X` M(`!A`&0`9`!I`'0`:0!O`&X`+``@`&$`(``D`#(`(`!M`&D`;`!L`&D`;P!N M`"``<`!A`'D`;0!E`&X`=``@`&D``!I`',`=`!I`&X` M9P`@`&$`9P!R`&4`90!M`&4`;@!T`"``:0!N`"``;P!R`&0`90!R`"``=`!O M`"``90!X`'``80!N`&0`(`!T`&@`90`@`',`8P!O`'``90`@`&\`9@`@`'0` M:`!E`"``9`!E`&8`:0!N`&D`=`!I`&\`;@`@`&\`9@`@`'0`:`!E`"``;`!I M`&,`90!N`',`90`@`&8`:0!E`&P`9``@`&8`<@!O`&T`(`!E`'8`60!S`&D` M;P`N`$0`=0!R`&D`;@!G`"``=`!H`&4`(`!T`&@`<@!E`&4`(`!M`&\`;@!T M`&@`0!S`"``3P!N`&4`(`!-`&4`9`!T`'(`;P!N M`&D`8P`@`',`=`!R`&$`=`!E`&<`>0`L`"``=`!H`&4`(`!#`&\`;0!P`&$` M;@!Y`"``8P!O`&X`=`!I`&X`=0!E`',`(`!T`&\`(`!P`'4`<@!S`'4`90`@ M`&\`<`!P`&\`<@!T`'4`;@!I`'0`:0!E`',`(`!T`&\`(`!S`'0`<@!E`&$` M;0!L`&D`;@!E`"``=`!H`&4`(`!O`'(`9P!A`&X`:0!Z`&$`=`!I`&\`;@`@ M`&$`;@!D`"``@!E`"``;P!R`"``8P!E`&X` M=`!R`&$`;`!I`'H`90`@`&,`90!R`'0`80!I`&X`(`!F`'4`;@!C`'0`:0!O M`&X`80!L`"``80!C`'0`:0!V`&D`=`!I`&4`0`@`&8`=0!R M`'0`:`!E`'(`(`!C`&\`;@!S`&\`;`!I`&0`80!T`&D`;@!G`"``;0!A`&X` M=0!F`&$`8P!T`'4`<@!I`&X`9P`@`&$`;@!D`"``90!L`&D`;0!I`&X`80!T M`&D`;@!G`"``8P!E`'(`=`!A`&D`;@`@`&X`;P!N`"T`8P!O`'(`90`@`'`` M<@!O`&0`=0!C`'0`(`!L`&D`;@!E`',`+``@`&$`;@!D`"``=`!O`"``9@!U M`'(`=`!H`&4`<@`@`&$`;`!I`&<`;@`@`'(`90!S`&\`=0!R`&,`90!S`"`` M80!R`&\`=0!N`&0`(`!T`&@`90`@`$,`;P!M`'``80!N`'D`0`@`'<`<@!I`'0`90`M`&\`9@!F M`',`(`!A`&X`9``@`'``<@!O`&0`=0!C`'0`:0!O`&X`+0!R`&4`;`!A`'0` M90!D`"``80!S`',`90!T`"``:0!M`'``80!I`'(`;0!E`&X`=`!S`"``80!N M`&0`(`!T`&@`90!R`&4`9@!O`'(`90`@`'<`80!S`"``<@!E`&,`;P!R`&0` M90!D`"``=P!I`'0`:`!I`&X`(`!C`&\`0!E`&4`(`!T`&4` M<@!M`&D`;@!A`'0`:0!O`&X`(`!C`&\`0!E`&$`<@`@`#(`,``P`#D`(`!I`&X`:0!T`&D` M80!T`&D`=@!E`"P`(`!I`&X`(`!T`&@`90`@`&8`:0!R`',`=``@`'$`=0!A M`'(`=`!E`'(`(`!O`&8`(`!F`&D`0!E`&4`(`!T`&4`<@!M`&D`;@!A`'0`:0!O M`&X`(`!C`&\``!I`&T`80!T`&4`;`!Y`"``,0`L`#4`,``P M`"``<`!O`',`:0!T`&D`;P!N`',`(`!F`&\`<@`@`&4`;`!I`&T`:0!N`&$` M=`!I`&\`;@`@`'<`:`!I`&,`:``@`'<`:0!L`&P`(`!B`&4`(`!A`&,`:`!I M`&4`=@!E`&0`(`!T`&@`<@!O`'4`9P!H`"``90!A`'(`;`!Y`"``<@!E`'0` M:0!R`&4`;0!E`&X`=``@`'``80!C`&L`80!G`&4`0!E`&4`0`@`#4`,``P`"``<`!O`',` M:0!T`&D`;P!N`',`(`!H`&$`=@!E`"``8@!E`&4`;@`@`&4`;`!I`&T`:0!N M`&$`=`!E`&0`(`!A`',`(`!O`&8`(`!*`'4`;`!Y`"``,P`Q`"P`(``R`#`` M,``Y`"X`(`!4`&@`90`@`'(`90!S`'0`<@!U`&,`=`!U`'(`:0!N`&<`(`!I M`&X`:0!T`&D`80!T`&D`=@!E`',`(`!A`'(`90`@`',`8P!H`&4`9`!U`&P` M90!D`"``=`!O`"``8@!E`"``0`@ M`&,`;P!M`'``;`!E`'0`90`@`&(`>0`@`'0`:`!E`"``90!N`&0`(`!O`&8` M(`!T`&@`90`@`&8`:0!R`',`=``@`'$`=0!A`'(`=`!E`'(`(`!O`&8`(`!F M`&D`0`@`'(`90!L M`&$`=`!E`&0`(`!T`&\`(`!T`&@`90`@`&8`:0!S`&,`80!L`"``>0!E`&$` M<@`@`#(`,``P`#D`(`!I`&X`:0!T`&D`80!T`&D`=@!E`"``:0!S`"``<`!R M`&4`0`@`#,`,0`L`"``,@`P`#``.0`) M``D`)``)`#8`,@`)``D`)``)`#``"0`)`"0`"0`V`#(`#0`-``T`1P!L`&\` M8@!A`&P`(`!2`&4`"P`!20!N`'8`90!S`'0`;0!E`&X`=`!S`!8``4D`;@!V M`&4``!T`"``0@!L`&\`8P!K`%T` M@`P!#0`-``T`3@!O`'0`90`@`#<`(``@`$D`;@!V`&4`0`@ M`&(`90!F`&\`<@!E`"``<@!E`&,`;P!V`&4`<@!I`&X`9P`@`&D`=`!S`"`` M8P!O`',`=`!S`"P`(`!O`'(`(``H`#,`*0`@`&0`;P!E`',`(`!N`&\`=``@ M`&4`>`!P`&4`8P!T`"``=`!O`"``<@!E`&,`;P!V`&4`<@`@`'0`:`!E`"`` M0`@`'0`:`!E`"``8P!R`&4` M9`!I`'0`(`!L`&\`@!E`&0`(`!I`&X`(`!E`&$`<@!N`&D` M;@!G`',`(`!W`&@`:0!L`&4`(`!T`&@`90`@`'(`90!M`&$`:0!N`&D`;@!G M`"``0`@`&$`<`!P`&P`>0`@`'0`:`!E M`"``<`!R`&\`=@!I`',`:0!O`&X`0`@`&\`=`!H M`&4`<@`M`'0`:`!A`&X`+0!T`&4`;0!P`&\`<@!A`'(`>0`@`&D`;0!P`&$` M:0!R`&4`9``@`&0`90!B`'0`(`!S`&4`8P!U`'(`:0!T`&D`90!S`"``90!X M`&D`0`@ M`&T`80!K`&D`;@!G`"``80`@`&,`=0!M`'4`;`!A`'0`:0!V`&4`+0!E`&8` M9@!E`&,`=``@`&$`9`!J`'4`0`@`&@`90!L`&0`(`!A`',` M(`!O`&8`(`!T`&@`90`@`&0`80!T`&4`(`!O`&8`(`!I`&X`:0!T`&D`80!L M`"``80!D`&\`<`!T`&D`;P!N`"``9@!R`&\`;0`@`'(`90!T`&$`:0!N`&4` M9``@`&4`80!R`&X`:0!N`&<`0`@`#,`,0`L`"``,@`P`#``.0`@`&D`@!E`&0`(``)``D`50!N`'(` M90!A`&P`:0!Z`&4`9``@``D`"0`)``T`#0`)`"@`:0!N`"``;0!I`&P`;`!I M`&\`;@!S`"D`"0`)`$,`;P!S`'0`"0`)`$<`80!I`&X`0!S`"``@!E`&0`(``)``D`"0`-``T`"0`H`&D` M;@`@`&T`:0!L`&P`:0!O`&X``!T`"``0@!L`&\`8P!K`%T`@`P!#0`-``T`3@!O M`'0`90`@`#@`(``@`$8`80!I`'(`(`!6`&$`;`!U`&4`(`!-`&4`80!S`'4` M<@!E`&T`90!N`'0`0`L`"``90!F`&8`90!C`'0`:0!V`&4`(`!!`'``<@!I M`&P`(``R`#8`+``@`#(`,``P`#@`+``@`&8`80!I`'(`(`!V`&$`;`!U`&4` M(`!U`&X`9`!E`'(`(`!3`$8`00!3`"``3@!O`"X`,0`U`#<`(`!&`&$`:0!R M`"``5@!A`&P`=0!E`"``30!E`&$`0`@`&$`<`!P`&P`:0!E`&0`(`!T`&\`(`!F`&D`;@!A`&X` M8P!I`&$`;``@`&$`0!S`"``9@!I`&X`80!N`&,`:0!A`&P`(`!S M`'0`80!T`&4`;0!E`&X`=`!S`"``;P!N`"``80`@`'(`90!C`'4`<@!R`&D` M;@!G`"``8@!A`',`:0!S`"``0`@`&P`90!V`&4`;``@`&8`;P!R`"``80!S M`',`90!T`',`(`!A`&X`9``@`&P`:0!A`&(`:0!L`&D`=`!I`&4`0`@`#,`,0`L M`"``,@`P`#``.0`)``D`3`!E`'8`90!L`"``,0`)``D`3`!E`'8`90!L`"`` M,@`)``D`3`!E`'8`90!L`"``,P`-``T`"0!!`',`0`@`',` M90!C`'4`<@!I`'0`:0!E`',`"0`)``D`,0`X``D`"0`)`#$`.``)``D`"0`M M``D`"0`)``D`+0`-``T`"0!$`&4`<@!I`'8`80!T`&D`=@!E`"``80!S`',` M90!T`',`"0`)``D`,0`V`#D`"0`)``D`,0`V`#,`"0`)``D`-@`)``D`"0`) M`"T`#0`-``D`5`!O`'0`80!L`"``80!S`',`90!T`',`"0`)`"0`"0`S`"P` M,@`P`#(`"0`)`"0`"0`S`#@`.0`)``D`)``)`#(`+``U`#@`.0`)``D`"0`D M``D`,@`R`#0`#0`-``T`"0!,`&D`80!B`&D`;`!I`'0`:0!E`',`.@`)``D` M"0`)``D`"0`-``T`"0!$`&4`<@!I`'8`80!T`&D`=@!E`"``;`!I`&$`8@!I M`&P`:0!T`&D`90!S``D`"0`D``D`-@`R``D`"0`D``D`-@`R``D`"0`D``D` M+0`)``D`"0`D``D`+0`-``T`"0!4`&\`=`!A`&P`(`!L`&D`80!B`&D`;`!I M`'0`:0!E`',`"0`)`"0`"0`V`#(`"0`)`"0`"0`V`#(`"0`)`"0`"0`M``D` M"0`)`"0`"0`M``T`#0`-``D`1@!A`&D`<@`@`%8`80!L`'4`90`)``D`1@!A M`&D`<@`@`%8`80!L`'4`90`@`$T`90!A`',`=0!R`&4`;0!E`&X`=`!S``T` M#0`)`&$`=``)``D`50!S`&D`;@!G`"``20!N`'``=0!T`',`(`!#`&\`;@!S M`&D`9`!E`'(`90!D`"``80!S``T`#0`)`"@`:0!N`"``;0!I`&P`;`!I`&\` M;@!S`"D`"0`)`$$`<`!R`&D`;``@`#(`-``L`"``,@`P`#``.0`)``D`3`!E M`'8`90!L`"``,0`)``D`3`!E`'8`90!L`"``,@`)``D`3`!E`'8`90!L`"`` M,P`-``T`"0!!`',`0`@`',`90!C`'4`<@!I`'0`:0!E M`',`"0`)``D`-@`Y`#<`"0`)``D`,0`W`#0`"0`)``D`-0`R`#,`"0`)``D` M"0`M``T`#0`)`$,`90!R`'0`:0!F`&D`8P!A`'0`90!S`"``;P!F`"``9`!E M`'``;P!S`&D`=``)``D`"0`R``D`"0`)`"T`"0`)``D`,@`)``D`"0`)`"T` M#0`-``D`3P!T`&@`90!R`"``80!S`',`90!T`"``8@!A`&,`:P!E`&0`(`!S M`&4`8P!U`'(`:0!T`&D`90!S``D`"0`)`#(`-P`X``D`"0`)`"T`"0`)``D` M,@`U`#4`"0`)``D`"0`R`#,`#0`-``D`30!A`'(`:P!E`'0`80!B`&P`90`@ M`&4`<0!U`&D`=`!Y`"``0`@`',`=0!C`&@`(`!T`&@`80!T`"``=`!H`&4`(`!D`&4`=`!E`'(`;0!I M`&X`80!T`&D`;P!N`"``;P!F`"``9@!A`&D`<@`@`'8`80!L`'4`90`@`'(` M90!Q`'4`:0!R`&4``!T M`"``0@!L`&\`8P!K`%T`@`P!#0`-``T`3@!O`'0`90`@`#D`(``@`$8`:0!N M`&$`;@!C`&D`;@!G`"``00!R`'(`80!N`&<`90!M`&4`;@!T`',`4P!E`&X` M:0!O`'(`(`!#`&\`;@!V`&4`<@!T`&D`8@!L`&4`(`!.`&\`=`!E`',`20!N M`"``00!P`'(`:0!L`"``,@`P`#``-@`L`"``=`!H`&4`(`!#`&\`;0!P`&$` M;@!Y`"``:0!S`',`=0!E`&0`(``D`#(`+@`R`#``,``@`&(`:0!L`&P`:0!O M`&X`(`!O`&8`(``Q`"X`-0`P`#``(`!P`&4`<@!C`&4`;@!T`"``4P!E`&X` M:0!O`'(`(`!#`&\`;@!V`&4`<@!T`&D`8@!L`&4`(`!.`&\`=`!E`',`(`!D M`'4`90`@`#(`,``Q`#$`(`!A`&X`9``@`"0`,@`N`#(`,``P`"``8@!I`&P` M;`!I`&\`;@`@`&\`9@`@`#$`+@`V`#(`-0`@`'``90!R`&,`90!N`'0`(`!3 M`&4`;@!I`&\`<@`@`$,`;P!N`'8`90!R`'0`:0!B`&P`90`@`$X`;P!T`&4` M0`@ M`&D`;@!T`&4`<@!E`',`=``@`&D`;@`@`&,`80!S`&@`(`!S`&4`;0!I`"T` M80!N`&X`=0!A`&P`;`!Y`"``:0!N`"``80!R`'(`90!A`'(`0`@`'<`:0!T`&@`(`!A`&P`;``@`&\`=`!H M`&4`<@`@`'4`;@!S`&4`8P!U`'(`90!D`"``80!N`&0`(`!U`&X`0`@`'``=0!R`&,`:`!A`',`90!D`"``8P!A`&P`;``@ M`&\`<`!T`&D`;P!N`',`(`!O`&X`(`!I`'0``!C`&4`0`@`'0`;P`@`'0`:`!E`"``:`!O`&P`9`!E`'(`0`@`#(`,``Q`#$` M(`!A`&X`9``@`'<`80!R`'(`80!N`'0`0`@`#(`,``Q`#,`+@!)`&X`(`!*`'4`;@!E`"`` M,@`P`#``.``L`"``=`!H`&4`(`!&`$$`4P!"`"``:0!S`',`=0!E`&0`(`!% M`$D`5`!&`"``20!S`',`=0!E`"``3@!O`"X`(``P`#<`+0`U`"P`(`!$`&4` M=`!E`'(`;0!I`&X`:0!N`&<`(`!7`&@`90!T`&@`90!R`"``80!N`"``20!N M`',`=`!R`'4`;0!E`&X`=``@`"@`;P!R`"``10!M`&(`90!D`&0`90!D`"`` M1@!E`&$`=`!U`'(`90`I`"``:0!S`"``20!N`&0`90!X`&4`9``@`'0`;P`@ M`&$`;@`@`$4`;@!T`&D`=`!Y`',`(`!/`'<`;@`@`%,`=`!O`&,`:P`@`"@` M10!)`%0`1@`@`$X`;P`N`"``,``W`"T`-0`I`"X`(`!%`$D`5`!&`"``3@!O M`"X`(``P`#<`+0`U`"``<`!R`&\`=@!I`&0`90!S`"``9P!U`&D`9`!A`&X` M8P!E`"``9@!O`'(`(`!D`&4`=`!E`'(`;0!I`&X`:0!N`&<`(`!W`&@`90!T M`&@`90!R`"``80!N`"``90!Q`'4`:0!T`'D`+0!L`&D`;@!K`&4`9``@`&8` M:0!N`&$`;@!C`&D`80!L`"``:0!N`',`=`!R`'4`;0!E`&X`=``@`"@`;P!R M`"``90!M`&(`90!D`&0`90!D`"``9@!E`&$`=`!U`'(`90`I`"``:0!S`"`` M:0!N`&0`90!X`&4`9``@`'0`;P`@`&$`;@`@`&4`;@!T`&D`=`!Y`"<`0`@`&\`<@`@`'<`:`!E`'0`:`!E`'(`(`!I`'0`(`!S`&@`;P!U`&P` M9``@`&(`90`@`&(`:0!F`'4`<@!C`&$`=`!E`&0`(`!A`&X`9``@`&,`;`!A M`',`0!E`&$`<@`@`#(`,``Q`#``+@`@`$D` M;@`@`&$`<`!P`&P`>0!I`&X`9P`@`$4`20!4`$8`(`!.`&\`+@`@`#``-P`M M`#4`+``@`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&,`;P!N`&,`;`!U`&0` M90!D`"``=`!H`&$`=``@`'0`:`!E`"``<`!U`'(`8P!H`&$`0`[`"``=`!H`'4``!E`&0`(`!T`&\`+``@`&$`;@!D`"``4`!O M`'0`90!N`'0`:0!A`&P`;`!Y`"``4P!E`'0`=`!L`&4`9``@`&D`;@`L`"`` M80`@`$,`;P!M`'``80!N`'D`0`N`"``50!N`&0`90!R`"``10!)`%0`1@`@ M`$X`;P`N`"``,``P`"T`,0`Y`"P`(`!T`&@`90`@`&X`;P!T`&4`0`@`&,`;`!A`',`0`@`&D`9@`@`"@`,0`I`'0`:`!E M`"``8P!O`&X`=`!R`&$`8P!T`"``<@!E`'$`=0!I`'(`90!S`"``<`!H`'D` M`!C`&@`80!N M`&<`90`@`%(`:0!S`&L`(`!-`&$`;@!A`&<`90!M`&4`;@!T`"``6P!4`&4` M>`!T`"``0@!L`&\`8P!K`%T`@`P!#0`-``T`3@!O`'0`90`@`#$`,``@`"`` M1`!E`'(`:0!V`&$`=`!I`'8`90!S`"``80!N`&0`(`!&`&\`<@!E`&D`9P!N M`"``10!X`&,`:`!A`&X`9P!E`"``4@!I`',`:P`@`$T`80!N`&$`9P!E`&T` M90!N`'0`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``=0!S`&4``!C`&@`80!N`&<`90`@`'(`80!T`&4`(`!C`&@`80!N`&<`90!S`"``;P!N M`"``90!A`'(`;@!I`&X`9P!S`"``80!N`&0`(`!C`&$``!C`&@`80!N`&<`90`@`'(`80!T`&4`(`!M`&\`=@!E M`&T`90!N`'0``!C`&@`80!N`&<`90`@`'(`80!T`&4`(`!C`&@`80!N`&<`90!S`"X` M(`!4`&@`90!S`&4`(`!C`&\`;@!T`'(`80!C`'0`0`@ M`'0`<@!A`&X`0`@`&0`;P!E`',` M(`!N`&\`=``@`&4`;@!T`&4`<@`@`&D`;@!T`&\`(`!F`&\`<@!W`&$`<@!D M`"``90!X`&,`:`!A`&X`9P!E`"``9`!E`'(`:0!V`&$`=`!I`'8`90`@`&,` M;P!N`'0`<@!A`&,`=`!S`"``9@!O`'(`(`!S`'``90!C`'4`;`!A`'0`:0!V M`&4`(`!P`'4`<@!P`&\`0`@`&<`80!I`&X`0`N`"``5`!H M`&4``!P M`&P`80!I`&X`0!P`&4` M0!S`"``8P!O`&X`9`!E`&X`@!E`&0`(`!C`'4`<@!R`&4`;@!T`&P`>0`@ M`&D`;@`@`&4`80!R`&X`:0!N`&<`0`@`&\` M9@!F`',`90!T`'0`:0!N`&<`(`!T`&@`90`@`&,`=0!R`'(`90!N`'0`(`!E M`&$`<@!N`&D`;@!G`',`(`!E`&8`9@!E`&,`=``@`&\`9@`@`'0`:`!E`"`` M<@!E`&P`80!T`&4`9``@`&8`;P!R`&4`:0!G`&X`(`!C`'4`<@!R`&4`;@!C M`'D`(`!D`&4`;@!O`&T`:0!N`&$`=`!E`&0`(`!A`',`0`@ M`#,`,0`L`"``,@`P`#``.0`@`'<`90!R`&4`(`!A`',`(`!F`&\`;`!L`&\` M=P!S`#H`(``-``T`#0`)`"@`:0!N`"``;0!I`&P`;`!I`&\`;@!S`"D`"0`) M``D`"0`)``T`#0`)`$0`90!R`&D`=@!A`'0`:0!V`&4``!P`&4`;@!S`&4`+``@`&X`90!T``D`"0`D``D`*``Y`#4`*0`-``T`#0!. M`&4`=``@`$D`;@!V`&4`0`I`"``:0!N`"``9@!O`'(`90!I`&<`;@`@`&\`<`!E`'(`80!T`&D` M;P!N`',`+@`@`$8`;P!R`"``:`!E`&0`9P!E`',`(`!T`&@`80!T`"``;0!E M`&4`=``@`&4`9@!F`&4`8P!T`&D`=@!E`&X`90!S`',`(`!R`&4`<0!U`&D` M<@!E`&T`90!N`'0`@!A`'0`:0!O M`&X`"0`)``D`*``X`#4`-0`I``D`"0`)`"@`,@`R`#8`*0`)``D`"0`H`#$` M-P`W`"D`"0`)``D`*``Q`"P`,@`U`#@`*0`-``T`"0!#`&$`<@!R`'D`:0!N M`&<`(`!V`&$`;`!U`&4`"0`)`"0`"0`R`"P`,@`P`#(`"0`)`"0`"0`Q`#0` M-P`)``D`)``)`#4`.0`)``D`)``)`#(`+``T`#``.``-``T`#0`)`$$`@!A`'0`:0!O`&X`(`!E`'@`<`!E`&X`0`@`#,`,0`L`"``,@`P`#``.0`@`&$`;@!D`"``2@!U`&P`>0`@`#(` M-0`L`"``,@`P`#``.``@`'<`80!S`"``)``W`#@`(`!M`&D`;`!L`&D`;P!N M`"``80!N`&0`(``D`#8`-@`@`&T`:0!L`&P`:0!O`&X`+``@`'(`90!S`'`` M90!C`'0`:0!V`&4`;`!Y`"X`10!S`'0`:0!M`&$`=`!E`&0`(`!A`&<`9P!R M`&4`9P!A`'0`90`@`&$`;0!O`'(`=`!I`'H`80!T`&D`;P!N`"``90!X`'`` M90!N`',`90`@`&(`80!S`&4`9``@`&\`;@`@`'0`:`!E`"``8P!U`'(`<@!E M`&X`=``@`&,`80!R`'(`>0!I`&X`9P`@`'8`80!L`'4`90`@`&\`9@`@`&$` M;0!O`'(`=`!I`'H`80!B`&P`90`@`&D`;@!T`&$`;@!G`&D`8@!L`&4`(`!A M`',``!P`&4`;@!S`&4`#0`-``D`4@!E`&T`80!I`&X`:0!N`&<`(``R`#``,0`P M``D`"0`D``D`,@`S`#``#0`-``D`,@`P`#$`,0`)``D`"0`R`#D`-``-``T` M"0`R`#``,0`R``D`"0`)`#(`-@`X``T`#0`)`#(`,``Q`#,`"0`)``D`,@`U M`#(`#0`-``D`,@`P`#$`-``)``D`"0`R`#0`,P`-``T`"0!4`&@`90!R`&4` M80!F`'0`90!R``D`"0`)`#$`+``Q`#(`,0`-``T`"0`D``D`,@`L`#0`,``X M`!,``5<`80!R`'(`80!N`'0`>0`@`$\`8@!L`&D`9P!A`'0`:0!O`&X`'@`! M5P!A`'(`<@!A`&X`=`!Y`"``3P!B`&P`:0!G`&$`=`!I`&\`;@`@`%L`00!B M`',`=`!R`&$`8P!T`%T`(``!5P!A`'(`<@!A`&X`=`!Y`"``3P!B`&P`:0!G M`&$`=`!I`&\`;@`@`%L`5`!E`'@`=``@`$(`;`!O`&,`:P!=`'D%`0T`#0`- M`$X`;P!T`&4`(``Q`#,`(``@`%<`80!R`'(`80!N`'0`>0`@`$\`8@!L`&D` M9P!A`'0`:0!O`&X`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``;P!F`&8`90!R M`',`(`!A`"``=P!A`'(`<@!A`&X`=`!Y`"``;P!N`"``=@!A`'(`:0!O`'4` M0`@`&(`90`@`&D`;@!C`'4`<@!R`&4`9``@`'4`;@!D M`&4`<@`@`&D`=`!S`"``=P!A`'(`<@!A`&X`=`!I`&4`0`@`&D`;@`@ M`'0`:`!E`"``80!M`&\`=0!N`'0`(`!O`&8`(`!S`'4`8P!H`"``8P!O`',` M=`!S`"``80!T`"``=`!H`&4`(`!T`&D`;0!E`"``=`!H`&4`(`!P`'(`;P!D M`'4`8P!T`"``:0!S`"``0!S M`"``=P!A`'(`<@!A`&X`=`!Y`"``;`!I`&$`8@!I`&P`:0!T`'D`(`!I`&X` M8P!L`'4`9`!E`"``=`!H`&4`(`!N`'4`;0!B`&4`<@`@`&\`9@`@`'4`;@!I M`'0`0`@`&,`;`!A`&D`;0!S`"``80!N`&0`(`!C`&\` M0`@`'``90!R`&D`;P!D`&D`8P!A`&P`;`!Y`"``80!S`',`90!S`',` M90!S`"``=`!H`&4`(`!A`&0`90!Q`'4`80!C`'D`(`!O`&8`(`!I`'0`0`@`&P`:0!A`&(` M:0!L`&D`=`!I`&4`0`@`'0` M:`!E`"``8P!L`&$`:0!M`"X`(`!4`&@`90`@`$,`;P!M`'``80!N`'D`(`!I M`&X`8P!L`'4`9`!E`',`(`!T`&@`90`@`&,`;P!V`&4`<@!E`&0`(`!C`&\` M0!S M`&D`0!S`"``<`!R`&\`9`!U`&,`=``@`'<`80!R`'(` M80!N`'0`:0!E`',`(`!D`'4`<@!I`&X`9P`@`'0`:`!E`"``=`!H`'(`90!E M`"``;0!O`&X`=`!H`',`(`!E`&X`9`!E`&0`(`!*`'4`;`!Y`"``,P`Q`"P` M(``R`#``,``Y`"``80!N`&0`(`!*`'4`;`!Y`"``,@`U`"P`(``R`#``,``X M`"``8P!O`&X`0`@`#,`,0`L`"``"0`)`$H`=0!L`'D`(``R`#4`+``@``T`#0`) M`#(`,``P`#D`"0`)`#(`,``P`#@`#0`-``D`0@!A`&P`80!N`&,`90`@`&$` M=``@`'0`:`!E`"``8@!E`&<`:0!N`&X`:0!N`&<`(`!O`&8`(`!T`&@`90`@ M`'``90!R`&D`;P!D`"``"0`)`"0`"0`S`#4`"0`)`"0`"0`T`#,`#0`-``D` M5P!A`'(`<@!A`&X`=`!Y`"``8P!L`&$`:0!M`',`(`!P`'(`;P!V`&D``!P`&4`;@!S`&4`(``H M`$D`;@!C`&\`;0!E`"D`+``@`&X`90!T`"D``4D`;@!T`&4`<@!E`',`=``@ M`$4`>`!P`&4`;@!S`&4`(``H`$D`;@!C`&\`;0!E`"D`+``@`&X`90!T`"`` M6P!!`&(``!P`&4`;@!S`&4`+P`H`$D`;@!C`&\` M;0!E`"D`+``@`&X`90!T`$D`;@!T`&4`<@!E`',`=``@`&D`;@!C`&\`;0!E M`"``80!N`&0`(`!I`&X`=`!E`'(`90!S`'0`(`!E`'@`<`!E`&X`0`@`#,`,0`L`"``,@`P`#``.0`@`&$`;@!D`"`` M2@!U`&P`>0`@`#(`-0`L`"``,@`P`#``.``@`&$`<@!E`"``80!S`"``9@!O M`&P`;`!O`'<`0`@`#,`,0`L`"``,@`P`#``.0`)``D`2@!U`&P`>0`@`#(` M-0`L`"``,@`P`#``.``-``T`"0!)`&X`=`!E`'(`90!S`'0`(`!I`&X`8P!O M`&T`90`)``D`)``)`"@`,P`X`"D`"0`)`"0`"0`H`#4`,@`I``T`#0`)`$D` M;@!T`&4`<@!E`',`=``@`&4`>`!P`&4`;@!S`&4`"0`)``D`,0`P`#0`"0`) M``D`.0`Y``T`#0`)`$D`;@!T`&4`/``;(`%R`&4`0`@`&$` M9`!J`'4`0`G M`',`(`!C`&$`@!E`&0`(`!G`&$`:0!N`"``;P!R M`"``;`!O`',`0!S`"``;P!N`"`` M:0!T`',`(`!O`'4`=`!S`'0`80!N`&0`:0!N`&<`(`!B`&\`<@!R`&\`=P!I M`&X`9P!S`"P`(`!I`&X`8P!L`'4`9`!I`&X`9P`@`',`:`!O`'(`=``M`"`` M80!N`&0`(`!L`&\`;@!G`"T`=`!E`'(`;0`@`&D`;@!S`'0`<@!U`&T`90!N M`'0``!E`',`%P`!20!N`&,`;P!M`&4`(`!4 M`&$`>`!E`',`(`!;`$$`8@!S`'0`<@!A`&,`=`!=`!D``4D`;@!C`&\`;0!E M`"``5`!A`'@`90!S`"``6P!4`&4`>`!T`"``0@!L`&\`8P!K`%T`3P8!#0`- M``T`3@!O`'0`90`@`#$`-0`@`"``20!N`&,`;P!M`&4`(`!4`&$`>`!E`',` M1`!U`'(`:0!N`&<`(`!T`&@`90`@`'0`:`!R`&4`90`@`&T`;P!N`'0`:`!S M`"``90!N`&0`90!D`"``2@!U`&P`>0`@`#,`,0`L`"``,@`P`#``.0`L`"`` M=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``<@!E`&,`;P!R`&0`90!D`"``80`@ M`"0`-P`@`&T`:0!L`&P`:0!O`&X`(`!B`&4`;@!E`&8`:0!T`"``80!S`',` M;P!C`&D`80!T`&4`9``@`'<`:0!T`&@`(`!)`'(`:0!S`&@`(`!R`&4```@`'(`90!T`'4`<@!N`',`(`!A`&X`9``@`&,`:`!A`&X`9P!E M`',`(`!T`&\`(`!U`&X`8P!E`'(`=`!A`&D`;@`@`'0`80!X`"``<`!O`',` M:0!T`&D`;P!N`"``<@!E`',`90!R`'8`90!S`"X`(`!4`&@`90!S`&4`(`!T M`&$`>``@`&$`9`!J`'4`0`@`#,`,0`L M`"``,@`P`#``.0`L`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`',`(`!G`'(` M;P!S`',`(`!U`&X`<@!E`&,`;P!G`&X`:0!Z`&4`9``@`'0`80!X`"``8@!E M`&X`90!F`&D`=`!S`"``:0!N`&,`<@!E`&$`0!S`"``=0!N`'(`90!C`&\`9P!N M`&D`>@!E`&0`(`!T`&$`>``@`&(`90!N`&4`9@!I`'0``!I`&T`80!T M`&4`;`!Y`"``)``T`#``,@`@`&T`:0!L`&P`:0!O`&X`(`!W`&\`=0!L`&0` M(`!I`&T`<`!A`&,`=``@`'0`:`!E`"``0P!O`&T`<`!A`&X`>0!S`"``90!F M`&8`90!C`'0`:0!V`&4`(`!T`&$`>``@`'(`80!T`&4`+@`@`%0`:`!E`"`` M0P!O`&T`<`!A`&X`>0`@`&,`;P!N`'0`:0!N`'4`90!S`"``=`!O`"``<@!E M`&,`;P!R`&0`(`!T`&@`90`@`&P`:0!A`&(`:0!L`&D`=`!Y`"``9@!O`'(` M(`!U`&X`<@!E`&,`;P!G`&X`:0!Z`&4`9``@`'0`80!X`"``8@!E`&X`90!F M`&D`=`!S`"``80!S`"``80`@`&P`;P!N`&<`+0!T`&4`<@!M`"``;`!I`&$` M8@!I`&P`:0!T`'D`(`!A`',`(`!I`'0`(`!D`&\`90!S`"``;@!O`'0`(`!E M`'@`<`!E`&,`=``@`',`:0!G`&X`:0!F`&D`8P!A`&X`=``@`'``80!Y`&T` M90!N`'0`0`@`'<`:0!L`&P`(`!C`&\` M;@!T`&D`;@!U`&4`(`!T`&\`(`!R`&4`8P!O`&<`;@!I`'H`90`@`&D`;@!T M`&4`<@!E`',`=``@`&$`;@!D`"``<`!E`&X`80!L`'0`:0!E`',`(`!R`&4` M;`!A`'0`90!D`"``=`!O`"``:0!N`&,`;P!M`&4`(`!T`&$`>``@`&T`80!T M`'0`90!R`',`(`!I`&X`(`!T`&@`90`@`'``<@!O`'8`:0!S`&D`;P!N`"`` M9@!O`'(`(`!I`&X`8P!O`&T`90`@`'0`80!X`&4`0`@`&D`;@`@`'0`:`!E`"``8P!U`'(`<@!E`&X`=``@`&\`<@`@ M`&P`;P!N`&<`+0!T`&4`<@!M`"``80!C`&,`<@!U`&4`9``@`&D`;@!C`&\` M;0!E`"``=`!A`'@`90!S`"``:0!N`"``=`!H`&4`(`!C`&\`;@!D`&4`;@!S M`&4`9``@`&,`;P!N`',`;P!L`&D`9`!A`'0`90!D`"``8@!A`&P`80!N`&,` M90`@`',`:`!E`&4`=`!S`"P`(`!A`',`(`!A`'``<`!R`&\`<`!R`&D`80!T M`&4`+@!!`',`(`!O`&8`(`!*`'4`;`!Y`"``,P`Q`"P`(``R`#``,``Y`"P` M(`!T`&@`90!R`&4`(`!H`&$`=@!E`"``8@!E`&4`;@`@`&X`;P`@`&,`:`!A M`&X`9P!E`',`(`!T`&\`(`!S`&D`9P!N`&D`9@!I`&,`80!N`'0`(`!U`&X` M<@!E`',`;P!L`'8`90!D`"``;0!A`'0`=`!E`'(```@`&$`=0!T`&@`;P!R`&D`=`!I`&4`0`@`&0`:0!L`'4`=`!I`'8`90`@`&,`;P!M`&T` M;P!N`"``0`@`&0`:0!L`'4`=`!I`'8` M90`@`',`:`!A`'(`90!S`"``;P!F`"``8P!O`&T`;0!O`&X`(`!S`'0`;P!C M`&L`(`!I`&X`8P!L`'4`9`!E`"``0!E`&$`<@`@`#(`,``Q`#``+``@`'0`:`!E`"``0P!O`&T`<`!A M`&X`>0`@`&$`9`!O`'``=`!E`&0`(`!&`%,`4``@`$4`20!4`$8`(`!.`&\` M+@`@`#``,P`M`#8`+0`Q`"X`(`!3`&4`90`@`$X`;P!T`&4`(``S`"``9@!O M`'(`(`!A`&0`9`!I`'0`:0!O`&X`80!L`"``:0!N`&8`;P!R`&T`80!T`&D` M;P!N`"``<@!E`&<`80!R`&0`:0!N`&<`(`!T`&@`90`@`&$`9`!O`'``=`!I M`&\`;@`@`&\`9@`@`$8`4P!0`"``10!)`%0`1@`@`$X`;P`N`"``,``S`"T` M-@`M`#$`+@`@`%``<@!E`',`90!N`'0`90!D`"``8@!E`&P`;P!W`"``:0!S M`"``80`@`'(`90!C`&\`;@!C`&D`;`!I`&$`=`!I`&\`;@`@`&(`90!T`'<` M90!E`&X`(`!B`&$`0`@`#,`,0`L`"``"0`)`$H`=0!L`'D`(``R`#4`+``@``T`#0`)`"@` M0!E M`&4`(`!R`&4``!I`&T`80!T`&4`;`!Y`"``-@`T`&T` M:0!L`&P`:0!O`&X`(`!A`&X`9``@`#(`,@`@`&T`:0!L`&P`:0!O`&X`(`!C M`&\`;0!M`&\`/``;(`%N`"``0`L`"`` M80!S`"``=`!H`&4`(`!E`'@`90!R`&,`:0!S`&4`(`!P`'(`:0!C`&4`(`!O M`&8`(`!T`&@`;P!S`&4`(`!O`'``=`!I`&\`;@!S`"``=P!A`',`(`!G`'(` M90!A`'0`90!R`"``=`!H`&$`;@`@`'0`:`!E`"``80!V`&4`<@!A`&<`90`@ M`&T`80!R`&L`90!T`"``<`!R`&D`8P!E`"``9@!O`'(`(`!T`&@`90`@`'`` M90!R`&D`;P!D`"P`(`!R`&4`0`@`#,`,0`L`"``,@`P M`#``.0`@`&$`;@!D`"``2@!U`&P`>0`@`#(`-0`L`"``,@`P`#``.``L`"`` M8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`(`!E`'$`=0!I`'8`80!L`&4`;@!T M`',`(`!R`&4`;`!A`'0`90!D`"``=`!O`"``=`!H`&4`(`!#`&\`;0!P`&$` M;@!Y`',`(``D`#0`+@`T`#``,``@`&(`:0!L`&P`:0!O`&X`(`!O`&8`(`!3 M`&4`;@!I`&\`<@`@`$,`;P!N`'8`90!R`'0`:0!B`&P`90`@`$X`;P!T`&4` M0!S`"``0`@`&\`9@`@`&$` M8P!T`&D`=@!I`'0`>0`@`&8`;P!R`"``90!A`&,`:``@`&,`;P!M`'``;P!N M`&4`;@!T`"``;P!F`"``80!C`&,`=0!M`'4`;`!A`'0`90!D`"``;P!T`&@` M90!R`"``8P!O`&T`<`!R`&4`:`!E`&X`@!E`&0`(`!'`&$`:0!N`"\`*`!, M`&\``!C`&@`80!N M`&<`90`@`$0`90!R`&D`=@!A`'0`:0!V`&4```@`&(`90!N`&4`9@!I`'0`(`!O`&X`(`!T M`&@`90`@`'4`;@!R`&4`80!L`&D`>@!E`&0`(`!L`&\``!C`&@`80!N`&<`90`@`&0`90!R`&D`=@!A M`'0`:0!V`&4``!T`"``0@!L`&\`8P!K`%T`?`8!#0`- M``T`3@!O`'0`90`@`#$`.``@`"``4P!T`&\`8P!K`"T`0@!A`',`90!D`"`` M0P!O`&T`<`!E`&X`0`@`&4`;`!E`&,`=`!E`&0`(`!T M`&@`90`@`&T`;P!D`&D`9@!I`&4`9``M`'``<@!O`',`<`!E`&,`=`!I`'8` M90`@`&T`90!T`&@`;P!D`"``;P!F`"``80!D`&\`<`!T`&D`;@!G`"``4P!& M`$$`4P`@`$X`;P`N`"``,0`R`#,`*`!2`"D`+``@`'4`;@!D`&4`<@`@`'<` M:`!I`&,`:``@`'``<@!I`&\`<@`@`'``90!R`&D`;P!D`',`(`!W`&4`<@!E M`"``;@!O`'0`(`!R`&4`=`!R`&\`80!C`'0`:0!V`&4`;`!Y`"``<@!E`',` M=`!A`'0`90!D`"X`(`!4`&@`90`@`'``<@!O`'8`:0!S`&D`;P!N`',`(`!O M`&8`(`!3`$8`00!3`"``3@!O`"X`(``Q`#(`,P`H`%(`*0`@`&$`<`!P`&P` M>0`@`'0`;P`@`&$`=P!A`'(`9`!S`"``9P!R`&$`;@!T`&4`9``@`&$`9@!T M`&4`<@`@`'0`:`!E`"``00!P`'(`:0!L`"``,@`Y`"P`(``R`#``,``V`"`` M90!F`&8`90!C`'0`:0!V`&4`(`!D`&$`=`!E`"X`(`!3`'0`;P!C`&L`+0!B M`&$``!P`&4` M;@!S`&4`(`!F`&\`<@`@`'0`:`!E`"``;@!O`&X`+0!V`&4`@!E`&0`(`!O`'8`90!R`"``=`!H`&4`(`!R`&4`;0!A`&D`;@!I M`&X`9P`@`',`90!R`'8`:0!C`&4`(`!P`&4`<@!I`&\`9``@`'4`@!E`&0`(`!F M`&\`<@`@`'0`:`!E`"``=`!H`'(`90!E`"``;0!O`&X`=`!H`',`(`!E`&X` M9`!E`&0`(`!*`'4`;`!Y`"``,P`Q`"P`(``R`#``,``Y`"``80!N`&0`(`!* M`'4`;`!Y`"``,@`U`"P`(``R`#``,``X`#H`#0`-``T`"0!4`&@`<@!E`&4` M(`!M`&\`;@!T`&@`0`@`#(`-0`L`"``#0`-``D`*`!I`&X`(`!M`&D` M;`!L`&D`;P!N`',`*0`)`#(`,``P`#D`"0`)`#(`,``P`#@`#0`-``D`4P!T M`&\`8P!K`"``;P!P`'0`:0!O`&X`0!E`&4`(`!S`'0`;P!C`&L`(`!P`'4`<@!C`&@`80!S`&4`(`!P`&P`/``; M(`%A`&X`"0`)``D`-0`)``D`"0`U``T`#0`)`%0`;P!T`&$`;``@`',`=`!O M`&,`:P`M`&(`80!S`&4`9``@`&,`;P!M`'``90!N`',`80!T`&D`;P!N`"`` M90!X`'``90!N`',`90`)``D`)``)`#8`,@`)``D`)``)`#4`-0`-``T`#0`) M`$,`;P!S`'0`(`!O`&8`(`!P`'(`;P!D`'4`8P!T`',`(`!S`&\`;`!D``D` M"0`D``D`-P`)``D`)``)`#<`#0`-``D`4@!E`',`90!A`'(`8P!H`"``80!N M`&0`(`!D`&4`=@!E`&P`;P!P`&T`90!N`'0`(`!E`'@`<`!E`&X`0`@`',`<`!O`&X`0`@`'``;`!A`&X`0`@`&$`;`!L`"``50`N`%,` M+@`@`&4`;0!P`&P`;P!Y`&4`90!S`"``80!N`&0`(`!M`&$`;@!Y`"``90!M M`'``;`!O`'D`90!E`',`(`!O`'4`=`!S`&D`9`!E`"``=`!H`&4`(`!5`"X` M4P`N`"``5`!H`&4`(`!N`&4`=``@`'``90!R`&D`;P!D`&D`8P`@`&(`90!N M`&4`9@!I`'0`(`!C`&\`0`@`#(`-0`L`"``"0`) M`$H`=0!L`'D`(``S`#$`+``@``D`"0!*`'4`;`!Y`"``,@`U`"P`(``)``D` M2@!U`&P`>0`@`#,`,0`L`"``"0`)`$H`=0!L`'D`(``R`#4`+``@``T`#0`) M`"@`:0!N`"``;0!I`&P`;`!I`&\`;@!S`"D`"0`R`#``,``Y``D`"0`R`#`` M,``X``D`"0`R`#``,``Y``D`"0`R`#``,``X``D`"0`R`#``,``Y``D`"0`R M`#``,``X``T`#0`)`%,`90!R`'8`:0!C`&4`(`!C`&\`@!A`'0`:0!O`&X`(`!O M`&8`(`!N`&4`=``@`&$`8P!T`'4`80!R`&D`80!L`"``;`!O`',``!P`&4`;@!S`&4`(`!F`'(`;P!M`"`` M=`!H`&4`0!E`&$`<@`@`#(`,``P`#D` M(`!R`&4``!T`"``0@!L M`&\`8P!K`%T`@`P!#0`-``T`3@!O`'0`90`@`#(`,``@`"``0P!O`&X`=`!I M`&X`9P!E`&X`8P!I`&4``!P`&4`;@!D`&D`=`!U`'(`90!S`"``;P!R`"``<@!E`',`=0!L M`'0`(`!I`&X`(`!L`&\`0`@`&D`;@`@`'0`:`!E`"``8P!O M`&X`0!E`'0`:``@`&$`;@!D`"``0P!O`'(`9`!I`',`(`!#`&\`<@!P M`&\`<@!A`'0`:0!O`&X`3P!N`"``1@!E`&(`<@!U`&$`<@!Y`"``,@`R`"P` M(``R`#``,``X`"P`(`!7`'D`90!T`&@`(`!A`&X`9``@`$,`;P!R`&0`:0!S M`"``0P!O`'(`<`!O`'(`80!T`&D`;P!N`"``*`!#`&\`<@!D`&D`0`L`"``80!L`&P` M90!G`&D`;@!G`"``=`!H`&$`=``@`$T`90!D`'0`<@!O`&X`:0!C`',`(`!% M`&X`9`!E`&$`=@!O`'(`(`!D`'(`=0!G`"T`90!L`'4`=`!I`&X`9P`@`',` M=`!E`&X`=``@`&D`;@!F`'(`:0!N`&<`90!S`"``=`!H`'(`90!E`"``50`N M`%,`+@`@`$T`;P!R`'(`:0!S`"``<`!A`'0`90!N`'0``!C`&P`=0!S`&D`=@!E`&P`>0`@`&P`:0!C`&4` M;@!S`&4`9``@`'0`;P`@`$,`;P!R`&0`:0!S`"X`(`!4`&@`90`@`$,`;P!M M`'``80!N`'D`(`!I`',`(`!I`&X`9`!E`&T`;@!I`&8`:0!E`&0`(`!F`&\` M<@`@`'0`:`!E`"``8P!L`&$`:0!M`',`(`!M`&$`9`!E`"``8@!Y`"``5P!Y M`&4`=`!H`"``80!N`&0`(`!#`&\`<@!D`&D``!P`&4`;@!S`&4`(`!R`&4`;`!A`'0`90!D`"``=`!O`"`` M9`!A`&T`80!G`&4`0`@`'``<@!O M`&(`80!B`&P`90`@`&\`<@`@`'(`90!A`',`;P!N`&$`8@!L`'D`(`!E`',` M=`!I`&T`80!B`&P`90`@`'4`;@!D`&4`<@`@`%,`1@!!`%,`(`!.`&\`+@`@ M`#4`+@!,`&D`=`!I`&<`80!T`&D`;P!N`"``=P!I`'0`:``@`$$`8@!B`&\` M=`!T`"``0P!A`'(`9`!I`&\`=@!A`',`8P!U`&P`80!R`"``4P!Y`',`=`!E M`&T`0`@`#(`-P`L`"``,@`P`#`` M.0`L`"``30!E`&0`=`!R`&\`;@!I`&,`(`!A`&X`;@!O`'4`;@!C`&4`9``@ M`&<`;`!O`&(`80!L`"``<@!E`',`;P!L`'4`=`!I`&\`;@`@`&\`9@`@`&$` M;`!L`"``;P!U`'0```@`',`90!T M`'0`;`!E`&T`90!N`'0`(`!A`&T`;P!U`&X`=``@`&D`;@!C`&P`=0!D`&4` M0`@`%,`<`!I`&X`90`@`"@` M9@!O`'(`;0!E`'(`;`!Y`"``1`!E`%``=0!Y`"\`00!C`'(`;P!-`&4`9``I M`"P`(`!A`"``0`@`&\`9@`@`$H`;P!H`&X` M0`I`"``9@!I`&P`90!D M`"```!T`"``0@!L`&\`8P!K`%T`/P@!#0`-``T`3@!O`'0`90`@`#(`,0`@`"`` M4P!E`&<`;0!E`&X`=``@`&$`;@!D`"``1P!E`&\`9P!R`&$`<`!H`&D`8P`@ M`$D`;@!F`&\`<@!M`&$`=`!I`&\`;@!3`&4`9P!M`&4`;@!T`"``:0!N`&8` M;P!R`&T`80!T`&D`;P!N`#H`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``9@!U M`&X`8P!T`&D`;P!N`',`(`!I`&X`(`!S`&4`=@!E`&X`(`!O`'``90!R`&$` M=`!I`&X`9P`@`',`90!G`&T`90!N`'0`0!S`&D`;P`M`$,`;P!N`'0`<@!O`&P`+@!%`&$`8P!H`"``;P!F`"`` M=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`',`(`!O`'``90!R`&$`=`!I`&X`9P`@ M`',`90!G`&T`90!N`'0`0!S`&D`;P`M`$,`;P!N`'0`<@!O`&P`(`!I`&X`=`!O`"``80!N M`"``:0!N`&0`90!P`&4`;@!D`&4`;@!T`"P`(`!P`'4`8@!L`&D`8P!L`'D` M(`!T`'(`80!D`&4`9``@`&,`;P!M`'``80!N`'D`+@`@`$@`;P!W`&4`=@!E M`'(`+``@`&$`0`@`#(`,``P`#<`+``@`&$`(`!V`&\`;`!U M`&X`=`!A`'(`>0`@`',`=0!S`'``90!N`',`:0!O`&X`(`!O`&8`(`!5`"X` M4P`N`"``0!S`&D`;P`M M`$,`;P!N`'0`<@!O`&P`(`!P`'(`;P!D`'4`8P!T`',`(`!M`&$`;@!U`&8` M80!C`'0`=0!R`&4`9``@`&$`=``@`&D`=`!S`"``9@!A`&,`:0!L`&D`=`!Y M`"``:0!N`"``4@!E`&0`;0!O`&X`9``L`"``5P!A`',`:`!I`&X`9P!T`&\` M;@`@`&D`;@`@`&\`<@!D`&4`<@`@`'0`;P`@`&$`9`!D`'(`90!S`',`(`!Q M`'4`80!L`&D`=`!Y`"``0!S`"``<`!L`&$`;@!S`"`` M=`!O`"``<`!U`'(`0!E`&$`<@`@`#(`,``Q`#``+@`@`$$`0`N``T`#0`-``D`1P!E`&\`9P!R`&$`<`!H`&D`8P`@`&D`;@!F`&\` M<@!M`&$`=`!I`&\`;@`)``D`"0`)``D`#0`-``T`"0!.`&4`=``@`',`80!L M`&4``!T`&4`<@!N`&$`;``@`&,`=0!S`'0`;P!M`&4` M<@!S`"``8@!Y`"``9P!E`&\`9P!R`&$`<`!H`'D`(`!A`'(`90`@`&$`0`@`#(`-0`L`"``#0`-``D`*`!I`&X`(`!M`&D` M;`!L`&D`;P!N`',`*0`)`#(`,``P`#D`"0`)`#(`,``P`#@`#0`-``D`50!N M`&D`=`!E`&0`(`!3`'0`80!T`&4```!I#@``?M!!UP`<`$0"``#<``X`.``.`!P`'``<`!P` M'``<`!P`'``^`A(`M@``````0```````````````H``$`&0`9``=``\``P`` M``````$`````````[P`&````-P````H````)"!````80`$88S0?!@```!@(` M``L"%````````````!4`````````O;@!``T``@`!``P``@!D``\``@`!`!$` M`@```!``"`#\J?'236)0/U\``@`!`"H``@```"L``@```((``@`!`(``"``` M`````````"4"!````/\`@0`"`,$$%````!4```"#``(```"$``(```"A`"(` M"0!D``$``0`!`$8`6`)8`@```````.`_````````X#\!`%4``@`(`'T`#``` M````MCP/````!`!]``P``0`"`+88#P````0`?0`,``,`_P`D"0\````$```" M#@``````%0```````P````@"$`````````#_`````````0\`"`(0``$````" M`/\````````!#P`(`A```@``````_P````````$/``@"$``#`````@#_```` M`````0\`"`(0``0``````/\````````!#P`(`A``!0````(`_P````````$/ M``@"$``&`````@#_`````````0\`"`(0``<````"`/\````````!#P`(`A`` M"`````(`_P````````$/``@"$``)`````@#_`````````0\`"`(0``H````" M`/\````````!#P`(`A``"P````(`_P````````$/``@"$``,`````@#_```` M`````0\`"`(0``T````"`/\````````!#P`(`A``#@````(`_P````````$/ M``@"$``/`````@#_`````````0\`"`(0`!`````"`/\````````!#P`(`A`` M$0````(`_P````````$/``@"$``2`````@#_`````````0\`"`(0`!,````" M`/\````````!#P`(`A``%`````(`_P````````$/`/T`"@``````%P`=```` M_0`*``$````7`!X```#]``H``0`!`!<`"@```/T`"@`!``(`%P`?````_0`* M``(````6`"````#]``H``P```!@`(0```+T`$@`#``$`'@``NJY`'@``]*Q` M`@#]``H`!````!8`(@```/T`"@`%````&``C````O0`2``4``0`=```PCD`= M``"XBD`"`/T`"@`&````&``D````O0`2``8``0`=```@=T`=``!`=$`"`/T` M"@`'````&``E````O0`2``<``0`=``!@E4`=``"8E$`"`/T`"@`(````&``F M````O0`2``@``0`=````3T`=````6$`"`/T`"@`)````&``G````O0`2``D` M`0`=``#`>T`=```````"`/T`"@`*````&``H````O0`2``H``0`=````6$`= M``#@8D`"`/T`"@`+````&``I````O0`2``L``0`=``"`4$`=``"`1T`"`/T` M"@`,````&``J````O0`2``P``0`@``!8JD`@``#.I4`"`/T`"@`-````&``K M````O0`2``T``0`@``"(@4`@``"8C$`"`/T`"@`.````&``L````O0`2``X` M`0`=````74`=````:$`"`/T`"@`/````&``M````O0`2``\``0`A``#0>T`A M``"8AD`"`/T`"@`0````&``N````O0`2`!```0`<``$`1$`<``$`4$`"`/T` M"@`1````&``O````O0`2`!$``0`<``$`1$`<``$`4$`"`/T`"@`2````&``P M`````P(.`!(``0`?`&9F9F9F8I%`?@(*`!(``@`?`(%X^T#]``H`$P```!@` M,0````,"#@`3``$`'P!F9F9F9FJ10'X""@`3``(`'P`AH?M`_0`*`!0````8 M`#(```!^`@H`%``!`!P``8`T0`,"#@`4``(`'`"J\=)-8A#(/]<`+@!Z!``` MD`$.`"H`#@`D``X`)``D`"0`)``D`"0`)``D`"0`)``D`"0`)``N`"X`/@(2 M`+8``````$```````````````*``!`!D`&0`'0`/``,````````!```````` M`.\`!@```#<````*````"0@0```&$`!&&,T'P8````8"```+`A@````````` M```H`````````.3``0#D`"`/T`"@`2````&`!&````O0`2`!(``0`@ M`(`%UT`@```)UT`"`/T`"@`3````%@!'````_0`*`!0````8`$@```"]`!(` M%``!`!T``)"$0!T``%"`0`(`_0`*`!4````8`$D```"]`!(`%0`!`!T``%!W M0!T``.!W0`(`_0`*`!8````8`$H```"]`!(`%@`!`!T``+"$0!T``"B,0`(` M_0`*`!<````8`$L```"]`!(`%P`!`!T``,!>0!T``$!@0`(`_0`*`!@````8 M`$P```"]`!(`&``!`!T``)"40!T``/"20`(`_0`*`!D````8`$T```"]`!(` M&0`!`"```'BH0"```):H0`(`_0`*`!H````8`$X```"]`!(`&@`!`!T``*.X M0!T``&VX0`(`_0`*`!L````8`$\```"]`!(`&P`!`!T``/!U0!T``)!T0`(` M_0`*`!P````8`%````"]`!(`'``!`!T``%!^0!T``+!]0`(`_0`*`!T````8 M`%$```"]`!(`'0`!`!T```!/0!T``,!<0`(`_0`*`!X````8`%(```"]`!(` M'@`!`!T``$!70!T``,!50`(`_0`*`!\````8`%,```"]`!(`'P`!`"```%_$ M0"```%/$0`(`UP!$`*X&``!L`@X`*@`.`"0`)``D`"0`)``D`"0`#@`D`"0` M)``D`"0`)``D`"0`#@`D`"0`)``D`"0`)``D`"0`)``D`"0`"`(0`"`````" M`/\````````!#P`(`A``(0``````_P````````$/``@"$``B`````@#_```` M`````0\`"`(0`",````"`/\````````!#P`(`A``)`````(`_P````````$/ M``@"$``E`````@#_`````````0\`"`(0`"8````"`/\````````!#P`(`A`` M)P````(`_P````````$/`/T`"@`@````&`!4````_0`*`"```0`;`%4```#] M``H`(``"`!L`50```/T`"@`A````%@!6````_0`*`"(````8`%<```"]`!(` M(@`!`!T``````!T```````(`_0`*`",````8`%@```"]`!(`(P`!`!T``,!; M0!T```!<0`(`_0`*`"0````8`%D```"]`!(`)``!`!T`@-W)0!T``.S)0`(` M_0`*`"4````8`%H```"]`!(`)0`!`!T``$!JP!T``$!IP`(`_0`*`"8````8 M`%L```"]`!(`)@`!`"```*S)0"```+_)0`(`_0`*`"<````8`%P```"]`!(` M)P`!`"$`@`770"$```G70`(`UP`4`+`!``",`"H`#@`D`"0`)``D`"0`/@(2 M`+8``````$```````````````*``!`!D`&0`'0`/``,````````!```````` M`.\`!@```#<````*````"0@0```&$`!&&,T'P8````8"```+`A0````````` M```&`````````&'%`0`-``(``0`,``(`9``/``(``0`1``(````0``@`_*GQ MTDUB4#]?``(``0`J``(````K``(```""``(``0"```@````````````E`@0` M``#_`($``@#!!!0````5````@P`"````A``"````H0`B``D`9``!``$``0!& M`%@"6`(```````#@/P```````.`_`0!5``(`"`!]``P``````+8\#P````0` M?0`,``$``@"V&`\````$`'T`#``#`/\`)`D/````!````@X```````8````` M``,````(`A``````````_P````````$/``@"$``!`````@#_`````````0\` M"`(0``(``````/\````````!#P`(`A```P````(`_P````````$/``@"$``$ M`````@#_`````````0\`"`(0``4````"`/\````````!#P#]``H``````!<` M70```/T`"@`!````%P`>````_0`*``$``0`7`%X```#]``H``0`"`!<`7P`` M`/T`"@`"````%@!@````_0`*``,````8`&$```"]`!(``P`!`!X``(!/0!X` M`(!.0`(`_0`*``0````8`&(```"]`!(`!``!`!X```#P/QX```#P/P(`_0`* M``4````8`&,```"]`!(`!0`!`!P``0`D0!P``0`D0`(`UP`0`"H!``!D``X` M*@`.`"0`)``^`A(`M@``````0```````````````H``$`&0`9``=``\``P`` M``````$`````````[P`&````-P````H````)"!````80`$88S0?!@```!@(` M``L"&````````````"D`````````/LT!`&C/`0`-``(``0`,``(`9``/``(` M`0`1``(````0``@`_*GQTDUB4#]?``(``0`J``(````K``(```""``(``0"` M``@````````````E`@0```#_`($``@#!!!0````5````@P`"````A``"```` MH0`B``D`9``!``$``0!&`%@"6`(```````#@/P```````.`_`0!5``(`"`!] M``P``````+8\#P````0`?0`,``$``@"V&`\````$`'T`#``#`/\`)`D/```` M!````@X``````"D```````,````(`A``````````_P````````$/``@"$``! M`````@#_`````````0\`"`(0``(``````/\````````!#P`(`A```P````(` M_P````````$/``@"$``$``````#_`````````0\`"`(0``4````"`/\````` M```!#P`(`A``!@````(`_P````````$/``@"$``'`````@#_`````````0\` M"`(0``@````"`/\````````!#P`(`A``"0````(`_P````````$/``@"$``* M`````@#_`````````0\`"`(0``L``````/\````````!#P`(`A``#`````(` M_P````````$/``@"$``-`````@#_`````````0\`"`(0``X````"`/\````` M```!#P`(`A``#P````(`_P````````$/``@"$``0`````@#_`````````0\` M"`(0`!$````"`/\````````!#P`(`A``$@````(`_P````````$/``@"$``3 M``````#_`````````0\`"`(0`!0````"`/\````````!#P`(`A``%0````(` M_P````````$/``@"$``6`````@#_`````````0\`"`(0`!<````"`/\````` M```!#P`(`A``&`````(`_P````````$/``@"$``9`````@#_`````````0\` M"`(0`!H``````/\````````!#P`(`A``&P````(`_P````````$/``@"$``< M`````@#_`````````0\`"`(0`!T````"`/\````````!#P`(`A``'@````(` M_P````````$/``@"$``?`````@#_`````````0\`_0`*```````7`&0```#] M``H``0```!<`-````/T`"@`!``$`%P`*````_0`*``$``@`7`!\```#]``H` M`@```!8`90```/T`"@`#````&``M````O0`2``,``0`>``#0>T`>``"8AD`" M`/T`"@`$````%@!F````_0`*``4````8`&<```"]`!(`!0`!`!T``(!G0!T` M`*!E0`(`_0`*``8````8`&@```"]`!(`!@`!`!T``(!%0!T```!#0`(`_0`* M``<````8`&D```"]`!(`!P`!`!T````@0!T````80`(`_0`*``@````8`&H` M``"]`!(`"``!`!T```!10!T````(P`(`_0`*``D````8`&L```"]`!(`"0`! M`!T```!/0!T``(!+0`(`_0`*``H````8`&P```"]`!(`"@`!`!T``````!T` M```FP`(`_0`*``L````6`&T```#]``H`#````!@`;@```+T`$@`,``$`'0`` M`#U`'0```$5``@#]``H`#0```!@`.@```+T`$@`-``$`'0``@$'`'0``@$W` M`@#]``H`#@```!@`;P```+T`$@`.``$`'0```&'`'0``0%3``@#]``H`#P`` M`!@`<````+T`$@`/``$`'0```/"_'0``@%M``@#]``H`$````!@`)P```+T` M$@`0``$`'0``P'M`'0```````@#]``H`$0```!@`<0```+T`$@`1``$`'0`` MX'[`'0``(&C``@#]``H`$@```!@`<@```+T`$@`2``$`(```:(-`(````(E` M`@#]``H`$P```!8`SV3````!0```` M`P````$````H````````@#`````$````.````````````````@```+`$```3 M````"00``!\````(`````!B`'(`;````/[_```%`@(````````` M``````````````(````"U XML 36 R25.xml IDEA: Retirement Benefit Plans 1.0.0.3 false Retirement Benefit Plans false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_RetirementBenefitPlansAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 19 &#8211; Retirement Benefit Plans<br/>&#160;<br/>The Company sponsors various retirement benefit plans, including defined benefit pension plans (pension benefits), post-retirement medical plans (post-retirement benefits), defined contribution savings plans and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. The net periodic benefit cost of the pension and post-retirement medical plans include the following components for the three months ended July 31, 2009 and July 25, 2008:</p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td width="190" height="17" align="center"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2" >&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>U.S. Pension Benefits</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="157" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Non-U.S. Pension Benefits</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>Post-Retirement Benefits</b></font></td></tr><tr><td width="190" height="17" align="center"><font size="2">&#160;</font></td><td width="12" height="17" align="center"><font size="2">&#160;< /font></td><td colspan="5" width="156" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="157" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td><td width="12" height="17" align="center"><font size="2">&#160;</font></td><td colspan="5" width="156" height="17" align="center" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;"><font size="2"><b>Three months ended</b></font></td></tr><tr><td width="190" height="17" align="left"><font size="2">&#160;</font></td><td rowspan="2" width="12" height="34" align="center"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="13" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17 " align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 31, </b></font></td><td width="12" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-top: 1px solid #000000;"><font size="2"><b>July 25, </b></font></td></tr><tr><td width="190" height="17" align="left"><font size="2"><b>(in millions)</b></font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></ font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" sty le="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td colspan="2" width="72" height="17" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2008&#160;</b></font></td></tr><tr><td width="190" height="18" align="left"><font size="2">Service cost</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;15&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td widt h="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;18&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;8&#160;</f ont></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;3&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="60" height="18" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Interest cost</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td wid th="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;17&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;15&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;5&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</ font></td><td width="60" height="17" align="right"><font size="2">&#160;6&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;4&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;3&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Expected return on plan assets</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="1 2" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(25)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(24)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(6)</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td wid th="60" height="17" align="right"><font size="2">&#160;(6)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(2)</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right"><font size="2">&#160;</font></td><td width="60" height="17" align="right"><font size="2">&#160;(3)</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Amortization of net actuarial loss</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom : 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;1&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font> ;</td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2"> &#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Net periodic benefit cost</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-to p: 1px solid #000000;"><font size="2">&#160;10&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;6&#160;</font></td><td width="13" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;8&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="righ t" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;5&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="190" height="17" align="left"><font size="2">Special termination benefits</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font>&l t;/td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;7&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="13" height="17" align="left"><font size ="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;2&#160;</font></td><td width="12" height="17" align="left"><font size="2">&#160;</font></td><td width="12" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="60" height="17" align=" right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;-&#160;</font></td></tr><tr><td width="190" height="35" align="left"><font size="2">Total cost for period</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;14&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="b order-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;10&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;6&#160;</font></td><td width="13" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;8&#160;</fon t></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;7&#160;</font></td><td width="12" height="35" align="left"><font size="2">&#160;</font></td><td width="12" height="35" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="60" height="35" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">&#160;4&#160;</font></td></tr><tr><td width="190" height="18" align="left"><font size="2">&#160;< /font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></t d><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="13" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td width="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="12" height="18" align="left"><font size="2">&#160;</font></td><td wid th="12" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td><td width="60" height="18" align="left" style="border-top: 3px double #000000;"><font size="2">&#160;</font></td></tr></table></div><div><font size="2"><p>As a result of the fiscal year 2009 restructuring initiative that began in the fourth quarter of fiscal year 2009, the Company has recognized special termination benefits in the three months ended July 31, 2009 related to employees electing to accept early retirement packages provided under the restructuring initiatives. The incremental expense from these special termination benefits is reflected in the table&#160;above. See Note 6 for additional information regarding the fiscal year 2009 restructuring initiative. <br/></p></font></div></body></html> Note 19 &#8211; Retirement Benefit Plans&#160;The Company sponsors various retirement benefit plans, including defined benefit pension plans (pension false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 37 R7.xml IDEA: Basis of Presentation 1.0.0.3 false Basis of Presentation false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_BasisOfPresentationAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>&#160;Note 1 &#8211; Basis of Presentation<br/>&#160;<br/>The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, financial condition and cash flows in conformity with U.S. GAAP. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the results of Medtronic, Inc. and its subsidiaries (Medtronic or the Company) for the periods presented. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. For further information, refer to the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended April 24, 2009.<br/><br/>All prior periods presented have been retrospectively adjusted for the impact of the adoption of Financial Accounting Standards Board (FASB) Staff Position (FSP) Accounting Principles Board (APB) Opinion No. 14-1, &#8220;Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)&#8221; (FSP APB No. 14-1), and FSP Emerging Issues Task Force (EITF) Issue No. 03-6-1, &#8220;Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities&#8221; (FSP EITF No. 03-6-1) (see Note 3).<br/><br/>The Company has evaluated its subsequent events through September 9, 2009, the filing date of the Company&#8217;s Quarterly Report on Form&#160;10-Q for the period ended July&#160;31, 2009.<br/>&#160;<br/>The Company&#8217;s fiscal years 2010, 2009 and 2008 will end or ended on April 30, 2010, April 24, 2009 and April 25, 2008, respectively.<br/></p></font></div></body></html> &#160;Note 1 &#8211; Basis of Presentation&#160;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 38 R17.xml IDEA: Inventories 1.0.0.3 false Inventories false 1 $ false false PerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 2 0 mdt_InventoriesAbstract mdt false na duration string No definition available. false false false false false true false false false 1 false false 0 0 false false No definition available. false 3 1 us-gaap_InventoryDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false 1 false false 0 0 <html><head><meta content="text/html; charset=utf-8" /></head><body><div><font size="2"><p>Note 11 &#8211; Inventories<br/><br/>Inventories are stated at the lower of cost or market, with cost determined on a first-in, first-out basis. Inventory balances are as&#160;follows:<br/></p></font></div><div><table style="border-collapse: collapse; margin-top: 20px;"><tr><td rowspan="2" width="530" height="31" align="left"><font size="2"><b>(in millions)</b></font></td><td rowspan="2" width="16" height="31" align="center"><font size="2">&#160;</font></td><td colspan="2" width="83" height="15" align="center"><font size="2"><b>July 31, </b></font></td><td width="14" height="15" align="left"><font size="2">&#160;</font></td><td colspan="2" width="84" heigh t="15" align="center"><font size="2"><b>April 24,</b></font></td></tr><tr><td colspan="2" width="83" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td><td width="14" height="16" align="left"><font size="2">&#160;</font></td><td colspan="2" width="84" height="16" align="center" style="border-bottom: 1px solid #000000;"><font size="2"><b>2009&#160;</b></font></td></tr><tr><td width="530" height="17" align="left"><font size="2">Finished goods</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="65" height="17" align="right" style="border-top: 1px solid #000000;"&g t;<font size="2">884&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="left" style="border-top: 1px solid #000000;"><font size="2">$</font></td><td width="65" height="17" align="right" style="border-top: 1px solid #000000;"><font size="2">854&#160;</font></td></tr><tr><td width="530" height="17" align="left"><font size="2">Work in process</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right"><font size="2">&#160;</font></td><td width="65" height="17" align="right"><font size="2">262&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right">< ;font size="2">&#160;</font></td><td width="65" height="17" align="right"><font size="2">251&#160;</font></td></tr><tr><td width="530" height="17" align="left"><font size="2">Raw materials</font></td><td width="16" height="17" align="left"><font size="2">&#160;</font></td><td width="18" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="65" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">346&#160;</font></td><td width="14" height="17" align="left"><font size="2">&#160;</font></td><td width="19" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size="2">&#160;</font></td><td width="65" height="17" align="right" style="border-bottom: 1px solid #000000;"><font size= "2">321&#160;</font></td></tr><tr><td width="530" height="18" align="left"><font size="2">&#160;&#160;&#160;&#160;&#160;Total</font></td><td width="16" height="18" align="left"><font size="2">&#160;</font></td><td width="18" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="65" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">1,492&#160;</font></td><td width="14" height="18" align="left"><font size="2">&#160;</font></td><td width="19" height="18" align="left" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">$</font></td><td width="65" height="18" align="right" style="border-top: 1px solid #000000;border-bottom: 3px double #000000;"><font size="2">1,426&#160;</font></td></tr></table></div></body></html> Note 11 &#8211; InventoriesInventories are stated at the lower of cost or market, with cost determined on a first-in, first-out basis. Inventory balances are false false No definition available. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true
-----END PRIVACY-ENHANCED MESSAGE-----